Science Based Authentication of Dietary Supplements: Studies on the Chemical Constituents, Analytical Method and Biological Activities of Scutellaria Spp and Pfaffia Paniculata by Li, Jing
University of Mississippi 
eGrove 
Electronic Theses and Dissertations Graduate School 
2010 
Science Based Authentication of Dietary Supplements: Studies on 
the Chemical Constituents, Analytical Method and Biological 
Activities of Scutellaria Spp and Pfaffia Paniculata 
Jing Li 
Follow this and additional works at: https://egrove.olemiss.edu/etd 
 Part of the Plant Sciences Commons 
Recommended Citation 
Li, Jing, "Science Based Authentication of Dietary Supplements: Studies on the Chemical Constituents, 
Analytical Method and Biological Activities of Scutellaria Spp and Pfaffia Paniculata" (2010). Electronic 
Theses and Dissertations. 179. 
https://egrove.olemiss.edu/etd/179 
This Dissertation is brought to you for free and open access by the Graduate School at eGrove. It has been 
accepted for inclusion in Electronic Theses and Dissertations by an authorized administrator of eGrove. For more 
information, please contact egrove@olemiss.edu. 
SCIENCE BASED AUTHENTICATION OF DIETARY SUPPLEMENTS 
---STUDIES ON THE CHEMICAL CONSTITUENTS, ANALYTICAL METHOD AND 
BIOLOGICAL ACTIVITIES OF SCUTELLARIA SPP AND PFAFFIA PANICULATA 
KUNTZE 
 
 
 
 
A Dissertation 
presented in partial fulfillment of requirements 
for the degree of Doctor of Philosophy 
in the Department of Pharmacognosy 
The University of Mississippi 
 
 
 
 
JING LI 
Nov. 2010 
 ii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright © 2010 by Jing Li 
All rights reserved 
 
 iii 
ABSTRACT 
During the last decade, the use of herbal medicine has expanded globally and gained 
popularity.  With the tremendous expansion in the use of herbal medicine worldwide, safety and 
efficacy as well as quality control of herbal medicines have become more and more issues of 
concern for both health authorities and the public.  Although herbal medicine has been in use for 
hundreds to thousands years, very limited science-based data exist to explicit its chemical 
constituents, pharmacological activities and toxicity.  Therefore, lack of scientific evidence for 
herbal medicine usage elicits the need for systematic studies of herbal medicine, including 
phytochemical, analytical, and biological investigation 
Two projects are included in the dissertation.  The first one is the “Science Based 
Authentication of Dietary Supplements - Studies of Scutellaria Species on the Chemical 
Constituents, Analytical Method, and Biological Activities”.  The second project is the 
“Phytochemical Investigation of Pfaffia paniculata Kuntze”.  American skullcap (Scutellaria 
lateriflora L.), belonging to the family Labiatae, is native to North America and was used as a 
tonic, tranquilizing, and antispasmodic remedies.  Since 1989 safety concerns about American 
skullcap were raised due to the reports of hepatotoxic reactions after skullcap-containing 
preparations were ingested.  Therefore, this plant was listed in the FDA Poisonous Plant 
Database and has been classified as an “Herb of Undefined Safety”.  Meanwhile, it was reported 
to be adulterated with germander, e.g. Teucrium chamaedry, and T. canadense, which is a group 
of plants with hepatotoxicity.  Very few studies have been previously reported associated with 
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the quality control, toxicity investigation, and pharmacological activities of this herbal medicine 
as well as compounds isolated from it.  The primary objective of this project is to explore the 
chemical constituents of American skullcap, which will be used as reference markers to develop 
a validated chemical fingerprinting method for the differentiation of it from its adulterant, 
germander.  From the MeOH extract of the aerial parts of this plant sixteen compounds, 
including three minor coumarins in which two are new, six flavonoids, four triterpenes, two 
steroids, and one fatty acid were isolated and characterized.  In order to compare the similarity of 
chemical components between American skullcap and Chinese skullcap (S. baicalensis), also to 
obtain more marker compounds, the chemical components of Chinese skullcap, which is the 
most often used herb medicine in this genus, were also studied and seventeen flavonoids have 
been isolated.  Based on the chemical constituents, a simple HPLC-PDA fingerprinting method 
was developed, which can be used to authenticate S. lateriflora species, to distinguish it from its 
potential adulterants, to compare the chemical profiles of related species in this genus, and to 
assess the quality of commercial products claiming to contain S. lateriflora.  In the present study 
three classes of compounds, including eleven flavonoids isolated from two Scutellaria species 
mentioned above and two phenylpropanoids, as well as one diterpene isolated from T. 
canadense, were used as markers simultaneously to provide comprehensive analysis for the 
above mentioned purposes.  As part of the efforts of this project, a HPLC/ESI-MS
n
 method was 
established which allowed a fast characterization of thirteen flavonoids and one stilbene 
derivative from American skullcap without time-consuming isolation of compounds even if 
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reference compounds are not available.  The biological activities of the two skullcap extracts and 
thirteen flavonoids isolated from them were evaluated on a panel of bioassays, including 
cytotoxicity, antioxidant, anti-inflammatory, estrogenic activity and activations on peroxisome 
proliferator-activated receptor-alpha and -gamma (PARP  and PPARγ).  Neither skullcap 
extracts nor pure compounds tested showed cytotoxicity against a panel of mammalian normal 
and solid tumor cell lines at the tested concentrations.  During the investigation of chemical 
constituents of American skullcap no neoclerodane diterpenes, which are responsible for the 
hepatotoxicity in germander (Kouzi et al., 1994), were found.  Taken together, these evidences 
suggest that the reports of hepatotoxic reactions on American skullcap might very likely be due 
to its adulterant germander.  In the present bioassay study, the most significant finding was the 
identification of PPARs activation of skullcap extracts as well as several characteristic 
flavonoids, such as baicalein, baicalin, wogonin, and chrysin etc. that provides some information 
on possible new application of skullcap, especially American skullcap, for the treatment of 
diabetic-related diseases.  Also the potent activity of these flavonoids on PPARs suggests the 
potential of these flavonoids as leads for PPARα and PPARγ agonists.  
P. paniculata Kuntze, belonging to the family Amaranthaceae, is a large, rambling, 
shrubby ground vine with an intricate, deep, and extensive root system.  It is the most employed 
species in commercial preparations in Brazil as “Brazilian ginseng” and has been commonly 
used for three centuries with the same indications as American and Asian ginseng.  More than 
fifty preparations, which contained or were produced from plant P. paniculata are available on 
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USA market, but no analytical method(s) existed to assess the quality of P. paniculata raw 
materials, and the products claiming to contain P. paniculata.  In order to develop an appropriate 
validated quantitative analytical method for the quality control of this plant material and dosage 
form the detailed phytochemical investigation of P. paniculata was carried out.  Two new 
nortriterpenoids pfaffine A and B, one new compound pfaffine C, along with eleven known 
compounds were isolated and identified from the roots of this plant.  These compounds will be 
used as markers for quality control of raw materials of P. paniculata as well as products claiming 
to contain this species. 
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Chapter 1 
Introduction 
 
1.1. General background  
Traditional medicine is the sum total of the knowledge, skills and practices based on the 
theories, beliefs and experiences indigenous to different cultures, whether explicable or not, used 
in the maintenance of health, as well as in the prevention, diagnosis, improvement or treatment 
of physical and mental illnesses (WHO definition).  It involves the use of herbal medicines, 
animal parts and minerals, among which herbal medicines are the most widely used.  The terms 
complementary/alternative medicine (CAM), non-conventional medicine are used 
interchangeably with traditional medicine in some countries.  During the last decade, use of 
traditional medicine has expanded globally and has gained popularity.  According to the World 
Health Organization (WHO), 80% of the population depends on traditional medicine for primary 
health care in some Asian and African countries.  In many developed countries, 70% to 80% of 
the population has used some form of alternative or complementary medicine (e.g. acupuncture).  
With the tremendous expansion in the use of herbal medicine worldwide, safety and efficacy as 
well as quality control of herbal medicines have become issues of concern for both health 
authorities and the public.  
The safety problems associated with herbal medicines may result from adverse effects of 
the herbs themselves and/or potential toxicity related to misidentification or mislabeling of the 
plant species used in herbal medicines; the use of incorrect parts of plants; adulteration and 
contamination with other plant species, undisclosed prescription or over-the-count drugs or 
 2 
heavy metals when the necessary naturally occurring plant substances are in short supply or 
expensive or when the supplier intends to intensify a specific pharmacologic effect.  In these 
cases science-based research is needed to provide solid evidence of questionable herbal 
medicines in order to ensure that traditional medicine is used properly.  
Several methods can be used to be certain that the correct plant species has been 
acquired.  These methods include taxonomic examination (macroscopic and/or microscopic) or 
biochemical [deoxyribonucleic acid (DNA) analysis using polymerase chain reaction (PCR) 
techniques] or chemical (chromatographic methods) analysis, or metabolomics study.  The 
taxonomic or genetic analysis can only be applied to intact or milled plants and are not possible 
for them to deal with plant extracts.  Under these circumstances chromatographic methods, 
including, but not limited to, high performance liquid chromatography (HPLC), gas 
chromatography (GC), capillary electrophoresis (CE), thin-layer chromatography (TLC), can be 
used. Among them HPLC coupled with different detectors, such as ultraviolet absorbance (UV) 
detector, evaporative light scattering detector (ELSD), or mass spectrometry (MS), are the most 
popularly used methods to identify plants used in the herbal medicines.  These methods 
commonly analyze a group of “active” molecules or arbitrarily chosen “marker” compounds in 
complex plant extracts.  Also, metabolomics can be applied to authenticate the plant raw 
materials as well as their products.  NMR and MS are currently considered to be the most 
universal approaches for metabolomics study.  Acquisition of a complete metabolite profile of a 
plant through metabolomics allows the identification of the plant species.  Some pioneer 
applications have been presented recently (Chio et al., 2004; Le Gall et al., 2004) 
1.2. Overview of the Scutellaria genus  
 3 
Scutelllaria is a unique cosmopolitan genus of the subfamily Scutellarioideae belonging 
to Labiatae (Lamiaceae) family.  About 360 species are found spread throughout the world and 
in different climate areas (Poton, 1992).  There are above 100 species in China and over 90 
species in North American. 
Essential oils, alcohols (derivatives of phenylethanol) and organic acids (esters and 
glycosides of vanillic, syringic, and ferulic acids), iridoids, sesquiterpenes, neoclerodane 
diterpenoids, steroids, cardenolides, tannins, and flavonoids have been isolated from the genus 
Scutellaria (Chemesova et al., 1993; Plant Resources of the USSR. 1991).  Among them 
phenolic compounds and clerodane diterpenoids are the main secondary metabolites reported.  
Malikov‟s group published a thorough summary of phenolic compounds isolated and identified 
from about 60 species in this genus up to 2002 (Malikov et al., 2002).  Additional new phenolic 
compounds have been reported from 2002 to 2010.  We have updated and summarized these data 
in Table 1-1.  These reported phenolic compounds include: flavones, flavanones, isoflavones, 
chalcones, biflavones, lignoflavones and phenylpropanoid glycosides.  The last one, so-called 
phenylpropanoids, are biogenetic precursors of flavonoids.  These compounds are known to 
contain reactive phenolic hydroxyls and carbonyls.  These groups of compounds are certainly 
interrelated and undergo mutual transformations (Mabry et al., 1975).  Owing to the ability to 
transform into chalcones and to form quinones, flavonoids are considered to be highly 
physiologically active compounds with a wide spectrum of pharmacological activities.  S. 
baicalensis is the most commonly used and thoroughly studied species in all aspects in this 
genus.  Sixty-four phenolic compounds have been isolated from this species.  Other species have 
been reported as rich sources of flavonoids including S. rivularis, S. indica, S. prastrata, S. 
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amoena, and S. discolor from which 38, 33, 29, 28, and 27 flavonoids have been isolated, 
respectively.  Neoclerodane diterpenoids are the other characteristic compounds in some species.  
Bruno et al. reviewed the neoclerodane diterpenoids isolated from this genus up to June 2001, 
and reported that 120 natural neoclerodane diterpenoids have been isolated from Scutellaria 
species.  Thereafter 27 additional new neoclerodane diterpenoids have been reported during 
2002-2010 and the data are compiled in Table 1-2.  Moreover, 22 new neo-clerodane diterpenoid 
alkaloids were reported from S. Barbata recently.  Among them, a few compounds have shown 
very potent activity against species of Lepidoptera, but whether this activity will be retained 
under field conditions is not known.  The responses of different species of insects to a specific 
neoclerodane vary and small changes to the structural composition of a molecule can 
significantly alter its activity (Bruno et al., 2002).  
Many species of this genus are extensively used in traditional medical systems of China, 
India, Korea, Japan, European countries, and North America.  Among them two species, 
including American skullcap (S. lateriflora L.) and Chinese skullcap (S. baicalensis Georgi) are 
the most popular ones with different medical uses, respectively.  Besides, Extracts of S. 
orientalis are used as anti-hypertensive agents (Zaprametov et al., 1988).  
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Table 1-1. The Species Studied and the Number of Phenolic Compounds Reported 
species number of 
compounds 
species number of 
compounds 
S. adenostegia Briq. 6 (15) S. orientalis L. 12 (6) 
S. adsurgens M. Pop. 4 (14) S. ovata Hill. 7 (7) 
S. alpina L. 20 (20) S. oxystegia Juz. 3 (3) 
S. altaica Fisch. ex. Sweet 1 (1) S. peregrina Ldb. 0 (1) 
S. altissima L. 11 (11) S. phyllostachya Juz. 16 (7)  
S. amoena C. H. Wright. 28 (16) S. planipes L. 21 (13) 
S. araxensis Grossh. 0 (5) S. polyodon Juz. 17 (13) 
S. baicalensis Georgi. 64 (62) S. prilipkoana Grossh. 0 (1) 
S. barbata D. Don. 16 (1) S. prostrata Jacq. et Benth. 29 (30) 
S. columnae L (All) 2 (2) S. przewalskii Juz. 17 (18) 
S. comosa Juz. 19 (14) S. pycnoclada Juz. 0 (16) 
S. creticola Juz. 10 (14) S. ramosissima M. Pop. 11 (11) 
S. discolor Colebr. 27 (23) S. rehderiana Diels. 10 (7) 
S. epilobiifolia A. Hamilt. 4 (10) S. repens Buch-Ham, ex D. 
Don 
14 (14) 
S. galericulata I. 4 (23) S. rivularis Wall. 38 (28) 
S. glabrata Vved. 6 (7) S. scandens Buch-Ham. ex 
D. Don. 
17 (16) 
S. granulosa Juz. 2 (2) S. scordifolia Fisch. ex 
Schrank 
2 (14) 
S. grossa Wall. 24 (19) S. sedelmeyeria Juz. 0 (3) 
S. ikonnikovii Juz. 7 (7) S. sevanensis Sosn. 19 (19) 
S. immaculata Nevski 25 (8) S. squarrosa Nevski 6 (6) 
S. incona Spreng. 0 (1) S. strigillosa Hemsl 15 (15) 
S. indica L. 36 (33) S. supina L. 0 (19) 
S. iskanderi Juz. 0 (10) S. tenax W. W. Smith. 9 (5) 
S. karjaginii Grossh 3 (3) S. tournefortii Benth. 0 (4) 
S. lateriflora L. 17 (1) S. transiliensis Juz. 0 (6) 
S. litwinowii Bornm. Et. Sint. 7 (10) S. ussuriensis (Regel) Kubo 2 (2) 
S. nepetoides M. Pop. 4 (4) S. virularis Wall 0 (2) 
S. ocellata Juz. 7 (7) S. viscidulla Bunge 13 (7) 
S. oreophila Grossh. 5 (5) 57 species 635 
The number in parenthesis indicates the data reported by Malikov‟s group. 
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Table 1-2. The Number of Neoclerodane Diterpenoid Reported in Scutellaria Species  
species number of 
compounds 
species number of 
compounds 
S. albida L. 7 S. hematochlora 1 
S. alpine L. 19 S. lateriflora L. 5 
S. alpine L.ssp. 
javalambrensis Pau. 
8 S. linearis Benth. 4 
S. altissima L. 2 Scutellaria parvula Michx. 1 
S. baicalensis Georgi. 1 S. orientalis ssp. pinnatifida 5 
S. barbata D. Don. 23 S. orientalis ssp sintenisii 
Sausskn. ex Bornm. 
2 
Scutellaria luteo-caerulea 
Bornm. & Sint. 
5 S. polyodon Juz. 15 
S. columnae L (All) 8 S. pontica C. Koch 9 
S. cypria Rech. fil. var. 
cypria 
3 S. repens Buch-Ham, ex D. 
Don 
16 
S. cypria Rech. var. elatior 
R. D. Meikle 
1 S. rivularis Wall. 11 
S. discolor Colebr. 13 Scutellaria rubicunda 
Hornem ssp linneana 
(Carnel) Rech. 
2 
S. drummondii Benth. 3 S. seleriana Loesen 1 
S. galericulata I. 8 S. violacea Heyne ex Wall. 2 
S. grossa Wall. 6 S. woronowii Juz. 2 
S. guatemalensis 4   
 
American skullcap is native to North America.  It was introduced into American 
medicine in 1773 by Dr. Lawrence Van Derveer who used it to treat cases of hydrophobia.  The 
name of mad-dog herb stems from this.  Subsequently, it came to be utilized primarily for its 
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reputed tonic, tranquilizing, and antispasmodic remedies.  It was introduced officially in The 
United States Pharmacopia in the edition of period from 1863 to 1916 and then in The National 
Formulary until it was dropped in 1947 (Claus, 1956). In America, skullcap is regulated as a 
dietary supplement (DS).  Since 1989 safety concerns of skullcap were raised.  A report in the 
British Medical Journal summarized the observed hepatotoxic effects of the herb in four women 
who had been consuming proprietary products supposedly containing skullcap for the relief of 
stress (MacGregor et al., 1989).  Two cases of “skullcap” poisoning, including one fatality, were 
reported from the Risk Hospital in Oslo, Norway, in 1991 (Huxtable, 1992).  This plant was 
listed in the FDA Poisonous Plant Database (FDA, 2008) and has been classified as an “Herb of 
Undefined Safety” (Awad et al., 2003). Studies in Britain showed that many wholesalers there 
were substituting germander for skullcap (Phillipson et al, 1984).  Germander is a group of 
Teucrium species, e.g. T. chamaedry, and T. canadense.  The capsules containing germander 
were marketed in France as a weight-control supplement and were associated with thirty cases of 
hepatotoxicity (Pittler et al., 2003).  Germander was banned in France and Italy in 1992.  The 
only approved use for germander in United State is as a natural flavoring in alcoholic beverages.  
The toxicological studies have shown that one of the major neoclerodane diterpenes in 
germander, teucrin A, is responsible for the hepatotoxicity.  The furan ring moiety of this 
diterpene is the key for toxicity.  When it was reduced to tetrahydrofuran the hepatotoxicity 
disappeared (Kouzi et al., 1994).  American Herbal Products Association (AHPA) recommends 
that appropriate steps be taken to assure that skullcap raw materials are free of the noted 
adulterant, germander. 
The root of S. baicalensis is used as a well known traditional Chinese medicine called 
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“Huang Qin”.  It was documented in an ancient Chinese herbal, “Shen-Nong-Ben-Cao-Jing”, as 
a remedy for suppurative dermatitis, diarrhea and inflammatory diseases, and is officially listed 
in the Chinese Pharmacopeia and Japanese Pharmacopeia JPXIII.  Traditional Chinese 
physicians use it as a remedy for fever, allergic disease and inflammation, especially against 
bacterial and viral infections of the respiratory and gastrointestinal tract, i. e., chronic bronchitis, 
bacillary dysentery, viral hepatitis, and acute biliary tract infection.  Other species, such as S. 
amoena C. H. Wright, S. hypericifolia Levl. S. tenax W. W. Smith var patentipillosa (N.-M.) G. 
Y. Wu, S. rehderiana Diels. S. viscidula Bge., and S. likiangensis Diels., have been used as 
substitute as “Huang Qin” in China (Song et al., 1981).  Over 60 phenolic compounds were 
isolated from S. baicalensis.  Only one diterpene was reported from it (Hussein et al., 1996).  The 
plant extract as well as some of  the phenolic compounds isolated from it demonstrated diverse 
bioactivities, including antitumor, antiviral, anti-inflammatory, antibacterial, antiallergic, 
antioxidant, and anti-SARS coronavirus activities.  But data associated with these bioactivities 
are scattered over a huge volume of literature.  Here we give a comprehensive review of the 
diverse bioactivities of S. baicalensis, the phenolic compounds isolated from it, and preparations 
containing this plant species.  
Anticancer activity 
The root extract of S. baicalensis (SBE) has a broad spectrum of anticancer activity.  It 
inhibits various cancer cell growths, including hepatocellular carcinoma, cholangiocarcinoma 
(Yano et al, 1994), pancreatic carcinoma (Motoo et al, 1994), urothelial carcinoma (Ikemoto et 
al, 2000) and breast cancer (So et al, 1997).  The results of these early investigations were 
substantiated by a series of studies.  Ye et al. demonstrated that SBE exhibited a concentration-
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dependent growth inhibitory effects on squamous cell carcinoma (KB, SCC-25), prostate cancer 
(PC-3, LNCaP), colon cancer (KM-12, HCT-15), breast cancer (MCF-7) and liver cancer 
(HepG2).  The inhibition concentration at 50% (IC50) for PC-3, LNCaP, MCF-7, KB, HepG2, 
KM-12, SCC-25, HCT-15 was 0.52, 0.82, 0.9, 1.0, 1.1, 1.1, 1.2, 1.5 mg/mL, respectively.  
Different types of cancers have different sensitivity to the effect of this herb, with prostate and 
breast cancer being most sensitive (Ye et al., 2002).  Because SBE has a strong anti-
inflammatory effect, Zhang et al. tested its anticancer activity on head and neck squamous cell 
carcinoma (HNSCC) in vitro and in vivo and investigated its effect on cyclooxygenase-2 (COX-
2), which converts arachidonic acid to prostaglandin E2 (PGE2) and is highly expressed in 
HNSCC.  They found the production of PGE2 was strongly inhibited by SBE in a dose-
dependent manner.  These findings suggested that the anticancer activity of SBE can be 
attributed, in part, to its inhibitory effect on PGE2 production via suppression of COX-2 
expression and arachidonic acid release from cell membrane (Zhang et al., 2003).  Further they 
evaluated SBE as an anti-cancer agent both in vitro (in androgen-dependent and androgen-
independent cell lines) and in vivo (in nude mice xengrafted with prostate cancer cells) and to 
explore its ability to affect both COX-2 and cell cycle regulation pathway.  The study, together 
with others (Bonham et al., 2005), demonstrated that SBE inhibits androgen-independent 
prostate cancer cells (PC-3) more strongly than it ihibits androgen-dependent cells (LCNaP), 
which could be viable alternative therapy to prostate cancer patients who fail to respond to 
conventional hormone-based treatment.  Another study showed that SBE inhibited the 
proliferation of lymphocytic leukemia, lymphoma and myeloma cell lines by induction of 
apoptosis associated with the modulation of the bc1 family of genes and mitochondrial damage.  
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These results suggested that SBE is a potential anti-cancer agent against these hematological 
malignancies (Kumagai et al., 2007). 
On the other hand, SBE showed potent activity in combined treatment with standard 
anticancer therapeutics as a biological modulator.  SBE pretreatment decreased cisplatin-induced 
kaolin intake in the rat model of simulated nausea.  It may play a therapeutic role in 
chemotherapy-induced emesis (Aung et al., 2003).  
S. baicalensis contains three major flavonoids, baicalein, baicalin and wogonin.  The 
anticancer activity of these compounds have been screened in different cell types (Chang et al., 
2001; Ikemoto et al., 2000; Lee et al., 2005; Ma et al., 2005; Sonoda et al., 2004).  Taken 
together, the differences in the anti-cancer activities of these flavonoids in different cell lines, in 
part, may be cell type specific.  For example, several studies implicated 12-lipoxygenase (12-
LOX) as a regulator of human cancer development.  As a 12-LOX inhibitor, baicalein
 
has been 
shown to induce apoptosis in human gastric, breast, colon, hepatoma, prostate, and pancreatic 
cancer cells (Chan et al, 2000; Chen et al, 2000; Ding et al, 1999; Kuntz et al, 1999; Po et al, 
2002; Wong et al, 2001).  One study showed that baicalein exerted a concentration-dependent, 
growth-inhibitory effect on three cell lines of human hepatocellular carcinoma (HCC).  Baicalein 
strongly inhibited the activity of topoisomerase II and suppressed the proliferation of all three 
cell lines after administration 6 h (Matsuzaki et al., 1996).  The mechanisms of antiproliferative 
effect of baicalein and related compounds, baicalin, wogonin, esculetin and scoparone, in human 
T-lymphoid leukemia cells (CEM cells) were investigated.  The results demonstrated that 
baicalein exhibited the greatest antiproliferative activity with an IC50  value of 4.7  0.5 μM and 
a maximal suppression of 91.5  1.4 % in CEM cells.  The protein tyrosine kinase activity in the 
 11 
CEM cells was significantly reduced by baicalein (10
-6
-10
-4
 M).  The reverse transcription-
polymerase chain reaction analysis of messenger ribonucleic acid (RNA) levels of platelet-
derived growth factor-A (PDGF-A) and transforming growth factor-β1 (TGF-β1) demonstrated 
that baicalein reduced the PDGF-A messenger RNA (mRNA) level, while less affected the TGF-
β1 mRNA.  Baicalein exhibited the greater reduction on the expression of PDGF-A mRNA than 
esculetin did (Huang et al., 1994).  So, antiproliferative effect of baicalein may be partly 
mediated through inhibition of growth-related signal, protein tyrosine kinase, and reduction of 
expression of growth factor, PDGF-A.  Baicalein also inhibited growth by suppressing the COX-
2 expression resulting in decreased levels of PGE2 of two HNSCC cell lines SCC-25 and KB 
(Zhang et al., 2003).  Others have shown that baicalin stimulated activator protein-1 (AP-1) and 
nuclear factor-κB (NF-κB) to induce expression of quinone reductase gene; this enzyme may be 
able to act as a potential cancer chemopreventive agent by induction of phase II detoxification 
enzyme (Park, H.J. et al., 2004).  Besides baicalin, wogonin has shown to have an apoptosis-
inducing activity against human monocytic leukemia cell line THP-1, but not in human fetal lung 
normal cells (Himeji et al., 2007). 
Antiviral activities 
SBE as well as its flavonoids showed anti-human immunodeficiency virus -1 (HIV-1), 
anti-hepatitis B (anti-HBV), and anti-respiratory syncytial virus (anti-RSV) activities 
(Buimovici-Klein et al., 1990; Ono et al., 1990). 
Baicalein was found to be a potent inhibitor of the activities of reverse transcriptases 
(RT) of murine leukemia viruses (MLV) and HIV.  Under the reaction conditions specified for 
each of the MLV- and HIV- reverse transcriptases, both enzyme activities were inhibited by 
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more than 90% in the presence of 2 μg/mL baicalein (Ono, K., 1989). 
Baicalin produced concentration-dependent inhibition of human T-lymphotropic virus 
type-1 (HTLV-1) replication in productively infected T and B cells.  Moreover, baicalin 
treatment selectively reduced the detectable levels of HTLV-1 p19 gag protein in infected cells 
by 70% at concentrations that produced insignificant effects on total cellular protein and DNA 
synthesis with no loss in cell viability.  Resistance to HTLV-1 infection and virus-mediated 
transformation was noted in uninfected peripheral blood lymphocytes pretreated with baicalin 
before cocultivation with lethally irradiated chronically infected cells.  Baicalin inhibited reverse 
transcriptase activity in HTLV-1-infected cells as well as the activity of purified reverse 
transcriptase from Moloney murine leukemia virus and Rous-associated virus type-2 (Baylor et 
al., 1992). 
The inhibitory effect of baicalin against HIV-1 infection and replication has been studied 
in vitro (Kitamura et al., 1998; Li et al., 1993).  The results showed that baicalin markedly 
inhibited replication of HIV-1 in a concentration-dependent manner in normal peripheral blood 
mononuclear cells (PBMC) stimulated with phytohemagglutinin (PHA).  The effect was more 
pronounced when the cells were pretreated with baicalin.  Further, baicalin inhibited HIV-1 
replication in PHA-stimulated PBMC from asymptomatic HIV-1-seropositive carries.  The 50% 
inhibitory concentration for HIV-1 replication was approximately 0.5 μg/mL.  At a concentration 
of 2 μg/mL of baicalin, copy numbers of HIV-1 proviral DNA were approximately 50 times less 
than in untreated controls.  In a cell-free infection system, baicalin inhibited the activity of HIV-
1 reverse transcriptase, but not the activity of human DNA polymerases α and γ (DNA 
polymerase β was slightly inhibited).  It also did not inhibit HIV-2 or murine leukemia virus RT.  
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The mechanism of its anti-HIV-1 activity remains to be determined.  Another study 
demonstrated that baicalin, at the noncytotoxic concentrations, inhibited both T cell topic (X4) 
and monocyte topic (R5) HIV-1 Env protein mediated fusion with cells expressing CD4/CXCR4 
or CD4/CCR5.  Furthermore, presence of baicalin at the initial stage of HIV-1 viral adsorption 
blocked the replication of HIV-1 early strong stop DNA in cells.  Since baicalin did not inhibit 
binding of HIV-1 gp 120 to CD4, it was proposed that baicalin may interfere with the interaction 
of HIV-1 Env with chemokine correceptors and block HIV-1 entry of target cells (Li et al., 
2000).  Baicalin coupling with Zn exhibited lower cytotoxicity and higher anti-HIV-1 activity 
without changing its target on HIV-1 RT and on HIV-1 entry compared with baicalin in vitro 
(Wang Q. et al., 2004).  Combination therapy for AIDs patients has been studied.  Synergistic 
anti-HIV effects of baicalin with 3′-Azido-2′, 3′-dideoxythymidine (AZT) have been reported 
(Inada et al., 1994), suggesting that baicalin might be potentially useful as part of a drug 
combination regimen for the treatment of HIV-1 infections. 
The difference in HIV-1 reverse transcriptase inhibitory activity between baicalein and 
baicalin has been examined.  The results indicated that HIV-1 reverse transcriptase inhibitory 
activity of baicalein was four times higher than baicalin (Wu et al., 2001).  The studies of 
structure-activity relationship revealed that the presence of both the unsaturated double bond 
between 2 and 3 of the flavonoid pyrone ring, and the three hydroxyl groups introduced on 
positions 5, 6 and 7, were a prerequisite for the inhibition of reverse transcriptase activity.  In 
general, the presence of substituents (hydroxyl and halogen) in the B-ring increase toxicity 
and/or decrease activity (Hu et al., 1994; Ono et al., 1990).  Lee et al investigated the in vitro 
effects of baicalein and baicalin on the three distinctive enzymic activities of the HIV-1 integrase 
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- endonucleolytic, integration, and disintegration activity.  They found that both compounds 
inhibited the three enzymatic activities in a dose-dependent manner.  The 50% inhibitory 
concentrations of baicalein and baicalin for endonucleolytic activities of HIV-1 integrase were 
4.4, 3.3 and 25.9, 4.0 μM, respectively.  In general, baicalein exhibited nearly 6- to 10-fold 
stronger inhibition than baicalin for the three enzymic activities.  These data demonstrated that 
baicalein or baicalin can be used as a leading compound to develop anti-acquired immune 
deficiency syndrome (anti-AIDS) chemotherapeutic agents targeting the HIV-1 integrase (Lee 
M.J. et al, 2003). 
SBE displayed anti-HBV effects at non-toxic dose, with inhibition percentage of 
41.3±2.5 (p<0.001).  Further study showed that the three major components (i.e., baicalein, 
baicalin, and wogonin) extracted from S. baicalensis displayed the most effective anti-HBsAg 
activities with inhibition percentage of 14.6±2.9, 19.5±3.4, and 45.4±2.7 respectively, at a dose 
of 20 µg/mL.  Only wogonin can suppress HBV surface antigen production (p<0.001) without 
evidence of cytotoxicity.  The latter action was confirmed by measuring an endogenous HBV 
DNA polymerase repairing activity, since both the relaxed circular and linear forms of HBV 
DNA are significantly reduced in the wogonin-treated group (Huang et al., 2000). 
70% EtOH extract of S. baicalensis showed potent antiviral activities against RSV with 
IC50 22.8 μg/mL and with selective index (SI=IC50/CC50) 1.7.  Further purification of the active 
extract of S. baicalensis led to the identification of wogonin and oroxylin A as the most potent 
anti-RSV components.  Their IC50 values were 7.4 μg/mL and 14.5 μg/mL, and SI values were 
16.1 and 4.0, respectively (Ma et al., 2002).  This data offered scientific support and chemical 
basis for the traditional uses of this herb to relieve viral infection in the upper respiratory tract.  
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Anti-inflammatory activity 
The methanol extracts of S. baicalensis, S. rivularis and their major constituents, 
including baicalein, baicalin and wogonin, possessed anti-inflammatory activity in vivo in 
several animal models of inflammation, including carrageenan-induced paw edema and 
adjuvant-induced arthritis in rats (Krakauer et al., 2001; Kubo et al., 1984; Lin et al., 1996; Park 
S. et al., 2004).  The anti-inflammatory action has been reported to be partly due to inhibition of 
leukotriene synthesis by lipooxygenase in leukocyte (Butenko et al., 1993; Kimura et al., 1987).  
Further investigations showed that these flavonoids possessed the inhibitory effects of 
cyclooxygenase-2 and inducible NO synthase (iNOS) expression in the lipopolysaccharide 
(LPS)-stimulated mouse macrophage cell line, RAW 264.7 (Chi et al., 2001; Kim et al., 1999; 
Wakabayshi et al., 2000).  Among them, wogonin was found to be one of the most potent 
suppressors.  Wogonin produced dose-dependent inhibitory effects on 12-O-
tetradecanoylphorbol-13-acetate (TPA) induced COX-2 expression, and prostaglandin E2 (PGE2) 
production on the dorsal skin of mice.  When applied topically (250-1000 μg/3 days) to the 
dorsal skin of mice, wogonin inhibited COX-2 expression and PGE2 production induced by 
multiple treatment with TPA.  At a dose of 200 μg/site/treatment, wogonin caused 55.3% 
reduction of PEG2 production on the dorsal skin compared with an increased production in the 
ATP-treated control group.  It also significantly inhibited mouse ear edema induced by TPA in 
both preventive (58.1% inhibition) as well as curative treatment (31.3% inhibition) schedules at 
200 μg/ear/treatment.  Also wogonin exhibited preventive effect against ethanol-induced gastric 
mucosal damage in rats by either anti-inflammatory effects through dual actions on arachidonic 
acid metabolism, i.e., induction of prostaglandin D2 and suppression of 5S-
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hydroxyeicosatetraenoic acid (5S-HETE), or preventive induction of profuse apoptosis in the 
stomach (Park, S. et al., 2004).  Wogonin was the only flavonoid proved to down-regulate COX-
2 expression in mouse skin induced by TPA treatment (Park et al., 2001).  In addition to 
inhibition of inflammation-associated enzymes, such as cyclooxygenases (COX) and 
lipoxygenases, these flavonoids have been found to regulate the expression level of several 
inflammation-associated genes.  For instance, baicalin inhibited the production of various 
cytokines from human peripheral blood mononuclear cells induced by super-antigen treatment 
(Krakauer et al., 2001).  Wogonin was also found to possess significant suppression on several 
inflammatory-associated genes expression in intact as well as in the TPA-induced inflamed 
mouse skin.  It potently reduced COX-2 and tumor necrosis factor (TNF)-а gene expression 
while intercellular adhesion molecule (ICAM)-1 and interleukin (IL)-1β were weakly affected.  
Therefore, from these results, it is suggested that the modulation of preinflammatory gene 
expression may be one of the in vivo action mechanisms of anti-inflammation by wogonin.  
Investigations reported, all together, give a scientific basis for using Scutellairae species as a 
source for anti-inflammatory agents (Chi et al., 2003).  
Antioxidant activity 
SBE could inhibit lipid peroxidation in rat liver homogenate (Kimura et al., 1981) and in 
beef heart mitochondria (Hodnick et al., 1994).  Antioxidant effects of SBE have been traced to 
several of its flavones, which include baicalein, wogonin, scullcapflavone I and II (Kimura et al., 
1982; Takaji et al., 1980).  Several results suggested that baicalein could inhibit iron-dependent 
lipid peroxidation in microsomes (Gao et al., 1995).  It was suggested that baicalein might be 
exerting its protective effect through chelation of metals.  Baicalein could also scavenge reactive 
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oxygen species (ROS) such as hydroxyl radicals (·OH), superoxide anion radicals (·O2
-
) 
(Hamada et al., 1993) and singlet oxygens (Criado et al., 1995).  When a hypoxanthine (HX)-
xanthine oxidase (XOD) system was used for generation of O2
-
, baicalein inhibited XOD 
(Hanasaki et al., 1994).  This observation is consistent with an early study (Chang et al., 1993), 
in which baicalein behaved as a non-competitive inhibitor of XOD.  Further direct free radical 
scavenging abilities of baicalein, baicalin, wogonin and wogonin glucuronide were examined by 
electron spin resonance (ESR) spectrometry method.  The results showed that the direct free 
radical scavenging abilities of the four flavonoids decreased in the order of baicalein > baicalin > 
wogonin > wogonin glucuronide.  Baicalein and baicalin were shown to protect several types of 
tissues against damage caused by ROS.  With an o-di-hydroxyl group in the A ring, baicalein and 
baicalin are much better free radical scavenger than wogonin and wogonoside.  The direct free 
radical scavenging abilities of baicalein and baicalin on alkyl radical and 2,2-diphenyl-l-
picrylhydrazyl (DPPH) radical suggested that flavonoid with o-di-hydroxyl structure in the A 
ring was an effective radical scavenger (Gao et al., 1998; 1999; 2000).  Morimoto et al identified 
a mechanism capable of consuming large amount of H2O2 via a peroxidase reaction that oxidizes 
baicalein to 6,7-dehydrobaicalein (Morimoto et al., 1998).  Kim et al reported that S. baicalensis 
prevented neuronal cell death in the hippocampal CA 1 region induced by a four-vessel 
occlusion (Kim et al., 2001), and attenuated apoptosis by inhibiting protein oxidation in a H2O2-
treated neuronal cell line (Choi et al., 2002).  Based on the radical quenching and antioxidative 
effects, baicalein could inhibit hippocampal neuronal death induced by 5 min of cerebral 
ischemia in gerbils (Hamada et al., 1993), and baicalin, as a biological response modifier, 
promoted the repair of DNA single strand breakage caused by H2O2 in cultured NIH3T3 
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fibroblasts (Chen X. et al., 2003).  Also, wogonin was reported to have a protective effect on 
neuronal cells damaged by oxygen and glucose deprivation in rat hippocampal slices in culture 
(Son et al., 2004), and could inhibit ischemic brain injury in a rat model of permanent middle 
cerebral artery occlusion (Choi et al., 2002).  In addition, baicalein as well as baicalin could 
reduce cytotoxicity of amyloid β protein in PC12 cells, possibly by reduction of oxidative stress; 
hence these flavonoids may be useful in the chemoprevention of Alzheimer‟s disease (Heo et al., 
2004).  
Antibacterial activity 
The water extracts of S. baicalensis were found to have growth-inhibition activity against 
Salmonella typhimurium.  The mechanism might be due to the fact that SBE could stimulate the 
transcription of polyphosphate kinase, especially, in the early growth-stage of S. typhimurium
 
(Hahm et al, 2001).  
In 1981, five flavonoids, including baicalein, baicalin and wogonin etc. isolated from S. 
baicalensis, were tested against several strains of bacteria, including Escherichia coli IFO 3301, 
Saracina lutae RIMD 3232, Bacillus subtilis IAM 1521, and Staphylococcus aureus 209P.  It 
was found that compound VIII [2(S)-5,7,2′,6′-tetrahydroxyflavanone] and baicalein had 
antibacterial activity at a concentration of 250 μg/ mL (Kubo et al., 1981).  Although baicalin 
used alone showed only moderate antibacterial activity against Staphylococcus aureus, 
significant synergistic activities against both methicillin-resistant Staphylococcus aureus 
(MRSA) and penicillin resistant S. aureus in combination with β-lactams were observed.  When 
combined with 16 μg/mL baicalin, minimum inhibitory concentrations (MICs) of benzypenicillin 
against methicillin-resistant Staphylococcus aureus (MRSA) and penicillin-resistant 
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Staphylococcus aureus were reduced from 125 and 250 μg/mL to 4 and 16 μg/mL, respectively.  
This activity of baicalin was dose-dependent.  Viable counts showed that the killing of MRSA 
and β-lactam-resistant S. aureus cells by 10 to 50 μg/mL ampicillin, amoxicillin, 
benzylpenicillin, methicillin and cefotaxime was potentiated by 25 μg/mL baicalin.  Therefore, 
baicalin has the potential to restore the effectiveness of β-lactam antibiotics against MRSA and 
other strains of β-lactam-resistant S. aureus (Liu et al., 2000).  In view of its limited toxicity, 
baicalin offers potential for the development of a valuable adjunct to β-lactam treatments against 
otherwise resistant strains of microorganisms.  
Antiallergic activity 
Leukotrienes (LTs) were reported to support various cell growths, and basophil as well as 
its precursor numbers increased in atopic patients (Reilly et al., 1987).  Baicalein was found to 
inhibit the production of LT B4 by human alveolar macrophages (Sakamoto, K. et al., 1980).  
The antiallergic effect of baicalein on human basophil growth in vitro was examined using 
different basophilic cells and shown that two-week cultured numbers of basophilic cell were 
inhibited by baicalein (1-100 μM) in a dose-dependent manner (Tanno et al., 1989; 1991).  
Further study was performed to examine the effects of baicalein on the proliferation and the 
differentiation of human basophilic leukemia cell line KU812F.  The results showed that 
baicalein suppressed the growth of basophilic leukemia cell at a concentration of approx. 10 μM, 
and suggested that baicalein may affect allergic diseases by suppressing the growth and the 
differentiation of basophils/mast cells (Tanno et al., 1994).  Koda and his colleagues reported the 
anti-allergic drug disodium cromoglycate (DSCG) and disodium baicalein 6-phosphate, which 
suppressed the increase in capillary permeability caused by 48 h homologous passive cutaneous 
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anaphylaxis (PAC) in rats, inhibited not only hyaluronidase activity in vitro but also the 
activation of hyaluronidase induced by PAC in a dose-related manner.  They suggested that 
potent hyaluronidase inhibitory substances might have anti-allergic effects (Kakegawa et al., 
1992; Sakamoto, K. et al., 1980).  The anti-allergic activity of baicalein was also evidenced from 
the facts that it inhibited the histamine release from rat peritoneal exudate cells induced by 
antigens, compound 48/80 and calcium ionophore A-23187, and from its inhibitory effect on 
Shultz-Dale reaction using sensitized guinea pig ileum (Kakegawa et al., 1992). 
Other activities 
SBE was observed to have a specific inhibitory effect on CYP1A1/2 among cytochrome 
P450 (CYP) enzymes involved in aflatoxin B1 (AFB1) metabolism by rat and human 
microsomes (Kim et al, 2001).  Further studies indicated that baicalein and wogonin might have 
beneficial effects against benzo(a)pyrene- and AFB1-induced toxicities (Ueng et al, 2003).  Also 
baicalein inhibited hepatic testosterone 6-hydroxylation (CYP3A4) activity with an IC50 of 17.4 
μM (Kim et al., 2002).  Baicalin had protective effects on acetaminophen (AP)-induced 
hepatotoxicity.  The hepatoprotective effects of baicalin against AP overdose may be due to its 
ability to block the bioactivation of AP by inhibiting CYP2E1 expression (Jang et al., 2003).  
Seki et al reported that the lipogenesis in the hamster sebaceous glands was suppressed 54% by 
10
-4
 M wogonin.  Thus, the therapeutic effects of experimentally used SBE for acne vulgaris 
could be due to inhibition of lipogenesis by its active ingredients such as wogonin (Seki et al., 
1993).  
Chinese skullcap and its principal active flavonoids exhibit diverse bioactivities, 
including anticancer, antiflammatory, antiviral, antioxidation, antiallergic, and antibacteria 
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activities, but the mechanisms of these activities have not been completely elucidated yet.  
Beside baicalein and baicalin some minor components might have others special bioactivities 
and should been investigated in the future. 
1.3. Objectives of the dissertation  
In America, the marketing of dietary supplement has grown dramatically following the 
passage of the Dietary Supplement and Health Education Act (DSHEA) in 1994.  Based on the 
National Health Statistics Reports published in 2008, approximately 38 percent of adults and 
approximately 12 percent of children in the United States are using some form of DS.  The 
annual sales exceed $23 billion. As use of these products increases, so does the potential for 
adverse effects.  The data provided by National Poison Control Center showed that the number 
of adverse reaction reports increased steady each year since 1994, and the total number of such 
reports was 35,400 from 1994 to 1999.  In the circumstances, more and more attention has been 
attracted from the government agencies, academic institutions, as well as industry.  Great effects 
have been made to prevent consumers from unsafe products.  For example, the American Herbal 
Products Association (AHPA) listed the known potential adulterants that have been encountered 
in trade (see Table 1-3), and recommends that appropriate steps be taken to assure that the listed 
raw materials are free of the noted adulterant; FDA set up the Poisonous Plant Database to list all 
plants which have shown some possible toxicity.  Also, FDA supported NCNPR by means of 
funds appropriated by the U.S. congress to develop authentication, identification tools and 
evaluate the safety of botanical dietary supplements in a broad range of fields including 
cultivation, taxonomy, microscopy, chemical analysis, genetic fingerprinting, safety evaluation 
and absorption, distribution, metabolism, and excretion (ADME) studies. Two projects of my 
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dissertation are part of these efforts. 
The objectives of the first project 
In America there are many skullcap dietary supplement products on the market.  As 
mentioned in section 1.2., this plant species has been classified as “Herb of Undefined Safety” by 
the FDA due to the reports of hepatotoxic reactions after skullcap-containing preparations were 
ingested.  Meanwhile, it was reported to be adulterated with germander, which is a group of 
plants with hepatotoxicity, e.g. Teucrium chamaedry and T. canadense.  But only limited data 
associated with its chemical & pharmacological aspects are available.  Therefore, the objectives 
of this project was to explore the chemical constituents in it, to develop a reliable analytical 
method(s) for the differentiation of skullcap from germander, to evaluate the toxicity as well as 
bioactivities of the crude extract and compounds isolated from it.  Taken together, all 
information generated here would be useful to solve the problems encountered with this herb and 
to provide solid scientific support for the traditional usages of this plant. 
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Table 1-3. Ten Commonly Used BDS and Their Potential Adulterants (AHPA) 
No. herb in commerce  adulterant 
1 Eleuthero root (Eleutherococcus 
senticosus) 
 Periploca sepium root 
2 Plantain leaf (Plantago lanceolata)  Digitalis lanata leaf 
3 Skullcap herb (Scutellaria lateriflora)  Germander herb  
(Teucrium chamaedrys) 
4 Stephania root (Stephania tetrandra)
a
  Aristolochia fangchi root  
5 Asian species of Cocculus spp., 
Diploclisia spp., Menispermum spp. and 
Sinomenium spp. root 
 Aristolochia fangchi root  
6 Asian species of Akebia and Clematis 
stem 
 Aristolochia mandshuriensis stem  
7 Costus root (Saussurea costus
a
)  Aristolochia debilis root 
8 Vladimiria souliei root  Aristolochia debilis root  
9 Black cohosh root/rhizome (Actaea 
racemosa
b
) 
 Chinese cimicifuga root/rhizome
c
 
(Actaea spp.) 
10 Ginkgo (Ginkgo biloba) leaf extract 
standardized to flavonol glycosides and 
terpenes 
 Ginkgo (Ginkgo biloba) leaf extract 
with added flavonol glycosides or 
aglycones (e.g., rutin, quercetin, etc.) 
a
. Synonym = Saussurea lappa; 
b
. Synonym = Cimicifuga racemosa 
c
. Also known as sheng ma or Rhizoma Cimicifugae; is Actaea cimicifuga, syn. Cimicifuga 
foetida; Actaea dahurica, syn. C. dahurica; A. heracleifolia, syn. C. heracleifolia; and possibly 
other Asian species of Actaea. 
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Chapter 2 
Extraction, Isolation and Characterization of  
Chemical Constituents of Scutellaria lateriflora L and S. baicalensis Georgi 
 
2.1 Introduction 
As mentioned in the previous chapter, the goal of this project was to develop and validate 
an analytical method to differentiate between S. lateriflora and its potential adulterant 
germanders, and to evaluate the bioactivities of individual compounds isolated from S. lateriflora 
and S. baicalensis to provide solid scientific support for the traditional usages of this plant. All of 
these can be achieved only when qualified reference standards are available.  
Literature data pertaining to the chemical constituents of S. lateriflora are limited.  
Sesquiterpenes were reported as the main components of the essential oil of S. lateriflora 
(Yaghmai, 1988).  Five neo-clerodane diterpenoids were isolated from the Me2CO extract of S. 
lateriflora collected in the „Orto Botanico dell‟Università di Milano‟ at Tuscolano (Brescia, 
Italy) (Bruno et al., 1998).  Three flavone glucuronides and a flavanone glucuronide were 
identified along with five flavones by HPLC-UV/MS (Gafner et al., 2003).  In order to obtain 
reference markers the present chemical investigation was undertaken.  During the course of this 
research, all efforts have been made to obtain more chemical markers with enough quantity for 
structural elucidation and quality control.  Flavonoids are rich in many species of genus 
Scutellaria, for instance S. baicalensis.  On this base, the study of chemical components of S. 
baicalensis was carried out since it was reported to be rich in flavonoids and more than sixty 
flavonoids have been identified from this plant (Malikov et al., 2002). 
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2.2 Experimental sections 
2.2.1. General experimental procedures 
Optical rotations were measured in MeOH using a Rudolph Research Auto Pol IV 
polarmeter with a sodium lamp (589 nm) and a 1 dm microcell.  UV spectra were acquired on a 
Varian 50 Bio UV spectrophotometer.  Circular dichroism (CD) spectra were measured using an 
Olis DSM 20 CD instrument.  Infrared (IR) spectra were obtained on a Bruker Tensor 27 
spectrometer.  Nuclear magnetic resonance (NMR) spectra were recorded in pyridine-d5 or 
methanol-d4 on either a Varian 600 or Bruker Avance 400 NMR.  All chemical shifts (δ) are 
given in ppm with reference to solvents and coupling constants (Ј) are given in Hz.  HRESIMS 
were acquired on a Bruker MicroTOF mass spectrometer.  A highly porous synthetic resin 
(Diaion HP-20) was purchased from Mitsubishi Kagaku, Ltd. (Tokyo, Japan).  Column 
chromatography (CC) was carried out on silica gel (40 µm for flash chromatography, J. T. 
Baker), 100 C18-reversed phase silica gel (Sigma-Aldrich, 230-400 mesh) and Sephadex LH-20 
(Mitsubishi Kagaku, Tokyo, Japan).  The fractions were monitored by TLC on normal-phase 
silica gel 60 F254 plates (Merck, Germany) and reversed-phase C18 F254s plates (Merck, 
Darmstadt, Germany).  Spots were visualized under UV light or by heating at 105 °C for 1-2 min 
after spraying with anisaldehyde/H2SO4 reagent.  HPLC was performed on an ODS column 
(Phenomenex Luna C18, 10x250 mm, 5 μm) as well as a silica NP-column (Phenomenex Luna 
Silica, 10x250 mm, 5 μm) and the elution was monitored at 240 nm. 
2.2.2. Plant material 
The aerial parts of S. lateriflora were purchased from Starwest botanicals 
(http://www.starwest-botanicals.com) and authenticated by Dr. Vaishali Joshi at the National 
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Center for Natural Products Research (NCNPR), University of Mississippi, where a voucher 
specimen (voucher no. 2120) has been deposited. 
S. baicalensis ethanol extract was purchased from Chinese Herbs Direct and 
authenticated by comparing its TLC profile with that of the authentic sample provided by Dr. 
Vaishali Joshi. A voucher specimen (Voucher No. 1181) has been deposited in the repository of 
NCNPR. 
2.2.3. Extraction and isolation 
The dried powder of the aerial parts (850 g) of S. lateriflora was extracted by immersing 
in MeOH (3 x 3 L) at room temperature for two days each time and the MeOH extracts were 
combined.  A brown crude viscous residue (127.6 g) was obtained after evaporation of the 
solvent in vacuo. This MeOH extract (126.0 g) was subjected to passage over a Diaion HP-20 
column (1.65 kg) eluting with 95% EtOH (7 L), MeOH-Me2CO (1:1, 8 L), Me2CO (6 L), EtOAc 
(5 L), and CHCl3 (5 L), successively, to give seven fractions (A-G) (see scheme 2-1).  Fraction D 
(9 g) was subjected to normal-phase silica gel CC (288 g) eluting with cyclohexane-EtOAc-
MeOH mixtures of increasing polarity, to afford scutellaric acid (11, 11.2 mg) and a mixture of 
1-triacontanol and 1-dotriacontanol in the ratio of 2:1 (32.1 mg).  Fraction E (21.45 g) was 
chromatographed on silica gel (556 g) and eluted with a gradient of CHCl3-MeOH (99:1 to 7:3) 
to give 52 fractions.  Fraction E-6 (128.1 mg) was subjected to reversed-phase silica gel 
chromatography (Biotage RP-18, 40 g), eluted with MeOH-H2O 92:8 to afford lupenol (42.1 
mg).  Fraction E-8 (407.7 mg) afforded β-sitosterol (14, 213.2 mg) after crystallization from 
MeOH.  Fraction E-9 (103.2 mg) was purified by preparative TLC using hexanes-EtOAc (9:1) to 
give a mixture of arachidic acid, behenic acid, and lignoceric acid in the ratio of 2:1:0.3 (42.7 
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mg).  Fraction E-10 was separated by Sephadex LH-20 CC, eluted with MeOH to afford two 
main subfractions.  Subfraction one was repeatedly purified by HPLC on RP-18 using a MeOH-
H2O gradient as well as on silica NP-column using a hexanes-EtOAc gradient to afford decursin 
(3, 0.37 mg), scuteflorin A (1, 0.95 mg), and B (2, 0.51 mg).  Fraction F (55 g) was subjected to 
flash CC on silica gel (761 g), [cyclohexane-EtOAc (83:17 to 4:6), CHCl3-MeOH (94:6 to 
87:13), MeOH] to give six main fractions.  Subfraction F-1 was purified further by 
crystallization from MeOH to furnish palmitic acid (16, 21.3 mg).  Subfraction F-2 (612.7 mg) 
was subjected to normal-phase silica gel chromatography with a gradient of cyclohexane-EtOAc 
(1:1 to 1:9) to give four fractions F2-1-F2-4.  Oroxylin A (5, 13.2 mg) was obtained by 
crystallization (MeOH) from fraction F2-2.  Fraction F2-1 and F2-3 were purified on Sephadex 
LH-20, eluted with MeOH to afford dihydrooroxylin A (9, 4.6 mg) and dihydrochrysin (8, 3.2 
mg), respectively.  The MeOH soluble part of subfraction F-3 (748 mg) was subjected to 
Sephadex LH-20 CC eluted with MeOH to afford oroxylin A (5, 21.5 mg), wogonin (6, 27.9 
mg), and chrysin (42.1 mg).  The MeOH insoluble part of subfraction F-3 was crystallized from 
MeOH to furnish ursolic acid (13, 57.9 mg).  Subfraction F-4 (1.0223 g) was subjected to 
Sephadex LH-20 CC, eluted with MeOH followed by normal-phase silica gel chromatography 
with a gradient of cyclohexane-EtOAc (93:7 to 4:6) to give oroxylin A (5, 12.9 mg), wogonin (6, 
12.7 mg), and pomolic acid (12, 17.9 mg).  Subfractions F-5 and F-6 were purified by 
crystallization from MeOH to afford 5,7-dihydroxy-8,2′-dimethoxyflavone (7, 7.8 mg) and 
daucosterol (15, 89.9 mg), respectively.  
Compound 1: white powder; [α]25D + 25.2 (c 0.032, MeOH); UV (MeOH) λmax (log ε) 
260 (1.31), 330 (0.58) nm; IR νmax 1720 (C=O), 1510-1620 cm
-1
 (aromatic –C=C–); for 1H 
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(aceton-d6, 600MHz) and 
13
C NMR (aceton-d6, 125 MHz) data, see Table 1; HR-ESI-MS m/z 
365.1013 (M+Na, calcd. for 365.1001) and 707.2011 (2M+Na, calcd. for 707.2105).  
Compound 2: white powder; [α]25D + 5.8 (c 0.017, MeOH); UV λmax (log ε) 255 (3.31), 
330 (1.17) nm; IR νmax 1730 (C=O), 1520-1610 cm
-1
 (aromatic –C=C–); for 1H (aceton-d6, 
600MHz) and 
13
C NMR (aceton-d6, 125 MHz) data, see Table 1; HR-ESI-MS m/z 365.1011 
(M+Na, calcd  for 365.1001) and 707.2085 (2M+Na, calcd. for 707.2105). 
Methods of circular dichroism (CD) calculations: All calculations were performed at 
298 K by the Gaussian03 program package (Frisch et al., 2003).  The AM1 method was 
employed to scan the potential energy surface (PES) to identify conformers of compound 1.  
Ground-state geometries were optimized at the B3LYP/6-31G** level, total energies of 
individual conformers were obtained, and vibrational analysis was done to confirm these 
minima.  Single point energies of conformers of compound 1 were calculated at the B3LYP-
SCRF/6-31G**//B3LYP/6-31G** level with the COSMO model in MeOH.  Conformational 
distributions were calculated at B3LYP/6-31G** and B3LYP-SCRF/6-31G**//B3LYP/6-31G** 
levels.  TDDFT was employed to calculate excitation energy (in nm) and rotatory strength R in 
dipole velocity (Rvel) and dipole length (Rlen) forms, at the B3LYP/6-31G** and B3LYP/AUG-
cc-pVDZ//B3LYP/6-31G** levels in the gas phase and at the B3LYP-SCRF/6-
31G**//B3LYP/6-31G** level in MeOH.  The calculated rotatory strengths were simulated into 
an electronic circular dichroism (ECD) curve by using the Gaussian function:  
 
Where ζ is the width of the band at 1/e height and ΔEi and Ri are the excitation energies 
and rotatory strength for transition i, respectively. ζ= 0.20 eV and Rlen were used.  
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The methanol soluble part of the extract of S. baicalensis was subjected to vacuum liquid 
chromatography (VLC) on silica gel eluting with gradients of CHCl3/MeOH to afford fifteen 
fractions.  Fraction 3, 6, 11, 13, and 15 were further separated using different chromatographic 
methods including silica gel column, Sephadex LH-20, and preparative thin layer 
chromatography as shown in scheme 2-2.  The methanol unsolvable part of the extract of S. 
baicalensis was dissolved in H2O and adjusted to pH 2 using HCl.  The acidic solution was 
treated by adding MeOH to give baicalin crystals.  
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SL 
( S. laterifloria, 850.6 g)
MeOH,  extract, 3000mlx3
MeOH portion 
(SL-1, 127.6g, 14%)
Reside 
(SL-2)
CHCl3, 3000mlx3
column with Diaion@ HP-20
eluting with differnt solvents
SLR-EtOAc
(2.38g)
SLR-14-20
9g
SLRE-12-13
5.7g
SLRE-10-11
10g
silica gel column
Hex-EtOAc
EtOAc-MeOH
MeOH
SLRE-9
3.47g
fatty acids
SLR-Me2CO
(30g)
SLRE-8
2.28g
SLRE-1-3 
6.77g
SLRE-4-6 
55g
CHCl3 portion 20g residue
SLR-CHCl3
VLC
SLRE46-14-18
0.748g
dissolve in MeOH
Sephadex LH-20
SL-R-E-4-6-14-18-83-101
PTLC
SL-R-E-4-6-14-18-83-101-1
JL-I-53-2-83-101-1
oroxylin A
SL-R-E-4-6-14-18-109-125
JL-I-53-2-109-125
chrysin
residue
SL-R-E-4-6-14-1
JL-I-53-1
uroslic acid
MeOH
JL-I-53-2
SLRE46-61-63
daucosterol
SL-R-E-4-6-14-18-83-101-2
JL-I-53-2-83-101-2
wogonin
SLRE46-1-2-s
Palmitic acid
SLRE46-19-21
1.0223g
SLRI-9-42-p
1-triacontanol:1-dotriacontanol (2:1)
SLRE46-10-13
0.6127g
SLRE46-22-23
5,7-dihydroxy-2',8-
dimethoxyflavone
Biotage
Hex:CHCl3 1:1 to 1:9
SLRE46-10-13-60-68
49.4 mg
Sephadex LH-20
SLRE46-10-13-60-68-1-13
dihydrooroxylin A
SLRE46-10-13-60-68-24-25
SLRE46-10-13-69-77
oroxylin A
SLRE46-10-13-1'-53'
19.6 mg
Sephadex LH-20
SLRE46-10-13-1'-53'-8
dihydrochrysin
SLRE46-10-13-1'-53'-3-4
SLRE46-10-13-81'-87'
8.1mg
Sephadex LH-20
SLRE46-19-21-20
chrysin wogonin
SLRE46-19-21-70-77
Biotage-RP
SLRI-43-47
3a,24-dihydroxy-olean-12-en-28-oic acid
SLRE46-19-21-70-77-86-91
3ß,19a-dihydroxy-urs-12-en-28-oic acid
SLRE46-19-21-70-77-16-61
JLI65
VLC
JLI65-61
lupenol
JLI65-81
sitosterol
SL-R-E-4-6-14-18-83-101
HPLC
lateriflorin A lateriflorin B
decursin
SLRI-9-42-p
arachidic acid:behenic 
acid: lignoceric acid 
(2:1:0.3)
Chart 2-1. Scheme for isolation of chemical constituents from S. lateriflora
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S. baicalensis extract
(184.6 g)
SB1-1 (86 g)
SB1-2
H2O, adjust pH
SB1-2-1
baicalin
Silica gel
VLC
fr.3 fr.6
fr.11 fr.13
silica gel column
SB1-3-36
skullcapflavone II
SB1-3-41-51
PTLC
SB1-3-41-51-1-1
wogonin
SB1-3-41-51-1 SB1-3-41-51-2
SB1-3-41-51-2-1
oroxylin A
SB1-6-1 solution
cry.
Sephadex LH-20
SB1-11-75-81
ganhuangenin
SB1-11-110-122
2,6,2',4'-tetrahydroxy
-6'-methoxychalcone
Sephadex LH-20
SB1-3-41-51-1-2
genkwanin
SB1-3-41-51-2-2
quercetin
SB1-6-1-1
daidzein
silica gel 
column
SB1-6-2
baicalein
SB1-13-A-8-11
ganhuangemin
SB1-13-86
hesperidin
fr.15
Sephadex LH-20
SB1-13-85
naringenin
SB1-15-1
rutin
Sephadex LH-20
Sephadex 
LH-20
MeOH
SB1-15-2
wogonoside
SB1-15-3,4
MW=574
SB1-13-45
hesperetin
SB1-13-54
viscidulin I
fr.1
Chart 2-2. Scheme for isolation of chemical constituents from S. baicalensis
MeOH+CHCl3
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2.3. Results and discussion 
From the MeOH extract of the aerial parts of S. lateriflora three minor coumarins, 
scuteflorins A (1) and B (2), and decursin (3), along with six flavonoids, chrysin (4, Yuldashev et 
al., 2005), oroxylin A (5, Xiao et al., 2003), wogonin (6, Xiao et al., 2003), 5,7-dihydroxy-2′,8-
dimethoxyflavone (7, Tomimori et al., 1988), dihydrochrysin (8, Jung et al., 1990), 
dihydrooroxylin A (9, Xiao et al., 2003), four triterpenes, lupenol (10, Patra et al., 1988), 
scutellaric acid (3a,24-dihydroxy-olean-12-en-28-oic acid) (11, Morota et al., 1995), pomolic 
acid (3ß,19a-dihydroxy-urs-12-en-28-oic acid) (12, An et al., 2005),
 
ursolic acid (13, An et al., 
2005 ), two steroids, β-sitosterol (14) and daucosterol (15, Tang et al., 2002) and palmitic acid 
(16, Huang et al., 2007) were obtained (Figure 2-1).  Among them two coumarins (1) and (2) are 
new.  Their structures were established by means of 1D and 2D NMR spectra as well as HRMS 
data.  The absolute configuration of them was determined by comparison of the experimental and 
theoretical calculated CD spectra.  The structures of known compounds were elucidated by 
comparison of their NMR data with those reported.  The absolute configuration of the two 
flavanones, dihydrochrysin and dihydrooroxylin A was determined based on the specific rotation 
data and comparison with the literature data.  All of the known compounds except chrysin and 
wogonin are reported for the first time from this plant. 
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Structural elucidation of two new compounds 
Scuteflorin A (1) was obtained as a white powder, [α]D + 25.2 (c 0.032, MeOH).  The 
HR-ESI-TOF-MS spectrum of compound 1 gave an [M+Na]
+
 ion at m/z 365.1013 and 
[2M+Na]
+
 at 707.2011 that are consistent with the pseudomolecular formula C19H18O6Na (calcd. 
for [M+Na]
+
 365.1001 and calcd. for [2M+Na]
+
 707.2105, respectively).  The characteristic 
bright blue fluorescence under UV 254 light and the UV absorption at λ 255 and 330 nm (α，β-
unsaturated C=O) along with an IR absorption band at 1719 cm
-1 (C=O of α-pyrone and ester) 
indicated that this compound might possess a coumarin skeleton.  The 
1
H NMR spectrum of 1 
(Table 2-1, Figure 2-3) shows a pair of doublets at δH 8.04 and 6.36 ascribable to H-3 and H-4 of 
a coumarin moiety.  The two singlets at δH 8.11 and 6.90 were assigned to H-5 and H-8 and 
suggested 6, 7-disubstitution of the aromatic ring.  The 6, 7-disubstitution was determined to 
result from a dihydro-γ-pyranone ring based on the 1H and 13C NMR data (Figure 2-3 and 2-4) 
and the (heteronuclear multiple-bond connectivity) HMBC correlations as depicted in Figure 2-2.  
H-5 (δH 8.11) correlated with a carbonyl carbon at C-4′ (δC 187.8), H-3′ (δH 5.71) with C-2′ (δC 
83.6 ), C-5′ (δC 26.2), C-6′ (δC 20.1), and C-4′ (δC 187.8), δH H-5′ (1.58) with C-2′, C-3′, and C-
6′, H-6′ (δH 1.39) with C-2′, C-3′, and C-5′.  The 4′-carbonyl substitution explained the downfield 
shift of H-5.  The remaining resonances in the 
1
H and 
13
C NMR spectra corresponded to a 
senecioyloxy group (Erdelmeier et al., 1985) which was located at C-3′ according to the HMBC 
correlation of H-3′ with C-1″ (δC 165.2 ppm).  Thus, the planar structure of compound 1 was 
deduced as 3′-senecioyloxy-4′-oxo-3′, 4′-dihydroxanthyletin and was given the trivial name 
scuteflorin A. 
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Table 2-1. NMR Data for Compounds 1 and 2 in Aceton-d6 
 compound 1   compound 2 
no. δC  δH (J in Hz) HMBC  δC δH (J in Hz) 
       
2 159.9     * 
3 115.6 6.36, d (9.6)   115.6 6.35, d (9.6) 
4 144.5 8.04, d (9.6)   144.4 8.04, d (9.6) 
5 128.7 8.11, s C-4,7,9, 4′  128.7 8.11, s 
6 118.2    118.1  
7 162.2    162.1  
8 106.0 6.90, s C-6,7,9,10  106.0 6.91, s 
9 160.6    160.4  
10 115.1    115.1  
2′ 83.6    83.5  
3′ 76.5 5.71, s C-2′,4′,5′,6′,1″  77.2 5.78, s 
4′ 187.8    187.6  
5′ 26.2 1.58, s C-2′,3′,6′  26.4 1.59, s 
6′ 20.1 1.39, s C-2′,3′,5′  20.1 1.41, s 
1″ 165.2    166.6  
2″ 115.5 5.85, br C-1″,3″,4″,5″  127.9  
3″ 160.5    140.4 6.27, qq (8.4, 1.5) 
4″ 27.5 1.97, d (1.2) C-2″,3″,5″  20.7 1.95, p (1.5) 
5″ 20.5 2.20, d (1.1) C-2″,3″,4″  16.1 2.00, dq (7.2, 1.5) 
* Not observed 
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Figure 2-2. Key HMBC correlations of compound 1. 
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Figure 2-3. 
1
H-NMR spectrum of compound 1 in aceton-d6 
 
 
Figure 2-4. 
13
C-NMR spectrum of compound 1 in aceton-d6 
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Figure 2-5. H-H COSY spectrum of compound 1 in aceton-d6 
 
Figure 2-6. HSQC spectrum of compound 1 in aceton-d6 
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Figure 2-7. HMBC spectrum of compound 1 in aceton-d6 
 
Compound 1 has a positive specific rotation (+ 25.2) compared to + 135 of (+)-decursin 
(3) with its C-3΄S absolute configuration (Nemoto et al., 2003).  However, due to the 
considerable structural differences between compounds 1 and 3 one may expect significant 
changes in optical rotation value.  We thus took recourse to ECD to determine its absolute 
configuration by comparing the experimentally observed and theoretically calculated ECD 
spectra.  Using this approach, we have successfully defined the absolute configuration of several 
natural products (Ding et al., 2007; 2008; 2009).  The potential energy surface of compound 1 in 
the gas phase was scanned at the AM1 level by rotating about the C3′-O (C1″), C1″-O (C3′) and 
C1″- C2″ bonds.  Six conformers were found and redefined at the B3LYP/6-31G** level.  
Conformational analysis indicated that conformer 1a is predominant [95.6% at the B3LYP/6-
31G** level in the gas phase by Gibbs free energies and 95.9% at the B3LYP-SCRF/6-
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31G**//B3LYP/6-31G** level in MeOH with “COnductor-like continuum Solvent MOdel” 
(COSMO) by total energies] (see Figure 8, Table 2-2).  Theoretical calculation of the ECD of 
conformer 1a was performed by the time dependent density functional theory (TDDFT) method 
at the B3LYP/6-31G** and B3LYP/AUG-cc-pVDZ//B3LYP/6-31G** levels in the gas phase, 
and at the B3LYP-SCRF/6-31G**//B3LYP/6-31G** level in MeOH.  The calculated ECD 
spectra of 1a in the gas phase and in MeOH, together with the experimental ECD of 1 in MeOH, 
are shown in Figure 9.  The overall patterns of the calculated ECD spectra are consistent with 
that of the experimental one, i.e., positive Cotton effects (CE) in the 250-300 nm region and 
negative CEs in the 300-350 nm region.  Considering the extended π-system of the dihydro-γ-
pyranone containing coumarin chromophore in 1, the positive CE near 260 nm and the shoulder 
near 290 nm in the experimental ECD would be characteristic for this molecule.  This is 
supported by analysis of the molecular orbitals involved in key transitions generating the ECD 
spectrum of 1a at the B3LYP/6-31G** level in the gas phase.  The calculated positive rotatory 
strength at 272 nm (Table 2-3), which likely contributes to the positive CE near 260 nm in the 
experimental ECD, originates via the transitions from MO88 to MO91 (Figure 2-10).  Another 
calculated positive rotatory strength at 294 nm, indicative of the shoulder near 290 nm in the 
experimental ECD, is derived from the transition from MO90 to MO92.  The calculated negative 
rotatory strength at 317 nm, which may be associated with the negative CE beyond 300 nm in the 
experimental ECD, is generated by the transition from MO90 to MO91.  All four MOs involve 
the π-electrons in the dihydro-γ-pyranone containing coumarin chromophore.  The calculated 
positive rotatory strength at 257nm (Table 2-3), which originates via the transition from MO86 
to MO93, also contributes to the positive CE near 260 nm in the experimental ECD spectrum 
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(Figure 2-10).  The strong calculated positive rotatory strength at 210 nm results from the 
transition from MO87 to MO93.  Since these three MOs involve the electrons of the -
unsaturated ester system that may rotate along the C3′-O (C1″), C1″-O (C3′) and C1″- C2″ bonds 
in solution, caution should be exercised in using the CEs near these wavelengths to predict 
absolute configuration.  Based on the above evidence, we conclude that compound 1 retains the 
same absolute configuration at C-3΄ as in (+)-decursin (3), but is assigned R in (1) due to the 
reversal of the Cahn–Ingold–Prelog (CIP) priorities.  
 
 
Figure 2-8. Optimized geometries of conformers of compound 1 at  
B3LYP/6-31G** level in the gas phase. 
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Table 2-2. Conformational Analysis of Compound 1. 
species 
in gas phase in methanol 
ΔEa PE%
b ΔE′c PE′%
d ΔGe PG%
f ΔEsg PEs%
h 
1a 0.00 93.1 0.00 94.3 0.00 95.6 0.00 95.9 
1b 4.83 0.0 4.99 0.0 5.73 0.0 4.95 0.0 
1c 8.17 0.0 7.96 0.0 8.08 0.0 6.66 0.0 
1d 1.95 3.4 2.08 2.8 2.24 2.2 2.29 2.0 
1e 7.27 0.0 7.31 0.0 7.71 0.0 7.14 0.0 
1f 1.95 3.4 2.08 2.8 2.24 2.2 2.29 2.0 
a,c,e 
Relative energy, relative energy with ZPE, and relative Gibbs free energy at B3LYP/6-
31G** level in the gas phase, respectively (kcal/mol). 
b,d,f 
Conformational distribution 
calculated by using the respective parameters above at B3LYP/6-31G** level in the gas phase. 
g,h 
Relative energy (kcal/mol) and conformational distribution in methanol solution at B3LYP-
SCRF/6-31G**//B3LYP/6-31G** level with COSMO model, respectively.
 
 
 
Figure 2-9. Calculated ECD spectra of conformer 1a and the experimental ECD of compound 1 
(red ▬ and olive ▬, in the gas phase at the B3LYP/6-31G** level; black ▬, in MeOH solvent 
at the B3LYP-SCRF/6-31G**//B3LYP/6-31G** level with COSMO; green ▬, in the gas phase 
at the B3LYP/AUG-cc-pVDZ//B3LYP/6-31G** level; blue ▬, experimental ECD in MeOH).  
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Table 2-3. Key Transitions and Oscillator and Rotatory Strengths of Conformer 1a of 
Compound 1 at the B3LYP/6-31G** Level in the Gas Phase. 
Excited State ΔEa (eV) b (nm) f 
c 
Rvel
d 
Rlen
e 
90→91 3.91 317 0.180 -21.8 -19.8 
90→92 4.21 294 0.162 25.8 26.4 
88→91 4.55 272 0.039 7.9 7.4 
86→93 4.83 257 0.011 18.6 19.2 
87→93 5.89 211 0.431 84.8 84.1 
a 
Excitation energy. 
b 
Wavelength. 
c 
Oscillator strength.  
d 
Rotatory strength in velocity form 
(10
 -40
 cgs). 
e 
Rotatory strength in length form (10
 -40
 cgs). 
 
 
Figure 2-10. Electron density surfaces of some orbitals involved in key transitions in the ECD 
spectra of 1 at the B3LYP/6-31G** level in the gas phase. 
 
Scuteflorin B (2) was obtained as white powder. [α]D + 5.8 (c=0.017, MeOH).  Its 
molecular formula C19H18O6 was determined to be same as compound 1 by the high resolution 
ESI-TOF-MS data 365.1011 (calcd. [M+Na]
+ 
for 365.1001) and 707.2085 (calcd. [2M+Na]
+
 for 
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707.2105).  Analysis of the NMR data [
1
H, 
13
C, heteronuclear single quantum coherence 
(HSQC), correlation spectroscopy (COSY) and HMBC] (shown in Figure 2-11, 2-12, 2-13, 2-14, 
and 2-15) of 2 showed that the 
1
H and 
13
C NMR data of 2 are similar to those of compound 1 
except that of the senecioyloxy group in 1 was replaced by an angeloyl group in 2 by comparison 
with literature data (Erdelmeier et al., 1985) and 2D NMR data.  Thus, compound 2 was assigned 
as 3′-angeloyloxy-4′-oxo-3′,4′-dihydroxanthyletin and was given the trivial name scuteflorin B. 
Since compound 2 is also dextrorotatory, the 3΄ R absolute configuration of 2 should be the same 
as in compound 1.  
 
 
Figure 2-11. 
1
H-NMR spectrum of compound 2 in aceton-d6 
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Figure 2-12. 
13
C-NMR spectrum of compound 2 in aceton-d6 
 
 
Figure 2-13. H-H COSY spectrum of compound 2 in aceton-d6 
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Figure 2-14. HSQC spectrum of compound 2 in aceton-d6 
 
 
Figure 2-15. HMBC spectrum of compound 2 in aceton-d6 
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Seventeen flavonoids have been isolated after repeated chromatographic purification 
from five fractions of S. baicalensis.  Their structures were elucidated as baicalein (17), baicalin 
(18), wogonin (6), wogonoside (19) and oroxylin A (5) (Miyaichi et al., 1988b), quercetin (24), 
rutin (25), naringenin (27), hesperetin (28), hesperidin (29), and daidzein (30) (Kimura et al., 
1981), viscidulin I (23) and 2,6,2',4'-tetrahydroxy-6'-methoxychalcone (31, Iinuma et al., 1989), 
skullcapflavone II (20, Kimura et al., 1981), ganhuangenin (21, Liu, Y.L. et al., 1984), 
genkwanin (22, Bosabalidis et al., 1998), ganhuangemin (26, Liu, M.L. et al., 1984) (see Figure 
2-16) using 
1
H-NMR, 
13
C-NMR, HMQC and HMBC as well as comparison with reported data.  
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R5=R6=R7=OH, R8=R2'=R4'=R6'=H                                     baicalein (17)
R5=R6=OH, R7=O-GlcUA, R8=R2'=R4'=R6'=H                   baicalin (18)
R5=R7=OH, R8=OCH3, R6=R2'=R4'=R6'=H                         wogonin (6) 
R5=OH, R8=OCH3, R7=O-GlcUA,  R6=R2'=R4''=R6'=H      wogonoside (19) 
R5=R7=OH, R6=OCH3, R8=R2'=R4'=R6'=H                         oroxylin A (5) 
R5=R2'=OH, R6=R7=R8=R6'=OCH3, R4'=H                         skullcapflavone II (20) 
R5=R7=R2'=R4'=OH, R8=R6'=OCH3, R6=H                         ganhuangenin (21) 
R5=R4'=OH, R7=OCH3, R6=R8=R2'=R6'=H,                        genkwanin (22)
2,6,2',4'-tetrahydroxy-6'-methoxychalcone (31)daidzein (30)
R3=R7=R2'=R6'=OH, R3'=R4'=H                                     ganhuangemin (26)
R7=R4'=OH, R3=R2'=R3'=R6'=H                                     naringenin (27) 
R7=R3'=OH, R4'=OCH3, R3=R2'=R6'=H                         hesperetin (28)
R7=O-rutinosyl, R3'=OH, R4'=OCH3, R3=R2'=R6'=H     hesperidin (29)
O
O
R8
R7
R6
R5
R3=R2'=R6'=OH, R3'=R4'=H                         viscidulin I (23)
R3=R3'=R4'=OH, R2'=R6'=H                         quercetin (24)
R3=O-rutinosyl, R3'=R4'=OH, R2'=R6'=H     rutin (25)
R2' R4'
R6'
R7
OH
R2'
R3'
R4'
R6'
O
R3
O
O
O
HO
R3'
R6'
R4'
R3
O
O
OH
HO
OH
Figure 2-16. Structures of compounds isolated from S. baicalensis
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O OH
OHH3CO
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OH
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2.4. Conclusion  
Two types of secondary metabolites, i.e. flavonoids and diterpenoids have been reported 
in many species of the genus Scutellaria, such as S. baicalensis, S. discolor, S. riuvlaris, S. 
galericulata etc.  However; this is the first report on the isolation of coumarins from the genus 
Scutellaria.  Similar prenylated dihyropyranocoumarins were reported from Chinese traditional 
medicines (e.g. Angelica gigas and Peucedanum spp) with cytotoxicity (Ahn, et al., 1997), 
neuroprotective (Kang et al., 2005, Lee J. et al., 2003) and protein kinase C (PKC) (Ahn, et al., 
1997) activating activities.  All the compounds except wogonin and chrysin are reported for the 
first time from S. lateriflora.  The major flavonoids isolated from S. baicalensis as well as S. 
lateriflora will be used as chemical markers for quality control analysis. Meanwhile, these pure 
compounds will be tested on a panel of bioassays to provide scientific support for their 
traditional uses as well as to find new applications. 
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Chapter 3 
Chemical Fingerprint Analysis of Scutellaria Species, Germander  
and Dietary Supplements Claiming to Contain Skullcap Using HPLC-PDA 
 
3.1 Introduction 
Quality control when dealing with botanicals is much more difficult than for synthetic 
drugs because of the high variability of chemical components involved.  As botanical dietary 
supplement (BDS), singular and in combinations, contain a myriad of mostly unique, or species-
specific compounds in complex matrices, it is difficult to completely characterize all of these 
compounds.  It is also equally difficult to know precisely which one is responsible for the 
therapeutic effects of an herbal medicine because these compounds often work synergistically.  
In recent years, significant efforts have been made to devise methods for the quality control of 
herbal materials as well as their products by utilizing quantitative methods and/or qualitative 
fingerprinting technologies (Lin et al., 2001; Yang et al., 2005).  Quantitative analysis methods 
commonly used by the industry are analyzing the product for the presence of chemical markers 
known to be present in the specific herbal as indicators or standards to assess quality of the 
herbal medicine.  Even though this has been an acceptable method for quality control, for herbal 
complex systems, the presence of the chemical markers do not always guarantee an individual is 
getting the actual herb stated by the product label, especially if the product has been spiked with 
the chemical markers.  So, the quantization method for the chemical markers can confirm the 
compounds presence, but it may not confirm the presence of the plant material.  Qualitative 
analysis is typically used to demonstrate the general characteristics of herbal materials or their 
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products.  Many kinds of chemical fingerprint analysis methods, such as TLC, GC, HPLC-UV, 
and HPLC-MS, are in rapidly developing that offer great potential for monitoring the quality of 
herbal materials, particularly for identifying a particular herb and distinguishing it from closely 
related species (Jiang, et al., 2005; Zschocke et al., 1998).  By fingerprinting the entire pattern of 
components present in one herb or its products, the complete information could be acquired.  The 
quality information acquired from fingerprinting profile makes the chemical composition in a 
given herb visible and comparable in wholeness to determine not only the presence or absence of 
desired markers or active constituents but the complete set of ratios of all detectable analytes.  
Fingerprinting profile possesses two levels of significance: the „elementary‟ quality control and 
„intensive‟ quality control.  The former („elementary‟ quality control) serves the routine 
authentication and rapid overall quantifiable estimation of herbs and their products even if some 
ingredients in the fingerprint are unknown yet (Xie et al., 2006).  And the latter („intensive‟ 
quality control) means chromatographic fingerprint coupled with chemometrics to enhance the 
high capability for processing the array of the parameters.  While the chromatographic 
fingerprint can also serve as „quality data bank‟ in which the intact suit of ingredients has been 
reserved for sustainable in-depth study.  Fingerprinting has been introduced and accepted by the 
WHO as a strategy for identification and quality evaluation of herbal medicinal products (WHO, 
1991).  Both the U.S. Food and Drug Administration (FDA) (FDA, 2004) and the European 
Medicines Agency (EMEA, 2001) clearly state that the appropriate fingerprint chromatograms 
should be used to assess the consistency of botanical products.  In 2004, the State Food and Drug 
Administration (SFDA) of China officially required all injections made from herbal medicine to 
be standardized by chromatographic fingerprints (SFDA, 2004).  
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Chromatographic techniques used for fingerprint analysis of herbal medicines include 
TLC, GC, HPLC, and hyphenation procedures.  Among them TLC is a convenient method for 
determining the quality and possible adulteration of herbal products due to the advantages of its 
simplicity, versatility, high velocity, specific sensitivity and simple sample preparation.  Even 
nowadays, TLC is still frequently used for the analysis of herbal medicines since various 
pharmacopoeias such as American Herbal Pharmacopoeia (AHP) (Upton, Santa Cruz, US, 
2002), Chinese drug monographs and analysis (Wagner, K¨otzting/Bayer, Wald, Germany, 
1997), Pharmacopoeia of the People‟s Republic of China (Pharmacopoeia Commission, Beijing, 
1997), etc. still use TLC to provide first characteristic fingerprints of many herbs.  It is worth 
noting that the technique of TLC is also being updated in progress and the different techniques 
like rotation planar chromatography (RPC), overpressured-layer chromatography (OPLC), and 
electroplanar chromatography (EPC) are reported (Nyiredy, 2003).  Over the past decades, GC 
has been a popular and useful analytical tool for the analysis of volatile compounds in herbal 
medicines with the advantage of high sensitivity of detection for almost all the volatile chemical 
compounds.  Especially, with the use of hyphenated GC–MS instrument, reliable information on 
the identity of the compounds is available as well.  However, the most serious disadvantage of 
GC is that it is not convenient for analysis of the samples containing polar and non-volatile 
compounds.  For this, it is necessary to use tedious sample work-up which may include 
derivatization.  Therefore, liquid chromatography becomes another necessary tool to be applied 
for the comprehensive analysis of the herbal medicines.  HPLC is a versatile method for analysis 
of almost all compounds in the herbal medicines when coupled with UV detector, ELSD, or 
hyphenated techniques, such as HPLC–MS, HPLC-NMR.  Some new techniques, including 
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micellar electrokinetic capillary chromatography (MECC) (Albert et al., 1997), high-speed 
counter-current chromatography (HSCCC), low-pressure size-exclusion chromatography (SEC) 
(Pervin et al., 1995), reversed-phase ion-pairing HPLC (RP-IP-HPLC) (Karamanos et al., 1997; 
Loganathan et al., 1990), and strong anion-exchange HPLC (SAX-HPLC) (Rice et al., 1989) 
have been developed for good separation for some specific extracts of some herbal medicines. 
In order to evaluate the similarity and difference between a number of chromatographic 
fingerprints obtained from the same herbal medicine or from different species, several 
chemometric approaches such as Hierachical Cluster Analysis, Principle Component Analysis, 
Pattern Recognition and K-Nearest Neighbour Analysis were employed to deal with the 
chromatographic fingerprint, and a great number of such papers have been published (Debeljak 
et al., 2005; Gan et al., 2006; Gong et al., 2003, 2004, 2006; Li et al., 2004; Mok et al., 2006; 
Nederkassel et al., 2006; Xu et al., 2006).  It is worth noticing that the principle behind these 
methods is statistical basis.  Therefore, a reliable sample size is critical and should be calculated 
properly before experiments to ensure the validity of the results. 
3.2 Background and objectives 
Flavonoids have been reported as characteristic components of Scutellaria genus. More 
than 600 flavonoids have been reported from about 60 Scutellaria species, of which over 60 were 
isolated from S. baicalensis (see section 1-2).  Previous studies for quality control of S. 
baicalensis were focused on the qualitative and quantitative determination of a few major 
flavonoids existed, including baicalein, baicalin, wogonin and wogonoside.  Different 
chromatographic techniques, such as HPLC-UV (Katsura et al., 1982; Ma et al., 2003; Miyaichi 
et al., 1986; Stojakowska et al., 1998; Takino et al., 1987; Tomimori et al., 1985; Zhang et al., 
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1998), HPLC–ESI tandem mass spectrometry (Guo et al., 2005; Zhang et al., 2007; Wu et al., 
2004a), CE (Myoung et al., 1999; Wang et al., 2005; Yu et al., 2007), MECC (Liu et al., 1994) 
have been applied to evaluate the quality of raw material as well as the preparation claiming to 
contain S. baicalensis.  
To date, only a few papers have touched the field related to the assessment of the quality 
of American skullcap and the discrimination between skullcap and its adulterant, germander.  
Gafner et al. (Gafner et al., 2003) reported methods, including HPTLC, and digital 
photomicroscopy to differentiate S. lateriflora and its potential adulterants T. canadense and T. 
chamaedrys.  In the HPTLC analysis, three flavonoids isolated from S. lateriflora, e.g. baicalein, 
baicalin, and ikonnikoside, two phenylpropanoids from T. canadense, e.g. verbascoside and 
teucrioside, were used as markers.  Gao‟s group (Gao et al., 2008) developed a HPLC-UV 
method to compare the flavonoid biomarker content (baicalein, baicalin, and wogonin) of eleven 
commercial tinctures derived from S. lateriflora aerial parts (n=7) and S. baicalensis (n=4).  
Results showed that the concentrations of these flavonoids varied widely.  Makino (Makino et 
al., 2008) analyzed the amounts of four flavonoids, including baicalein, baicalin, wogonin, and 
wogon-7-O-glucuronide, in the roots, stems, and leaves of S. baicalensis and S. lateriflora, and 
in the commercial products prepared from S. lateriflora.  Experimental results indicated that 
these flavonoids were detected in the roots of S. baicalensis, however, not in its aerial parts.  The 
contents of these flavonoids in the aerial parts of S. lateriflora were higher than that in the roots.  
Recently, Zhang et al established an HPLC method to analyze twelve phenolic compounds, 
including 10 flavonoids and two phenylethanoid glycosides, in commercial American skullcap 
products from different sources (Zhang et al., 2009).  The total analyzed ingredients varied 
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widely for different samples and the relative proportions of ingredients in each sample were 
significantly different.  They suggested that the chemical variability of the commercial American 
skullcap products might come from the plant raw materials that had variable chemical 
compositions.  In another study, an HPLC-DAD/ESI-MS method was used to distinguish 
between S. lateriflora and its adulterants using the phenylpropanoid verbascoside and teucrioside 
as markers (Lin et al., 2009).  Although the above mentioned methods had made progress, these 
methods are limited in their ability to ensure identity of skullcap plant material being used in the 
product.  
Hence the main objective of our study was to develop a HPLC-PDA fingerprinting 
method that can be applied to authenticate S. lateriflora, to distinguish it from its potential 
adulterants, and to compare the chemical profiles of different species in this genus.  In the 
present study three classes of compounds, including eleven flavonoids isolated from Scutellaria 
species, two phenylpropanoids verbascoside and teucrioside and one diterpene teucrin A isolated 
from T. canadense, were used as markers to provide comprehensive analysis for the above 
mentioned purposes.  Since the UV patterns are different and specific for each type of 
compounds investigated, analysis of UV spectra of the known markers and relevant peaks in 
samples will be quite valuable for identification of different species.  
3.3. Experimental sections 
3.3.1. Reagents and chemicals  
All solvents, including acetonitrile, water and acetic acid, were of HPLC grade and 
provided by Fisher Scientific (Fair Lawn, JN, USA) and Sigma (St. Louis, MO, USA), 
respectively.  The eleven standard flavonoids used in this study; namely baicalein (17), baicalin 
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(18), oroxylin A (5), wogonin (6), chrysin (4), quercetin (24), rutin (25), daidzein (30), 
naringenin (27), hesperetin (28), and hesperidin (29), were isolated from Scutellaria species by 
authors (see Chapter 2 for details).  The phenylpropanoids, including verbascoside (I) and 
teucrioside (II), one diterpene, teucrin A (III), were isolated at the National Center for Natural 
Products Research (NCNPR).  Their structures (see Figure 3-1) were elucidated based on the 1D 
and 2D NMR spectra, HRMS data as well as comparison with reported data.  The purity of these 
standards was confirmed by chromatographic methods (TLC and HPLC).  
3.3.2. Standard solutions 
An individual stock solution of the standard compounds was prepared at a concentration 
of1 mg/mL in methanol.  10 μL of each standard flavonoid solution was mixed and the mixture 
was further diluted to a concentration of 50 μg/mL which was then used for HPLC analysis.  3 
μL of each standard phenylpropanoid solution was mixed with 30 μL of teucrin A standard 
solution to get the working solution for HPLC analysis.  All these solutions were stored in 
refrigerator. 
3.3.3. Sample preparation  
Ten species (total fourteen samples), including seven scutellaria related species and three 
Teucrium species, were investigated in this study.  The data associated with each species, such as 
source and code number are listed in Table 3-1. 
General extraction procedure - The dried powder of each plant material (about 1.000 g) 
was extracted with 20 mL MeOH under ultrasonication for 30 min followed by centrifugation for 
5 min at 1550 rpm.  The supernatant was transferred to a 100 mL flask.  The extraction was 
repeated two more times and the respective supernatants were combined and evaporated to 
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dryness.  2 mL of HPLC grade methanol were added to the dried extract and transferred to 5 mL 
volumetric flask.  The flask was rinsed with about 1.5 mL methanol twice and the final volume 
was adjusted to 5 mL with methanol. 
Prior to injection, this solution was mixed thoroughly and filtered through 0.45 μm 
membrane.  The first 0.5 mL was discarded and the remaining volume collected for HPLC 
analysis.  Each sample solution was injected in triplicate.  
Three dietary supplements claiming to contain S. lateriflora were purchased through 
commercial sources (see Table 3-2).  The dosage form of these three samples is tincture.  2.0 mL 
of sample solution was filtered through 0.45 μm membrane.  The first 0.5 mL was discarded and 
the remaining volume was collected then diluted to proper concentration for HPLC analysis. 
3.3.4 Instrumentation and HPLC conditions 
HPLC-PDA analysis was performed on a Waters 2695 Alliance Separations Module 
(Waters, Milford, MA) connected with a Waters 2996 Photodiode Array Detector and separation 
was investigated using two different HPLC columns, a Luna column RP-18 and a Gemini RP-18 
column (250 x 4.6 mm i.d.; 5 µm particle size for each of column) from Phenomenex (Torrance, 
CA, USA).  The column was equipped with a 2 cm LC-18 guard column (Phenomenex Inc.).  
The temperature of the column was maintained at 25 °C.  The mobile phase consisted of 
acetonitrile (A) and water (B), all containing 0.2% acetic acid, which were applied in the 
following gradient: 0-5 min, 15%-20% A; 5-30 min, 20%-25% A; 30-60 min, 25%-55% A; 60-
65 min, 55% A; 65-70 min, 55%-100% A, then hold 5 min.  Each run was followed by a 5 
minutes washing procedure with 100% acetontrile.  The flow rate was adjusted to 1 mL/min, and 
the injection volume was 10 µL.  Re-equilibration was done with 15% A for 12 min.  Total run 
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time was 75 min.  
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Figure 3-1. Chemical structures of fourteen standard compounds used in this study
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Table 3-1. Species Analyzed in Present Study 
 
Table 3-2. Products Claiming to Contain S. lateriflora 
product       code          dosage form 
Scullcap 7825:11/11/2009; SCLAL tincture (59-65% alcohol by volume) 
Scullcap 7827:11/11/2009; SCLAL alcohol-free extract (1:1) 
Scullcap 7828:11/11/2009; SCLAL alcohol-free extract (1:1) 
 
3.3.5. Method development  
The qualified standards described in Chapter 2, and authenticated species S. lateriflora 
(1180:6-4-2004; SCLAL) were used for analytical method development in this study. 
species code number source 
S. amoena 534:1/28/2003; SCAML  Da Li, Yun Nan, China 
S. baicalensis 522:1/28/2003; SCABL (leaf)  
S. baicalensis 503:1/27/2003; SCABL (root) Nei Meng Gu, Wu Chuan Xian, China 
S. barbata 533:1/28/2003; SCABL Si Chuan, China 
S. barbata 535:1/28/2005 SCABL Shen Yang, China 
S. integrifolia SAR01204 unknown 
S. lateriflora #198 w/H-tet unknown 
S. lateriflora 1180:6/4/2004; SCLAL Starwest Botanicals , Inc. USA 
S. lateriflora 7828:11/11/2009; SCLAL Bazaar of India 
S. lateriflora 3257: 04/17/2007: SCLAL FRONTIER NATURAL PRODUCTS 
CO.OP (www.frontiercoop.com) 
S. likiangensis SCLIL Yun Nan, China 
S. rehderiana 524:1/28/2003; SCREL Liao Ning, China 
T. chamaedry 4849;11/16/2008; TECHL Monsento 
T. canadense 6544;06/03/2009; TECAL Missouri Botanical Garden 
2893;02/22/2008; TECAL American Mercentile Corperation 
T. fruticans 8073;12/09/2009; TEFRL  Missouri Botanical Garden 
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Initial fingerprinting method development began by extracting authenticated S. lateriflora 
with methanol.  The extract was then analyzed on two different HPLC columns, a Luna column 
RP-18 and a Gemini RP-18 column, with a gradient solvent system (shown in Table 3-3). Three 
UV wavelengths, including 250, 280 and 350 nm, were chosen for analysis.  Regardless of the 
gradient solvent system, a level baseline could be achieved only using a Luna column.  Then, an 
optimized mobile phase gradient for the Luna column was determined for the fingerprint 
analysis.  Initially, a mobile phase consisting of acetonitrile (A) and water (B), all containing 
0.1% acetic acid, was used to investigate the separation of the extract of S. lateriflora.  The 
mobile phase was pumped at 1 mL/min under gradient manner (see Table 3-3).  The HPLC 
chromatogram of the plant extract is shown in Figure 3-2.  In order to achieve good resolution 
for a series of peaks to elute in less than 20 min in the HPLC chromatogram attempts were made 
to modify gradient system (shown in Table 3-4) and the separation of the peaks in less than 20 
min was achieved (shown in Figure 3-3).  Subsequently, the continued method development 
involved in applying further modified mobile phase (shown in Table 3-5) to get better separation 
for the peaks occurring between 45-60 min.  Even though separation was achieved under these 
conditions, the peak shapes were not satisfactory due to peak tailing (see Figure 3-4).  Therefore, 
the concentration of acetic acid in binary mobile phase was adjusted from 0.1% to 0.2% and peak 
shapes were optimized (shown in Figure 3-5).  Once the fingerprint method had been developed 
through the use of authenticated plant material, the mixture of standard solutions and other 
species had to be tested to ensure its usefulness.  All species of Scutellaria and Teucrium tested 
are listed in the experimental section (Table 3-1).  This method was applied successfully to the 
mixture of eleven standard flavonoids (shown in Figure 3-6 and Table 3-7) and most of 
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Scutellaria related samples investigated.  Meanwhile, using this method good separation was 
achieved for the mixture of three standards isolated from T. canadense (see Figure 3-7) and 
Teucrium samples.  The proper sample concentration was obtained by testing a series of 
concentrations for each sample.  
The HPLC fingerprint method in the present study was validated by analysis of 
chromatograms in the intra-and inter-day precision tests.  Five peaks were selected as 
characteristic peaks in the chromatogram of the S. lateriflora (see Figure 3-8) as they had 
relatively large peak areas and good resolution.  Peak 4th was used as the reference peak.  The 
relative peak retention time (RPRT) and relative peak area (RPA) of each characteristic peak 
related to the reference peak were calculated for expression of the HPLC fingerprint pattern.  The 
detection wavelength was 250 nm.  Four individual samples of S. lateriflora on three consecutive 
days under optimized HPLC conditions were analyzed.  
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Table 3-3. HPLC Gradient Condition I for Fingerprint Analysis  
time (min) flow (mL/min) %ACN w/ 0.1% HOAc %water w/ 0.1% HOAc 
0.01 1.00 20.0 80.0 
5.00 1.00 20.0 80.0 
30.00 1.00 30.0 70.0 
55.00 1.00 55.0 45.0 
65.00 1.00 55.0 45.0 
70.00 1.00 100.0 0.0 
75.00 1.00 100.0 0.0 
 
A
U
0.00
0.20
Minutes
0.00 5.00 10.00 15.00 20.00 25.00 30.00 35.00 40.00 45.00 50.00 55.00 60.00 65.00 70.00 75.00
 
Figure 3-2. HPLC chromatogram of S. lateriflora under the gradient elution system shown in 
Table 3-3. 
 
Table 3-4. HPLC Gradient Condition II for Fingerprint Analysis  
time (min) flow (mL/min) %ACN w/ 0.1% HOAc %water w/ 0.1% HOAc 
0.01 1.00 15.0 85.0 
5.00 1.00 20.0 80.0 
30.00 1.00 25.0 75.0 
55.00 1.00 50.0 50.0 
65.00 1.00 55.0 45.0 
70.00 1.00 100.0 0.0 
75.00 1.00 100.0 0.0 
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Figure 3-3. HPLC chromatogram of S. lateriflora under the gradient elution system shown in 
Table 3-4. 
 
Table 3-5. HPLC Gradient Condition III for Fingerprint Analysis  
time (min) flow (mL/min) %ACN w/ 0.1% HOAc %water w/ 0.1% HOAc 
0.01 1.00 15.0 85.0 
5.00 1.00 20.0 80.0 
30.00 1.00 25.0 75.0 
60.00 1.00 55.0 45.0 
65.00 1.00 55.0 45.0 
70.00 1.00 100.0 0.0 
75.00 1.00 100.0 0.0 
 
A
U
0.00
0.10
0.20
Minutes
0.00 5.00 10.00 15.00 20.00 25.00 30.00 35.00 40.00 45.00 50.00 55.00 60.00 65.00 70.00 75.00
 
Figure 3-4. HPLC chromatogram of S. lateriflora under the gradient elution system shown in 
Table 3-5. 
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Table 3-6. HPLC Gradient Condition IV for Fingerprint Analysis  
ime (min) flow (mL/min) %ACN w/ 0.2% HOAc %water w/ 0.2% HOAc 
0.01 1.00 15.0 85.0 
5.00 1.00 20.0 80.0 
30.00 1.00 25.0 75.0 
60.00 1.00 55.0 45.0 
65.00 1.00 55.0 45.0 
70.00 1.00 100.0 0.0 
75.00 1.00 100.0 0.0 
 
A
U
0.00
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Minutes
0.00 10.00 20.00 30.00 40.00 50.00 60.00 70.00
 
Figure 3-5. HPLC chromatogram of S. lateriflora under the gradient elution system shown in 
Table 3-6.  
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Figure 3-8. HPLC chromatographic fingerprinting profile of S. lateriflora (250 nm, for 
precision study) 
1′ 
2′ 
3′ 4′ 
5′ 
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Figure 3-6. HPLC chromatogram of a mixture of eleven standard flavonoids under optimized 
gradient system.  
 
Table 3-7. Retention Times and UV Absorptions of Standard flavonoids Obtained Under 
Optimized HPLC Conditions 
compound retention time (min) UV λmax (nm) 
rutin (25) 11.06 254, 354 
hesperidin (29) 18.15 283 
baicalin (18) 26.80 214, 277, 316 
daidzein (30) 30.78 247, 301 (sh) 
quercetin (24) 37.44 209, 254, 372 
naringenin (27) 43.97 216, 289 
hesperitin (28) 45.95 286 
baicalein (17) 47.09 216, 276, 322 
wogonin (6) 55.74 218, 275 
chrysin (4) 56.45 213, 267, 314 
oroxylin A (5) 57.44 216, 271, 316 
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Figure 3-7. HPLC chromatogram of a mixture of three standard compounds isolated from T. 
candense under optimized gradient system.  
 
3.4. Results and discussion 
The optimized chromatographic conditions were obtained after evaluation of different 
HPLC columns and running different mobile phases (described in experimental section).  The 
complex nature of the extract necessitated a relatively long analytical run to improve resolution.  
Use of a PDA detector was extremely valuable for peak identification during the initial method 
development.  Multiple injections showed low standard error, indicating that the results were 
highly reproducible.  Precisions of RPRT and RPA of all characteristic peaks were within the 
acceptable relative standard deviation (RSD) (n=4) 3.0%, indicating that the conditions used in 
the qualitative chromatographic fingerprint analysis are satisfactory.  The chemical fingerprint 
method developed in this study was applied to verify S. lateriflora species present in ground 
plant material and to distinguish between S. lateriflora and its potential adulterants, germander.  
Also, it was applied to compare the chemical fingerprint profiles of different species in this 
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The comparison of the fingerprint profiles of S. lateriflora with its potential adulterants is 
shown in Figure 3-9.  Meanwhile, the mixture of three markers isolated from T. candense is 
included.  The comparison of the chromatograms of two sets of standard mixtures at 250, 280 
and 350 nm (shown in Figure 3-6 and 3-7) found that selecting 250 nm as the detection 
wavelength resulted in an acceptable response and enabled the detection of all 14 standards used 
in this study.  In Figure 3-9, the chromatogram of authenticated S. lateriflora species exhibits 
very different fingerprint profile compared to that of Teucrium species.  Since the UV spectra of 
three standard markers isolated from T. canadense are different from that of flavonoids, the 
combined analysis of the chromatograms and the UV spectra of a series of peaks occurring in 
these two species allowed us to differentiate S. lateriflora from its potential adulterants  
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Figure 3-9. Comparison of HPLC profiles of S. lateriflora with its potential adulterants 
detected at wavelength 250 nm. 
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Some species such as S. amoena, S. likiangensis, and S. rehderiana have been used as 
substitutes as “Huang Qin” in China (Song et al., 1981).  In the present study we found the 
fingerprint profiles of these species are similar to that of S. baicalensis (shown in Figure 3-10) 
which provided scientific support for this conventional use.  As to the chromatograms of S. 
lateriflora and S. baicalensis, their fingerprint profiles are not very similar.  In addition, the 
HPLC profile of S. barbata is different from that of S. baicalensis.  In China, S. barbata named 
“banzhilian” was used for different indication as S. baicalensis.  From the chemical point of 
view, the present results provide scientific evidence for their different uses. 
Three samples of S. lateriflora obtained from different sources were investigated in this 
study and Figure 3-11 details the fingerprint comparison of them with an authenticated sample.  
The chromatogram of sample from India showed similar HPLC profile to that of authenticated 
sample, but the fingerprints of the other two samples varied widely.  Two samples of S. barabata 
obtained from different sources were compared and the chromatograms of them are similar 
(shown in Figure 3-12).  For the different parts of the plant investigated, for example, S. 
baicalensis, the contents of flavonoids in the leaves were different from those in the root (see 
Figure 3-13) which is consistent with the results reported ((Makino et al., 2008)).  This method 
was also applied to analyze three commercial products claiming to contain S. lateriflora and the 
comparison of their HPLC profiles are shown in Figure 3-14.  The results indicated that the 
contents of flavonoids in the product of skullcap 7825 are similar to that of skullcap raw 
materials, but different from the product of skullcap 7827 and 7828.  
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Figure 3-10. Comparison of HPLC profiles of Scutellaria related species detected at 
wavelength 280 nm. 
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Figure 3-11. Comparison of HPLC profiles of S. lateriflora obtained from different sources 
detected at wavelength 280 nm. 
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Figure 3-12. Comparison of HPLC profiles of S. barabata from different sources detected 
at wavelength 280 nm. 
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Figure 3-13. Comparison of HPLC profiles of different part of S. baicalensis detected at 
wavelength 280 nm. 
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Figure 3-14. Comparison of HPLC profiles of commercial products claiming to contain S. 
lateriflora detected at wavelength 280 nm. 
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3.5. Conclusion 
The HPLC-PDA fingerprinting analysis method described in this study is the first 
detailed report of qualitative analytical method capable of using two sets of standards.  The 
mixture of eleven standard flavonoids allows not only analyzing the presence or absence of 
desired markers in different Scutellaria species but also helping in comparison of the HPLC 
profiles of all Scutellaria species.  Meanwhile two sets of standards used in this study allow us to 
differentiate S. lateriflora from its potential adulterants.  The developed method in the present 
study can be applied for the authenticity of S. lateriflora plant material and distinguishing it from 
germander; also it will assist in the quality and safety assessment of commercial products 
claiming to contain S. lateriflora.  
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Chapter 4 
Identification of Phenolic Compounds in Scutellaria lateriflora Using  
High-Performance Liquid Chromatography-Electrospray Tandem Mass Spectrometry-
Ultraviolet Photodiode Array  
 
4.1. Introduction 
The plant kingdom represents an extraordinary reservoir of novel molecules, of which 
only a small percentage has received phytochemical investigation (Wolfender et al., 1996).  It is 
estimated that about 2% of all carbon photosynthesized by plants is converted into flavonoids or 
closely related compounds (Markham, 1982).  Flavonoids constitute a highly prominent class of 
polyphenolic compounds and embrace a diversity of chemical structures.  The structure of 
flavonoids is composed of three rings with a basic C15 phenyl-benzopyrone skeleton (Figure 4-
1).  The substitution pattern of C ring, regarding the site of the B-ring as well as the keto, 
hydroxyl, methoxyl, and glycosyl groups, defines the different flavonoid groups, including 
flavones, flavonols, flavanones, flavanols, and isoflavones, etc. (Figure 4-2).  In plant, flavonoids 
are often present as O- or C-glycosides.  The O-glycosides have sugar substituents bonded to a 
hydroxyl group of the aglycone, whereas the C-glycosides have sugar substituents bonded to a 
carbon of the flavonoid aglycone, generally at position 6-C and 8-C.  The flavonoids act in plants 
as antioxidants, antimicrobials, photoreceptors, visual attractors, and feeding repellants (Pietta, 
2000).  Many studies have suggested that flavonoids exhibit a broad array of pharmacological 
activities, which include anti-inflammatory, antiallergic, antiviral, antioxidant, cancer preventive 
activities and other benefits to human health which was summarized in chapter 1.  
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Figure 4-1. Basic ring structure of flavonoids with labelling convention 
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Figure 4-2. Basic structures of the major flavonoid classes  
 
From the view point of phytochemical identification of flavonoids, difficulties mainly 
arise because many of them are isomers, especially given that the biological activities of 
flavonoids correlate with specific structural features.  Therefore, 2D NMR spectroscopy is 
commonly used for the unambiguous assignment of the structures of flavonoids, even in the case 
of simple known compounds, such as wogonin, oroxylin A, and gankwanin.  The introduction of 
LC-MS in the analysis of crude plant extract has represented an important step for the on-line 
identification of unknown compounds or for dereplication of known constituents.  Mass 
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spectrometer is a universal detector.  It can achieve very high sensitivity and provide information 
on the molecular weight as well as chemical structure (Wolfender et al., 1994).   
To date, about seventeen flavonoids, including flavone, flavanone, and their glycosides, 
five diterpenoids and three minor dihydropyranocoumarins, have been reported from the aerial 
parts of American skullcap (Gafner et al., 2003; Li et al., 2009; Maurizio et al., 1998; Zhang et 
al., 2009).  The flavonoid components far outnumber the diterpenoids found in the aerial parts of 
this plant.  From the HPLC chromatogram of this plant (shown in chapter 3), it can be concluded 
that some flavonoids have not been identified yet.  Therefore, detailed identification of the 
indigenous flavonoid components is necessary for better understanding of its traditional uses and 
authentication of skullcap as well as its products.  Quantitative determination of its major 
flavonoids has been reported recently (Gao et al., 2008; Lin et al., 2009).  However, no efforts 
have been attributed to develop LC-MS/MS methods for the identification of all the main 
phenolic compounds. 
For the purpose of phytochemical screening of flavonoids in S. lateriflora, a method of 
analysis was developed based on liquid chromatography with photodiode array and tandem mass 
spectrometric detection (LC-DAD/ESI-MS
n
) to identify the flavonoids of S. lateriflora. 
In this study, thirteen flavonoids and one stilbene derivative were identified in S. 
lateriflora, seven of which are described for the first time in S. lateriflora. 
4.2. Experimental sections 
4.2.1. Reagents and chemicals  
All solvents, including acetonitrile, water and acetic acid, were of HPLC grade and 
provided by Fisher Scientific (Fair Lawn, JN, USA) and Sigma (St. Louis, MO, USA), 
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respectively. 
Twelve standard flavonoids used in this study (shown in Figure 4-3), namely baicalein 
(17), baicalin (18), chrysin (4), oroxylin A (5), wogonin (6), gankwanin (22), quercetin (24), 
rutin (25), naringenin (27), hesperetin (28), hesperidin (29), and daidzein (30), were isolated 
from Scutellaria species by authors (see Chapter 2 for details).  Their structures were elucidated 
based on the 1D and 2D NMR spectra, HRMS data as well as comparison with reported data.  
The purity of these standards was confirmed by chromatographic methods (TLC and HPLC).  
R5=R6=R7=OH, R8=R4'=H                      baicalein (17)
R5=R6=OH, R7=O-GlcUA, R8=R4'=H    baicalin (18)
R5=R7=OH, R6=R8=R4'=H                      chrysin (4)
R5=R7=OH, R8=OCH3, R6=R4'=H          wogonin (6) 
R5=R7=OH, R6=OCH3, R8=R4'=H          oroxylin A (5)
R5=R4'=OH, R7=OCH3, R6=R8=H          genkwanin (22)
R7=OH, R3'=H, R4'=OH                        naringenin (27) 
R7=OH, R3'=OH, R4'=OCH3                 hesperetin (28)
R7=O-rutinosyl, R3'=OH, R4'=OCH3    hesperidin (29)
O
O
R8
R7
R6
R5
R3=OH                quercetin (24)
R3=O-rutinosyl    rutin (25)
R7
OH
R3'
R4'
O
O
O
O
HO
OH
OH
R3
OH
daidzein (30)
O
O
OH
HO
R4'
Figure 4-3. Chemical structures of twelve standard flavonoids investigated  
 
4.2.2. Standard solutions 
Standard flavonoid solutions were prepared at a concentration of 1 mg/mL in methanol.  
Working solutions were obtained by twenty folds dilutions of concentrations from 1mg/mL to 50 
μg/mL.  All these solutions were stored in refrigerator. 
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4.2.3. Sample preparation  
The aerial parts of S. lateriflora investigated were purchased from Starwest botanicals 
(http://www.starwest-botanicals.com) and authenticated by Dr. Vaishali Joshi at the National 
Center for Natural Products Research, University of Mississippi, where a voucher specimen 
(voucher no. 2120) has been deposited. 
The dried powder of the aerial parts (1.0520 g) of S. lateriflora was extracted with 20 mL 
MeOH under ultrasonication for 30 min followed by centrifugation for 5 min at 1550 rpm.  The 
supernatant was transferred to 100 mL flask.  This process was repeated twice and respective 
supernatants were combined and evaporated to dryness.  The residue was dissolved in 2 mL of 
HPLC grade methanol and transferred to 5 mL volumetric flask.  The flask was rinsed with about 
1.5 mL methanol twice and the final volume was adjusted to 5 mL with methanol. 
Prior to injection, this solution was mixed thoroughly and 2 mL of it was filtered through 
0.45 μm membrane.  The first 0.5 mL was discarded and the remaining volume was collected 
into the HPLC sample vial for analysis. 
4.2.4. LC/ESI-MS
n
 conditions 
Mass spectrometry experiment was performed on a LCQ ion trap instrument (Finnigan 
MAT. Thermo Scientific, Waltham, MA, USA) with an electrospray source.  Ultrahigh pure 
helium (He) was used as the collision gas and high purity nitrogen (N2) as the nebulizing gas.  
The operating parameters were optimized for baicalin in the negative ion mode .  The optimized 
MS conditions were as follows: electrospray voltage of the ion source at 3.5 kV with the shealth 
gas at 45 arbitrary units (AU), capillary voltage at 28 V, auxiliary gas at 15 AU, capillary 
temperature at 300 C, and tube lens offset voltage at -10 V.  For full scan MS analysis, the 
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spectra were recorded over the range of m/z 100–1000.  A syringe pump was used for the direct 
injection of pure standard dissolved in MeOH (about 50 μg /mL).  Following each first-order MS 
scan, the most intense ion (usually pseudomolecular ion during compound elution) was selected 
and fragmented up to the MS
4
 stage by CID, each successive most-abundant fragment ion being 
selected again as precursor ion for the next step.  The collision energy for CID was between 30-
45%, and the isolation width of precursor ions was 1.0 U.  The data were analyzed using the 
XCalibur software.  
The HPLC system employed in the LCQ ion trap instrument consists of a model TSP 
P4000 quaternary pump coupled with a mode TSP AS3000 autosampler and a model TSP 
UV6000 diode-array detector. The chromatographic analysis was conducted at ambient 
temperature and the chromatographic separations were carried out on the same column using the 
same elution program as developed in chapter 3. 
4.3. Results and discussion 
In the present study, we have examined the mass fragmentation behavior of twelve 
standard flavonoids present in Scutellaria species in the negative ion mode and obtained 
fragmentation patterns for each compounds.  Thereafter we have characterized the phenolic 
compounds from the methanol extract of S. lateriflora.  For the identification of the different 
compounds from the extract, sample was injected in full scan mode in order to choose the 
compounds of interest.  Then, the MS-MS scan mode was selected based on the predominant 
ions obtained in the mass spectrum in full scan mode.  The structure of each compound was 
identified by the elucidation of its fragmentation pathway as well as by the comparison of its 
fragmentation information to that of standard flavonoid obtained and reported data.  
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For the convenience of discussion the CID-MS-MS spectra, the fragments recorded for 
the two bonds cleavages of C ring have been annotated according to the nomenclature proposed 
by Ma et al (Ma et al., 1997).  Scheme 4-1, adapted from Ma et al. shows the various 
retrocyclization fragments observed in this study.  The 
i,j
A
-
 and 
i,j
B
-
 represent product ions 
containing intact A and B rings, the superscript i and j indicate the C-ring bonds that have been 
broken. 
 
Scheme 4-1. Nomenclature adopted for the different retrocyclization cleavage fragments of 
deprotonated flavones, flavonols and flavanones observed in this study (adapted from Ma)
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4.3.1 Fragmentation pathways of twelve standard flavonoids  
In this study the ESI-MS
n
 fragmentation behaviors as well as their corresponding UV 
characteristics of twelve flavonoids (their structures shown in Figure. 4-3), including flavones 
(baicalein, baicalin, chrysin, wogonin, oroxylin A, gankwanin), flavonols (quercetin and rutin), 
flavanones (hesperetin, hesperidin and naringenin), and isoflavone (daidzein), have been 
investigated in detail and summarized in Table 4-1.  Some common features, for instance the 
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losses of small neutral molecules and/or radicals from [M-H]
-
 ions, such as CO (28 Da), CO2 (44 
Da), H2O (18 Da), and/or 
.
CH3 (15 Da), can be observed.  It has been demonstrated that the 
losses of CO and CO2 from the [M-H]
-
 ion are due to the contraction of C ring (Fabre et al., 
2001) and other characteristic neutral losses are very useful for determination of the presence of 
specific functional groups.  Negative ion mode was chosen for ESI-MS
n
 analysis in this study, 
since background noise and interfering peaks derived from mobile phase were found to be much 
less than in the positive mode. 
Fragmentation pathways of hydroxylated flavones 
The deprotonated molecular ion of baicalein with tri-hydroxyl groups on A ring, [M−H]− 
at m/z 269, was obtained after full-scan ESI-MS.  In the ESI-MS
2
 experiment, the product ion at 
m/z 251 as base peak was observed, which is resulted from the loss of H2O from [M−H]
−
 at m/z 
269.  Same product ion could not be observed for chrysin in this study as well as for luteolin 
reported (Fabre et al., 2001), in which two hydroxy groups are located on C-5 and C-7 position, 
respectively.  Therefore, the ion involved in the loss of H2O can be observed only when the 
flavone has vicinal hydroxy groups.  The ion at m/z 241 is due to the loss of CO, and the m/z 223 
ion is due to the successive loss of H2O and CO (see Scheme. 4-2).  Baicalin is an O-glucuronide 
of baicalein.  Upon CID, the glycosidic bond was easily cleaved to generate an ion at m/z 269 
attributed to the neutral loss of a glucuronic acid (∆m = 176 Da).  In the MS3 experiment, ion at 
m/z 269 produced the same fragments as baicalein described above. 
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Table 4-1 LC-UV/MS
n
 Characteristics of Twelve Standard Flavonoids  
compound UV 
λmax 
(nm) 
[M-H]
-
 
m/z 
MS
n
 ions m/z (relative abundance) 
baicalein  
(17) 
216, 
274, 
322 
269 MS full scan: 269 (100); 
MS
2
 [269]: 251 (100), 241 (30), 223 (32), 197 (20), 169 (7); 
MS
3
 [251]: 223(100), 213 (7) 
baicalin  
(18) 
216, 
275, 
316 
445 MS full scan: 891 (100), 445 (83),269 (62); 
MS
2
 [445]: 269 (100), 175 (16) 
wogonin  
(6) 
216, 
274 
283 MS full scan: 283 (100); 
MS
2
 [283]: 268; 
MS
3
 [268]: 240 (56), 239 (100), 224 (14), 223 (34), 212 
(22), 211 (34), 163 (44); 
MS
4
 [239]: 211 (100) 
oroxylin A  
(5) 
215, 
271, 
317 
283 MS full scan: 283 (100); 
MS
2
 [283]: 268; 
MS
3
 [268]: 240 (36), 239 (100), 224 (12), 223 (20), 212 
(38), 211 (25), 163 (7); 
MS
4
 [239]: 211 (100) 
gankwanin 
(22)  
215, 
266, 
336 
283 MS full scan: 283 (100); 
MS
2
 [283]: 268; 
MS
3
 [268]: 240 (9), 239 (3) 
hesperetin  
(28) 
286 301 MS full scan: 301 (100); 
MS
2
 [301]: 286 (100), 283 (48), 257 (59), 242 (99), 233 (4), 
215 (9), 199 (12), 125 (9); 
MS
3
 [286]:258 (97), 242 (100), 201 (36), 174 (22), 164 (16) 
hesperidin 
(29)  
283 609 MS full scan: 609 (100); 
MS
2
 [609]: 301 (100) 
quercetin  
(24) 
205, 
255, 
370 
301 MS full scan: 301 (31); 603 (100), 905 (31); 
MS
2
 [301]: 273 (13), 257 (11), 193 (5), 179 (100), 151 (45); 
MS
3
 [273]:245 (17), 229 (100), 163 (16); 
MS
3
 [257]:239 (79), 229 (100), 211 (67); 
MS
3
 [179]: 169 (30), 151 (100) 
rutin (25) 206, 
255, 
355 
609 MS full scan: 609 (100); 1219 (69); 
MS
2
 [609]: 301 (100), 300 (91), 271 (13); 
MS
3
 [301]:273 (15), 271 (97), 257 (12), 255 (57), 179 (100) 
narigenin  
(27) 
216, 
287 
271 MS full scan: 271 (100); 
MS
2
 [271]: 177 (17), 151 (100); 
MS
3
 [177]:133 (12), 109 (100); 
MS
3
 [151]: 107 (100); 
chrysin  
(4) 
212, 
267, 
311(sh) 
253 MS full scan: 253 (100); 
MS
2
 [253]: 225 (2), 209 (20), 181 (2), 151 (4) 
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daidzein  
(30) 
247, 
302 
(sh) 
253 MS full scan: 253 (100); 507 (54); 
MS
2
 [253]: 225 (16), 209 (7); 
 
 
 
Fragmentation pathways of methoxylated flavone isomers 
Wogonin (8-OCH3), oroxylin A (6-OCH3), and genkwanin (7-OCH3) are three 
methoxylated flavone isomers with the same MW of 284.  They exhibited a significant [M-H-
CH3]
−•
 radical anion at m/z 268 as base peak and no other fragmentation was observed in their 
MS
2
 spectra.  The loss of a CH3 radical (15 Da) from the [M-H]
−
 ion explained the presence of a 
methoxy group.  The MS
3
 product ion spectra of these three compounds, obtained under the 
same conditions, are shown in Figure 4-4.  In MS
3
 experiment of the [M-H-CH3]
−•
 ion of 
genkwanin, no any other fragmentation, except low signal intensity ions at m/z 240 (9, -CO) and 
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239 (3, -COH
•
), were observed.  This suggested that this radical anion is probably rearranged to a 
stable 7-keto-diconjugated-3,4-enol derivative avoiding any further fragmentation for this 7-
methoxy-4′-hydroxyflavone aglycone (Fabre et al., 2001).  But six ions were observed in MS3 
spectra for both wogonin and oroxylin A.  The product ion at m/z 240 was produced by the loss 
of CO from 4-position, and ion at m/z 224 was produced by loss of CO2 from 1-O and 4-CO as 
discussed in the literature (Fabre et al., 2001).  The notable ions are those at m/z 239 and 223, 
and the base peak at m/z 239.  It was proposed that these ions are due to the respective losses of 
COH
•
 and CO2H
•
 (Wu et al., 2004b) and is as shown in Scheme 4-3.  The mechanism for the loss 
of COH
•
 may be loss from 4-CO and one hydrogen atom from the molecule, thus the molecule is 
easy to form steady conjugated system.  A similar fragmentation for the loss of CO2H
•
 from the 
loss of 1-O and 4-CO and one hydrogen atom has been observed.  The ion at m/z 212 was 
produced by the loss of two CO, the position is not known.  Although the fragments of wogonin 
were almost identical to those of oroxylin A in MS
3
 experiment, interesting differences between 
these two isomers could be observed from MS
3
 spectra when we compared these two spectra 
carefully (show in Table 4 -2).  The relative abundance of ion 
0,2
A
-
 at m/z 163 is higher than that 
of the ion at m/z 212 for wogonin.  On the contrary, the relative abundance of ion 
0,2
A
-
 at m/z 163 
is lower than that of the ion at m/z 212 for oroxylin A.  This allowed us to distinguish these two 
isomers.  Based on the different fragmentation behaviors of their MS
3
 spectra these three isomers 
can be differentiated.  
 
 
 
(a)  (b) 
 84 
wogonin.268 #7 RT: 0.15 AV: 1 NL: 5.66E3
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Figure 4-4. ESI-MS
3
 spectra of three methoxylated flavone isomers: (a) wogonin; (b) oroxylin 
A; (c) gankwanin 
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Table 4-2. ESI-MS
n
 Product Ions of Three Methoxylated flavonoids  
scan mode ion(s) produced wogonin oroxylin A gankwanin 
MS full scan [M-H]
-
 283 283 283 
 
MS
2
 [283] 
[M-H-CH3]
.-
 268 268 268 
[M-H-CH3-CO]
.-
 240 (56) 240 (36) 240 (9) 
[M-H-CH3-COH]
.-
 239 (100) 239 (100) 239 (3) 
 
 
MS
3
 [268] 
[M-H-CH3-CO2]
.-
 224 (14) 224 (12)  
[M-H-CH3-CO2H]
.-
 223 (34) 223 (20)  
[M-H-CH3-2CO]
.-
 212 (22) 212 (38)  
0,2
A
-
 163 (44) 163 (7)  
 
Fragmentation pathways of flavanones 
The fragmentation of three flavanones, narigenin, hespertin, and hesperidin, were 
investigated. 
The MS
2
 spectra of narigenin yielded the 
1,3
A
-
 ion at m/z 151 as the base peak.  Also the 
ion at m/z 177 with low relative intensity was observed, which was resulted from the loss of B 
ring system.  The ion at m/z 107 in the MS
3
 experiment was produced by the loss of CO2 from 
the ion at m/z 151 (see Scheme 4-4).  
The MS
2
 fragmentation pathway of hesperetin is much more complex than that of 
narigenin (shown in Scheme 4-5).  There are two main fragmentation pathways for hespertin.  
The first pathway begins with the loss of CH3 from the anion [M-H]
-
 to form the radical anion 
[M-H-CH3]
−•
, followed by the losses of CO and CO2 in the MS
3
 experiment to form the ions at 
m/z 258 and 242, respectively.  The second main pathway related to almost all other fragmental 
ion at m/z 257, 233, and 125, corresponding to the neutral loss of CO2, C3O2, and 
1,4
A
-
 ion, from 
the [M-H]
-
 ion.  
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Fragmentation pathways of flavonols 
The fragments proposed for quercetin consecutive to CO and CO2 losses (b and d) are 
similar to the corresponding luteolin fragments reported by Fabre (Fabre et al., 2001).  Further 
losses of CO2 and CO from b and d, respectively, give rise to the resonance-stabilized ion c (see 
Scheme 4 -6).  The most interesting fragment concerns the base peak at m/z 179.  This 
1,2
A
-
 
diagnostic ion undergoes further loss of CO giving rise to a 
1,2
A
-
 - CO ion at m/z 151.  It is worth 
mentioning that this specific pathway, involving the 1,2 bonds, observed in this study, was 
consistent with the result observed for fisetin by other group (Fabre et al., 2001).  In the MS
2
 
experiment of rutin, the ion at m/z 301 as base peak was observed suggesting the loss of rutinose 
residue.  
Fragmentation pathways of isoflavonoidh 
In this study the consecutive loss of CO from pseudomolecular ion of daidzein can be 
observed in negative mode (see Scheme 4-7).  Also it is worth noticing that the fragmentation 
pathway of isoflavonoid daidzein is analogous to that of flavone chrysin in negative mode.  But 
the ratio of relative abundance of product ions at m/z 225 and 209 for these two types of 
compounds with the hydroxy group at different ring is different (shown in table 4-3).  
 
Table 4-3. Relative Intensity of Ions in ESI-MS/MS of Chrysin and Daidzein 
compound m/z=225 [M-H-CO] (%) m/z=209 [M-H-CO2] (%) 
chrysin  2 20 
daidzein  16 7 
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4.3.2 Characterization of phenolic compounds from S. lateriflora using HPLC-DAD/ESI-MS
n
  
The LC-MS chromatogram (TIC) of the methanolic extract of skullcap in negative ion 
mode is shown in Figure 4-5.  The molecular mass of each component at its retention time (tR) in 
full scan mode was recorded.  Fourteen phenolic compounds were identified by the elucidation 
of their fragmentation pathways and by comparison of their MS fragmentation patterns as well as 
UV spectra (see Figure 4-6 and Table 4-4) with standard flavonoids or reported data.  
 
 
Figure 4-5. HPLC-ESI-MS
n
 analysis of the extract of skullcap. (a)HPLC-UV chromatogram 
monitored at 280 nm; (b) LC-negative ion ESI-MS total ion current (TIC) chromatogram. 
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Table 4-4. LC-UV/MS
n
 Identification of Phenolic Compounds in S. lateriflora  
 
 
 
 
 
 
 
 
 
 
 
 
Peak 
no. 
tR 
(min) 
UV .λmax 
(nm) 
[M-H]
-
 
m/z 
ESI-MS (MS
n
) m/z 
(relative abundance) 
identification 
32 24.50 251, 301 417 ESI-MS: 417, 255;  
MS
2
 [417]: 255 (7), 237 
(100), 211 (18) 
5-(β-D-glucosyloxy)-
3-hydroxy-trans-
stilbene-2-carboxylic 
acid
b
 
33  27.72 
 
275, 350 
(sh) 
445 ESI-MS: 445, 269;  
MS
2
 [445]: 269 (100), 251 
(83), 241 (15), 223 (30), 197 
(18), 171 (9), 151 (5), 137 (5) 
norwogonin-7-O-
glucuronide 
b
  
 
18  28.44 268, 315 445 ESI-MS: 445, 269; 
MS
2
 [445]: 269 (100), 251 
(72), 241 (37), 223 (37), 197 
(22), 171 (9), 145 (5) 
baicalin 
a
 
 
34  30.36 
 
242, 282, 
348 (sh) 
447 ESI-MS: 447, 271;  
MS
2
 [447]: 271 (100); 
MS
3
 [271]: 253 (49), 243 
(100), 227 (24), 199 (13), 167 
(8) 
5,6,7-trihydroxy 
flavanone-7-O-
glucuronide 
b 
(dihydrobaicalin) 
35  36.22 232, 282 445 ESI-MS: 445, 269; 
MS
2
 [445]: 269 (76), 241 
(65), 225 (100), 197 (45), 183 
(7), 181 (9), 171 (8) 
galangin-7-O- 
glucuronide 
b
 
36  36.62 237, 282 
 
461 ESI-MS: 461, 285; 
MS
2
 [461]: 285 (100), 270 
(22); 
MS
3
 [285]: 270 (31), 269 
(100), 243 (6), 166 (11) 
dihydrooroxylin A-7-
O-glucuronide 
b
 
37  37.59 268, 308 459 ESI-MS: 459, 283; 
MS
2
 [459]: 283 (100), 268 
(51), 175 (5), 113 (11) 
MS
3
 [283]: 268 (100), 239 (8) 
oroxylin A-7-O-
glucuronide 
b
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Table 4-4. LC-UV/MS
n
 Identification of Phenolic Compounds in S. lateriflora  
 (Cont.) 
a
 Identified by comparing the retention time, UV spectra and MS
n
 data with standard flavonoids. 
b
 Identified by UV and MS
n
 data in comparison with literature data. 
 
 
 
 
 
 
 
 
 
Peak 
no. 
tR 
(min) 
UV .λmax 
(nm) 
[M-H]
-
 
m/z 
ESI-MS (MS
n
) m/z 
(relative abundance) 
identification 
19  39.67 236, 268 
 
459 ESI-MS: 459, 283; 
MS
2
 [459]: 283 (100), 268 (70), 
175 (4); 
MS
3
 [283]: 268 (100), 137 (4) 
wogonin-7-O-
glucouronide 
b
 
38  39.80 237, 280, 
329  
489 ESI-MS: 489, 313; 
MS
2
 [489]: 313 (100), 298 (83), 
283 (26); 
MS
3
 [313]: 298 (100), 283 (3), 
269 (5), 254 (5), 214 (3), 193 
(3), 167 (3) 
5,7-dihydroxy-6,8-
dimethoxy flavone-
7-O-glucuronide 
b
 
39 40.34 239, 291 461 ESI-MS: 461, 285; 
MS
2
 [461]: 285 (100), 270 (32); 
MS
3
 [285]: 270 (100), 243 (6), 
223 (5), 166 (8) 
dihydrowogonin-7-
O-glucuronide 
b
 
17 47.50 270, 320 269 ESI-MS: 269, 251; 
MS
2
 [269]: 251 (100), 241 (33), 
223 (30), 197 (18), 169 (7) 
baicalein 
a
 
6 56.22 280 283 ESI-MS: 283.18, 268.36; 
MS
2
 [283]: 268 (100); 
MS
3
 [268]: 240 (53), 239 (100), 
224 (14), 223 (36), 212 (20), 211 
(34), 163 (44) 
wogonin 
a
 
5 58.06 272, 316 283 ESI-MS: 283.18, 268.36; 
MS
2
 [283]: 268 (100); 
MS
3
 [268]: 240 (32), 239 (100), 
224 (14), 223 (20), 212 (39), 211 
(27), 163 (8)  
 
oroxylin A 
a
 
4 56.62 271, 
320(sh) 
253 ESI-MS: 253, 209; 
MS
2
 [253]: 225 (4), 209 (26), 
181 (2), 151 (6) 
chrysin 
a
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Compound 32 exhibited a UV spectrum with characteristic bands at 251 nm and 301 nm, 
which are not consistent with the typical UV spectral pattern of flavonoids, suggesting a 
nonflavonoid type of compounds.  The characteristics of the UV spectrum of this compound are 
identical with those of trans-stilbene (Beale et al., 1953; Suzuki et al., 1960).  The ESI-MS in full 
scan mode gave an ion [M-H]
-
 at m/z 417 and an ion [M-H-164]
-
 at m/z 255 produced by the loss 
of a glucose residue.  In the MS
2
 experiment, the ion at m/z 237 represented the base peak 
resulted from the loss of H2O of [M-H-164]
-
, suggesting vicinal hydroxy groups or a hydroxy 
and one free carboxylic group present in the molecule.  The ion at m/z 211 was attributed to the 
neutral loss of CO2, supporting the presence of carbony group.  The proposed fragmentation 
pathway of 32 was shown in scheme 4-8.  Based on these results compound 32 was tentatively 
identified as 5-(β-D-glucosyloxy)-3-hydroxy-trans-stilbene-2-carboxylic acid, which has been 
isolated from Scutellaria scandens (Miyaichi et al., 1988a).  
 
O
OH
COOH
O
O
C
O
OH
-H2O
-CO2
O
m/z=237
m/z=211
m/z=255
Scheme 4-8. Proposed fragmentation pathways of compound 32 agylcone 
 
Compound 33, 18 and 35 are isomers with the same ion [M-H]
-
 at m/z 445 in full scan 
mode.  The product ion [M-H-176]
-
 at m/z 269 was observed as base peak in MS
2
 experiment for 
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these three isomers, indicating the neutral loss of a glucuronic acid reside from [M-H]
-
 ion.  
Since the glucoside bond of O-glucuronide was easily cleaved to generate its aglycone, this 
neutral loss is very useful for the identification of O-glucuronides.  In the MS
2
 experiment of 
compound 33 and 18, ion at m/z 269 of both compounds produced the identically diagnostic 
neutral losses of H2O (18 Da), CO (28 Da), and the losses of both H2O and CO (46 Da), resulting 
in the ion at m/z 251, 241 and 223, respectively, whose fragmentation mechanism was consistent 
with the standard baicalein.  Since the tR value as well as the UV spectrum of compound 18 were 
identical to those of authentic baicalin, it was identified as baicalin.  Compound 33 exhibited the 
same UV behavior as norwogonin 7-O-glucuronide (Oi et al., 1988), indicating 33 is 
norwogonin-7-O-glucuronide.  In the MS
2
 experiment of compound 35, no product ion attributed 
to the neutral loss of H2O from its precursor ion at m/z 269, indicating absence of vicinal 
hydroxy groups in A ring, whereas product ions at m/z 241 and 225, which resulted from the 
neutral losses of CO and CO2 respectively, were predominant, suggesting 35 is galangin-7-O-
glucuronide.  The MS
2
 fragmentation behaviors as well as UV spectrum of this compound were 
identical to those of reported data (Han et al., 2007). 
The peak 34 showed [M-H]
-
 ion at m/z 447 and aglycone [M-H-176]
-
 signal at m/z 271 in 
full scan mode, which are indicative of the presence of a glucuronic acid residue.  Further MS
2
 
spectra of m/z 271 yielded the ions at m/z 253, 243, 227, and 167.  The ion at m/z 253 resulted 
from the loss of H2O, revealing the presence of two OH groups in ortho position.  The ions at 
m/z 243 and 227 resulted from the neutral losses of CO and CO2 from the corresponding [M-H-
176]
-
 ion.  The ion at m/z 167 was attributed to the 
1,3
A
-
, suggesting the occurrence of three OH 
groups in A ring.  The molecular mass of this compound was 2 Da greater than that of baicalin. 
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Also band I, associated with the absorption ascribed to the B-ring cinnamoy system, was weak in 
its UV spectrum, while band II, associated with absorption involving the A-ring benzoy system, 
showed bathochromic shift with respect to the value of baicalin, indicating a flavanone-type  
compound.  Based on the evidence that all 7-O-glucuronides showed essentially identical UV 
spectra with their corresponding aglycones (Liu et al., 2009), 7-OH glycosylation was proposed 
for 34.  On the basis of comparing the UV spectrum of 34 with reported data (Liu et al., 2009), 
this compound was characterized as 5,6,7-trihydroxy-flavanone-7-O-glucuronide. 
Peak 37 and 19 are isomers with the molecular weight of 460 Da.  They showed the same 
product ion [M-H-176]
-
 at m/z 283, which indicated the loss of a glucuronic acid moiety as 
discussed above.  For the aglycone part of these two compounds a significant [M-H-CH3]
−•
 
radical anion at m/z 268 presented as base and sole peak in their MS
2
 spectra, suggesting the 
presence of a methoxy group for both compounds.  To further investigate the structures of these 
two isomers, tandem mass experiments were employed on the two [M-H-176-15]
-
 ions at m/z 
269.  Although the products ions of m/z 269 for these two compounds were identical, the relative 
intensities of ion at m/z 212 and m/z 163 were different.  Comparison with the results obtained 
for authentic wogonin and oroxylin A suggested that peak 37 and 19 are oroxylin A-7-O-
glucuronide and wogonin-7-O-gluconide, respectively. 
Compounds 36 and 39 both gave an [M-H]
-
 ion at m/z 461 and their agylcone ion at m/z 
285 (-176 Da), which suggested the presence of a glucuronic acid moiety.  The UV spectra of 
these two compounds only exhibited band II, indicating a flavanone skeleton.  The MS
2
 spectra 
of the ion at m/z 285 yielded an ion at m/z 270, which resulted from the loss of a CH3 radical (15 
Da) from the ion [M-H-176]
-
 at m/z 285.  In addition, the ion 
1,3
A
-
 at m/z 166, which are the 
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characteristic of flavanone, suggested that these two compounds are either dihydrowogonin or 
dihydrooroxylin A.  Compound 36 was identified as dihydrooroxylin A-7-O-glucopyranoside 
since its UV spectrum was consist with the literature (Miyaichi et al., 1995) and 39 as 
dihydrowogonin-7-O-glucopyranoside. 
Compounds 38 exhibited an [M-H]
-
 ion at m/z 489.  CID of this compound produced ion 
[M-H-176]
-
 at m/z 313, which was resulted from the neutral loss of a glucuronic acid residue.  
Fragments of m/z 298 and 283, due to the sequential losses of CH3 radicals, indicated the 
presence of two methoxy groups.  In the MS
3
 experiment of m/z 313, the product ion at m/z 298 
was base peak.  The product ion at m/z 269 was produced by the loss of COH
•
, and ion at m/z 
254 was produced by loss of CO2 from m/z 298.  The ion 
0,2
A
-
 at m/z 193 along with above 
mentioned two ions at m/z 269 and 254 were indicative for the second methoxy group on A ring.  
The UV spectrum of 38 was same as 5,7-dihydroxy-6,8-dimethoxy flavone-7-O-glucuronide 
reported in the literature (Liu et al., 2009).  Thus, compound 38 was identified as 5,7-dihydroxy-
6,8-dimethoxy flavone-7-O-glucuronide. 
The peak at tR=12.9 min in TIC showed an [M-H]
-
 ion at m/z 623 as well as product ion 
[M-H-162]
- 
at m/z 461 and [M-H-162-146]
-
 at m/z 315 resulting from the sequential losses of 
glucosyl (162 Da) and rhamnosyl (146 Da) residues, and revealing the presence of one glucose 
and one rhamnose moieties.  The molecular weight of the agylcone of this compound is 316.  
This compound was tentatively characterizated as isorhamnetin-7-O-rhamnosylglucoside by Guo 
et al (Han et al, 2007).  The same compound was also observed by Yao‟s group (Liu et al., 2009) 
from S. baicalensis, and they doubted the result from Guo et al since the UV spectrum for 
isorhamnetin and its 7-O-glycosides reported were characterized by two bands at 253 and 370 
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nm, which are quite different from that of the compound studied with absorptions at 290 and 330 
nm.  No conclusion was made based on the data obtained by Yao‟s group.  In the present study 
same UV spectral behavior and MS fragmentation patterns were also observed.  We endeavored 
to elucidate its structure based on the data obtained, but further MS/MS experiments are needed 
to get sufficient information.   
Compound 17, 6, 5, and 4 were positively characterized as baicalein, wogonin, oroxylin 
A, and chrysin, respectively, by the comparison of their UV spectrum and MS
n
 fragmentation 
patterns with corresponding standards. 
4.4. Conclusion 
As has been demonstrated, the MS-MS spectra of the deprotonated molecules [M-H]
-
 for 
four types of flavonoids yielded different fragmentation profile.  The diagnostic fragment ions 
resulted from the cleavage of two bonds at positions 1/3, 0/2 and 0/4 of the C-ring are very 
helpful for the structural determination of the A- and B-ring substitution patterns.  Furthermore, 
loss of internal sugar moiety linked to aglycone in the flavonoid glycoside together with those 
fragment ions mentioned above are also useful for the determination of the properties of the 
linkage between the sugar and aglycone (O- or C-glycosides), and the position of sugar 
substitution in the aglycone.  In addition, losses of H2O and 
.
CH3, etc. are valuable in the 
determination of the presence of some functional groups.  Based on the differences in the relative 
abundances of some specific ions isomeric methoxylated flavonoids can be discriminated.  These 
fragmentation patterns have been used as guidelines for the determination of the compounds in 
crude plant extracts. 
LC/ESI-MS
n
 is a very promising complementary tool for the characterization of 
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flavonoids.  The LC/MS-MS method developed in the NCNPR was successfully employed to 
separate and identify the major flavonoids from S. lateriflora, which provides knowledge of both 
its chemical composition and its potential use as a source of natural antioxidants.  In this study, 
we have demonstrated how the combination of UV spectra and ESI-MS
n
 spectra allows a fast 
characterization of thirteen flavonoids and one stilbene derivative without time-consuming 
isolation of compounds even if reference compounds are not available or on hand.  It is worthy 
noted that the choice of appropriate conditions for collision induced fragmentation is very 
important to assure acquisition of enough fragmentation information for structural 
characterization of these types of compounds.  Also special care should be taken during the 
interpretation of MS data since there are many isomers co-existed in the skullcap extract.  
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Chapter 5 
Evaluation of Bioactivities of Methanol Extracts of S. baicalensis L. and S. lateriflora 
Georgi and Flavonoids Isolated from Them 
 
5.1. Introduction  
American skullcap has been reputed as a nerve tonic, sedative, and anticonvulsant among 
Native Americans and Europeans (Millspaugh, 1974).  It has been traditionally used to treat 
epilepsy and other neurological disorders such as nervous tension states, hysteria, chorea, 
anxiety, and insomnia.  Despite its extensive uses, there are limited data on its bioactive 
constituents, the pharmacological properties and its safety issues.  Results from in vivo animal 
behavior trials suggested that the aqueous extract of plant material of American skullcap has 
anxiolytic property, and that the flavonoids, and possibly the amino acids contents, may be 
responsible for this activity (Awad et al., 2003).  Two flavone-glycosides, scutellarein and 
ikonnikoside I isolated from American skullcap, have been found to bind to one of the serotonin 
receptors, the 5-HT7 receptor, in brain (Gafner et al., 2003).  The 5-HT7 receptor is thought to 
play a role in the pathogenesis of various ailments such as sleep disorders, depression, and 
migraine (Gafner et al., 2003).  Significant anxiolytic effects have been demonstrated in a double 
blind, placebo-controlled study of healthy volunteers and results indicated that commercial 
American skullcap products have clinical benefits as a relaxing nervine with no overt evidence of 
toxicity or side effects (Wolfson et al, 2003).  
Chinese skullcap has attracted attention since 1980‟s, and a number of studies related to 
the evaluation of the bioactivities of aqueous extract of this species as well as its major 
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flavonoids, including baicalein, baicalin, and wogonin, have been reported.  The results showed 
that both aqueous extract and the flavonoids isolated from it demonstrated diverse bioactivities, 
as summarized in chapter 1.   
The aim of the present study is to evaluate the bioactivities of crude extracts of the two 
above mentioned skullcap species as well as thirteen individual flavonoids isolated from them to 
provide scientific support for the traditional usages of these plants.  In the present study, the 
methanol extracts of S. baicalensis George (SBE), and S. lateriflora L (SLE) together with 
thirteen flavonoids, including baicalein (17), baicalin (18), chrysin (4), oroxylin A (5), wogonin 
(6), genkwanin (22), viscidulin I (23), quercetin (24), rutin (25), naringenin (27), hesperetin (28), 
hesperidin (29) and daidzein (30), isolated from these two species, were tested in a panel of 
bioassays to determine their anticancer, antioxidant, anti-inflammatory, estrogenic activity and 
cytotoxic activities.  In addition, their activities on peroxisome proliferator-activated receptor-
alpha and -gamma (PARP  and PPARγ) were also evaluated.  
5.2. Materials and methods 
5.2.1. Materials  
The aerial parts of S. lateriflora were purchased from Starwest botanicals 
(http://www.starwest-botanicals.com) and authenticated by Dr. Vaishali Joshi at NCNPR, 
University of Mississippi, where a voucher specimen (voucher no. 2120) has been deposited. 
S. baicalensis ethanol extract was purchased from Chinese Herbs Direct and 
authenticated by comparison of its TLC profiles with that of the authentic sample provided by 
Dr. Vaishali Joshi.  A voucher specimen (Voucher No. 1181) has been deposited in the 
repository of NCNPR. 
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Both samples were extracted with MeOH and the MeOH extracts were dried in vacuo for 
bioassay. 
Thirteen standard flavonoids used in this study were isolated from S. baicalensis and S. 
lateriflora.  Their structures were elucidated based on the 1D and 2D NMR spectra, HRMS data 
as well as comparison with reported data.  The purity of these standards was confirmed by 
chromatographic methods (TLC and HPLC).  
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R5=R6=R7=OH, R8=R4'=H                              baicalein (17)
R5=R6=OH, R7=O-GlcUA, R8=R4'=H            baicalin  (18) 
R5=R7=OH, R6=OCH3, R8=R4'=H                  oroxylin A  (5) 
R5=R7=OH, R8=OCH3, R6=R4'=H                  wogonin  (6)
R5=R4'=OH, R7=OCH3, R6=R8=H,                 genkwanin  (22)
R5=R7=OH, R6=R8=R4'=H                              chrysin  (4)
daidzein (30)
R7=R4'=OH, R3=R3'=H                                     naringenin (27) 
R7=R3'=OH, R4'=OCH3, R3=H                         hesperetin (28)
R3=H, R7=O-rutinosyl, R3'=OH, R4'=OCH3     hesperidin (29)
O
O
R8
R7
R6
R5
R3=R2'=R6'=OH, R3'=R4'=H                         viscidulin I (23)
R3=R3'=R4'=OH, R2'=R6'=H                         quercetin (24)
R3=O-rutinosyl,  R3'=R4'=OH, R2'=R6'=H,   rutin (25)
R2'
R3'
R4'
R5'
R6'
R7
OH
R3'
R4'
O
R3
O
O
O
HO
R3'
R6'
R4'
R3
O
O
OH
HO
OH
Figure 5-1. Structures of flavonoids tested
R2'
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5.2.2. Methods 
5.2.2.1. Assays for in vitro cytotoxicity 
The samples were tested for their in vitro cytotoxicity against a panel of normal cell lines 
(Vero: monkey kidney fibroblasts and LLC-PK11: pig kidney epithelial cells) and solid tumor 
cell lines (HepG2: human hepatocellular carcinoma, SK-MEL: human malignant melanoma, KB: 
human epidermal carcinoma (oral), BT-549: human breast carcinoma, and SK-OV-3: human 
ovary carcinoma) (Mustasa et al., 2004)  All cell lines were obtained from American Type 
Culture Collection (ATCC) and grown in RPM1-1640 medium supplemented with 10% bovine 
calf serum (BCS) and amikacin (60 mg/L).  HepG2 cells were grown in DMEM-F12 medium 
supplemented with 10% fetal bovine serum (FBS).  Cells (25,000 cells/well) were seeded in the 
well of a 96-well plate and incubated for 24 h.  Samples were added and followed by incubation 
for 48 h.  The number of viable cells was determined using the supravital dye Neutral Red.  
Briefly, the cells were washed with saline and incubated for 3 h with a solution of neutral red.  
The cells were washed again to remove extracellular dye.  A solution of acidified ethanol was 
added to liberate the incorporated dye from viable cells and the absorbance was read at 450nm. 
5.2.2.2. Assay for antioxidant activity (inhibition of intracellular ROS generation) 
Antioxidant activity was determined by the DCFH-DA method.  Myelomonocytic HL-60 
cells (1 × 10
6
 cells/mL, ATCC) were suspended in RPMI-1640 medium (Roswell Park Memorial 
Institute) supplemented with 10% FBS and antibiotics at 37 
o
C in 5% CO2: 95% air.  The cell 
suspension (125 µL) was added to a 96-well plate.  After treatment with test compounds for 30 
min, cells were stimulated with 100 ng/mL phorbol 12-myristate-13-acetate (PMA, Sigma) for 
30 min.  2′,7′-dichlorodihydrofluorescein diacetate (DCFH-DA, Molecular Probes, 5 µg/mL) was 
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added and cells were further incubated for 15 min.  Levels of DCF were measured on a 
SpectrMax plate reader with excitation wavelength at 485 nm and emission at 530 nm.  
Antioxidant activity of test samples is determined in terms of % decrease in DCF production 
compared to the vehicle control.  The cytotoxicity to HL-60 cells was also determined after 
incubating the cells (2 x 10
4
 cells/well in 225 µL) with test samples for 48 h by XTT {2,3-bis (2-
methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino) carbonyl]-2H-tetrazolium hydroxide} method 
(Zhao et al, 2008).  Briefly, 25 µL of XTT-PMS (phenazine methosulfate) solution (1 mg/mL 
XTT solution supplemented by 25 µM of PMS) was added to each well.  After incubating for 4 h 
at 37
o
C, absorbance was measured on a plate reader (EL312e; Bio-Tek instruments, Winooski, 
VT) at a dual wavelength of 450 - 630 nm. 
5.2.2.3. Assay for anti-inflammatory activity (inhibition of NF-kB) 
The SW1353 human chondrosarcoma cells were cultured in 1:1 mixture of dulbecco's 
modified eagle medium/nutrient mixture F-12 (DMEM/F12) supplemented with 10% FBS, 100 
U/mL penicillin G sodium, and 100 µg/mL streptomycin at 37 C in an atmosphere of 5% CO2 
and 95% humidity. NF-kB luciferase plasmid construct was provided by Dr. David Pasco, 
NCNPR, the University of Mississippi. 
Cells (1.2 x 10
7
) were washed once in an antibiotic and FBS-free DMEM/F12, and then 
resuspended in 500 µL of antibiotic-free DMEM/F12 containing 2.5% FBS.  NF-kB luciferase 
plasmid construct was added to the cell suspension at a concentration of 50 μg/mL and incubated 
for 5 min at room temperature.  The cells were then electroporated at 160 V and one 70-ms pulse 
using BTX disposable cuvettes model 640 (4-mm gap) in a BTX Electro Square Porator T 820 
(BTX I, San Diego, CA).  After electroporation, 1.25 x 10
5
 cells per well were plated in 200 µL 
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of DMEM/F12 containing 10% FBS and antibiotics.  After 24 h, cells were treated with different 
concentrations of test compounds for 30 min and then induced with PMA (70 ng/mL) for 8 h.  
Cells were lyzed by adding 40 µL of a 1:1 mixture of lucLite reagent and PBS containing 1 mM 
calcium and magnesium (Packard Instrument Company, Meriden, CT).  Light output was 
detected on SpectraMax.  Relative luciferase units (RLU) were 12-15 folds higher in PMA 
induced cells versus uninduced controls (Ma, et al, 2007).  
5.2.2.4. Assay for estrogenic activity 
Yeast cells (Saccharomyces cerevisiae) expressing the human estrogen receptor alpha, 
were cultured in 25 mL of growth medium for 24 h at 30 ˚C in a shaking incubator (Tabanca et 
al., 2004).  For the assay, seeded assay medium was prepared by adding 1.5 mL of this culture 
and 250 L of chlorophenol red β-D-galactopyranoside (CPRG, 10 mg/mL) to 25 mL of fresh 
growth medium (Routledge et al., 1996).  Sample was dissolvd in DMSO (10 mM for pure 
compounds and 10 mg/mL for extracts).  Six serial dilutions were made on a 96-well plate and 
10 L of diluted sample was transferred to the assay plate followed by addition of 190 L of 
seeded assay medium to each well.  Test concentrations ranged from 7.8 µg/mL to 250 µg/mL 
for extract and 7.8 to 250  for pure compounds in duplicates.  17 β -Estradiol (E2) was used 
as positive control and a dose-response curve with concentrations ranging from 3.1 nM to 100 
nM was run in parallel to samples in every assay.  The highest concentration of DMSO in the 
vehile control was 0.25 %.  The plates were shaken for 5 min and incubated for 72 h at 30 ºC.  At 
the end of incubation the plates were shaken, and the absorbance was measured at 540 nm.  
Absorption at 630 nm was subtracted to correct for turbidity.  % Maximal E2 response was 
calculated as described earlier (Zhao et al, 2008).  
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5.2.2.5. Assay for the activation of PPARα and PPARγ in CHO cells. 
Chinese hamster ovary (CHO) cells were cultured in Ham‟s F12 medium containing 5% 
newborn calf serum (NCS), 50 U/mL penicillin G and 50 µg/mL streptomycin sulfate at 37 
o
C in 
an atmosphere of 90% humidity and 5% CO2.
 
The assay for activation of PPARα and PPARγ was performed as described earlier 
(Jaradat et al., 2001) with some modifications. 
The plasmids were kindly provided by Dr. Dennis Feller, Department of Pharmacology, 
School of Pharmacy, the University of Mississippi.  CHO cells were transfected for PPARα with 
25 µg of PPARα plasmid and for PPARγ with 25 µg of PPRE-aP2-tk-luc reporter and 25 µg of 
the expression construct pcMV-PPARγ.  Electroporation was performed (Electro square porator 
model T820) at 155 V for 70 msec and one pulse.  Transfected cells were seeded into 96-well 
tissue culture plate at a density of 5 x 10
4
 cell/well and incubated for 24 h.  Tested compounds at 
different concentrations (0.1-30 µM) were added and after incubation with compounds for 24 h, 
cells were lysed and the luciferase activity was determined by using luciferase assay system 
(Promega).  Plates were read on Spectra Max (Molecular Devices Corporation).
 
Fold induction in the activity of PPARα and PPARγ was calculated in comparison to the 
vehicle control (0.3% DMSO) and presented as mean ± SME (n=3). Wy14643 and ciglitazone 
were used as positive control for PPARα and PPARγ, respectively.  
5.3. Results and discussion 
5.3.1. In vitro cytotoxicity 
The cytotoxicities of SBE and SLE together with thirteen flavonoids were evaluated 
against a panel of normal cell lines and solid tumor cell lines.  No cytotoxicity was observed for 
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most of the samples up to a highest concentration of 50 μM for purified compounds and 50 
μg/mL for the extracts in any of the cell lines tested (data shown in Table 5-1).  Based on these 
results a conclusion might be made that the toxicity of American skullcap is very low and the 
reports of hepatotoxic reactions of American skullcap is likely due to its adulterant germanders. 
5.3.2. Antioxidant activity  
Potent antioxidant activity was observed for the SEB and SLE with IC50 values of 2.5 
μg/mL and 1.5 μg/mL, respectively.  These results are consistent with published data (Cole et al., 
2008; Wojcikowshki et al., 2007).  Compounds 17, 18, 6, 24 ,25, and 29 showed strong 
inhibition of ROS generation with IC50 values of 0.52, 0.32, 0.7, 0.7, 0.13, and 0.9 μM, 
respectively (see Table 5-2) in comparison to the IC50 value of 0.01 μM for the positive control, 
vitamin C.  In order to determine the specificity of the antioxidant effect, their cytotoxicity to 
HL-60 cells was also tested.  The purpose of this experiment is to rule out the possibility that 
antioxidant activity was not observed due to their toxicity.  No cytotoxicity was observed for all 
samples at the concentration of 12.5 μM or 62.5 μM (as indicated in Table 5-2).  
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Table 5-1. Cytotoxicities (IC50) of Skullcap Extracts and Flavonoids Isolated from Them 
sample  VERO PK-11 HepG2 SK-MEL KB BT-549 SK-OV-3 
SBE NA*  NA*  NA*  NA*  NA*  NA*  NA*  
SLE NA*  NA*  NA*  NA*  NA*  NA*  NA*  
baicalein (17) >50µM NA  NA  35 µM NA  NA  NA  
baicalin (18) NA  NA  NA  NA  NA  NA  NA  
wogonin (6) NA  NA  NA  NA  NA  NA  NA  
oroxylin A (5) NA  NA  NA  NA  NA  NA  NA  
genkwanin (22) NA  NA  NA  NA  NA  NA  NA  
chrysin (4) NA  NA  NA  NA  NA  NA  NA  
viscidulin I (23) NA  NA  NA  NA  NA  NA  NA  
quercetin (24) NA  NA  NA  35 µM NA  50 µM NA  
rutin (25) NA  NA  NA  NA  NA  NA  NA  
daidzein (30) NA  NA  NA  NA  NA  NA  NA  
naringenin (27) NA  NA  NA  NA  NA  NA  NA  
hesperetin (28) NA  NA  NA  NA  NA  NA  NA  
hersperidin (29) NA  NA  NA  NA  NA  NA  NA  
doxorubicin >5 0.5 0.5 0.9 0.9 1 0.6 
NA*: no cytotoxicity observed at 50µg/mL. 
NA: no cytotoxicity observed at 50µM. 
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Table 5-2. Antioxidant Activities of Skullcap Extracts and Flavonoids Isolated from Them 
sample antioxidant activity IC50   
(μM) 
cytotoxicity 
(HL-60 cells) (μM) 
SBE 2.5
#
 NC
#
 
SLE 1.5
#
 NC
#
 
baicalein (17) 0.52 NC* 
baicalin (18) 0.32 NC*  
oroxylin A (5) NA NC  
wogonin (6) 0.7 NC* 
genkwanin (22) NA NC 
chrysin (4) NA NC  
viscidulin I (23) NA NC 
quercetin (24) 0.7 NC*  
rutin (25) 0.13 NC* 
daidzein (30) NA NC 
naringenin (27) NA >62.5 
hesperetin (28) 2.3 NC  
hesperidin (29) 0.9 NC*  
vitamin C 0.01  
NA: no activity up to 62.5 μM; NC: no cytotoxicity up to 62.5 μM; NC*: no cytotoxicity up to 
12.5 μM.  
#
: IC50 in μg/mL. 
 
5.3.3. Anti-inflammatory activity  
The anti-inflammatory activity was determined in terms of inhibition of NF-κB mediated 
 112 
transcription in SW1353 cells induced by PMA and the results were shown in Table 5-3.  A 
moderate activity was observed for compounds 6, 4, 24, and 25 with IC50 values of 39, 33, 40, 
and 39 μM, respectively, in comparison with the positive control, parthenolide (IC50 of 4.1 μM).  
In this experiment, a luciferase construct with binding sites for Sp-1 was used as a control 
because this transcription factor is unresponsive to inflammatory mediators such as PMA.  
Hence, the measurement of Sp-1-mediated luciferase expression is useful for detecting agents 
that nonspecifically inhibit luciferase expression because of cytotoxicity, inhibition of luciferase 
enzyme activity or light output (Ma et al., 2007).  None of the samples inhibited Sp-1 dependent 
luciferase expression, indicating that their effect on NF-κB was specific.  
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Table 5-3. Anti-inflammatory Activity of Skullcap Extracts and Flavonoids Isolated from Them: 
Effect on NF- κB Mediated Transcription 
sample IC50 (μM) 
 NF- κB SP-1 
SBE NA
#
 NA 
SLE >50
#
 NA 
baicalein (17) NA NA 
baicalin (18) NA NA 
oroxylin A (5) >50 NA 
wogonin (6) 39 NA 
genkwanin (22) NA NA 
chrysin (4) 33 NA 
viscidulin I (23) NA NA 
quercetin (24) 40 NA 
rutin (25) 39 NA 
daidzein (30) NA NA 
naringenin (27) NA NA 
hesperetin (28) NA NA 
hesperidin (29) NA NA 
parthenolide 4.1 6.2 
NA: no activity up to 50 μM. 
    #
: IC50 in μg/mL. 
 
5.3.4. Estrogenic activity 
Phytoestrogens comprise a large group of plant-derived compounds, which include 
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isoflavonoids, lignans, stilbenes and flavonoids.  They have attracted scientific interest due to 
their possible medical applications in the prevention of certain cancers and treatment of 
osteoporosis and cardiovascular diseases (Munro et al., 2003; Ross et al., 2002; Stopper et al., 
2005).  The estrogenic effects vary according to the phytoestrogenic substance studied, the 
experimental system, and species.  The mode of action of phytoestrogens seems to be complex, 
and their efficacy and safety need to be evaluated individually (Fitzpatrick et al., 2003; 
Moutsatsou et al., 2007; Ren et al., 2001; Sirtori et al., 2005).  
In the present study, yeast estrogen screen (YES) assay was used to compare the 
estrogenic activity of 17 β -Estradiol on estrogen receptor (ER)-α with two crude extracts SBE 
and SLE and thirteen flavonoids isolated from SBE and SLE.  Estrogenic response of E2 at 100 
nM was defined as 100% and % maximal 17 β -Estradiol response of sample tested was 
calculated at the highest effective dose in comparison to 100 nM 17 β -Estradiol.  The extracts 
SBE and SLE did not show any significant effect at the highest dose of 250 µg/mL.  Out of the 
tested compounds naringenin and daidzein showed strong estrogenic effects with 98% maximal 
17 β -Estradiol response at 250 µM (naringenin) and 40% maximal 17 β -Estradiol response at 
62.5 µM (daidzein) (Table 5-4).  For most of the compounds highest effective dose was 250 µM 
except for diadzein.  The effect of daidzein was maximum at 125 and 62.5 µM.  Toxic effect at 
the highest dose of 250 µM could be responsible for a low estrogenic effect of daidzein at this 
concentration.  Previously, the estrogenic potency of naringenin was controversially discussed.  
Strong estrogenic activity of naringenin was observed by Zand et al. (Rosenberg Zand et al., 
2000).  Whereas, Ruh et al. reported that naringenin is a weak estrogen that also exhibits partial 
antiestrogenic activity in the female rat uterus and MCF-7 human breast cancer cells (Rhu et al., 
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1995).  Daidzein, which is one of the two major isoflavonic phytoestrogens in soy bean, has been 
shown to have dual function, i. e. the estrogenic and anti-estrogenic properties in the presence of 
high or low 17 β -Estradiol levels (Ni et al., 2010).  Different results for the same compound 
might be due to the differences in the test system used.  The major conclusion that could be 
drawn from the present study is that subtle changes in the structure of compounds, for instance 
naringenin and hesperetin, can bring about a large change in their estrogenic activity. 
 
Table 5-4. Estrogenic Response of Scutellaria Extracts and Flavonoids Isolated from Them 
sample % max E2 response 
at 250 µM 
% max E2 response  
at 125 µM 
% max E2 response 
at 62.5 µM 
SBE NA
#
   
SLE NA
#
   
baicalein (17) NA   
baicalin (18) NA   
oroxylin A (6) 30% 18%  
wogonin (5) 13% 10%  
genkwanin (22) 16% 9%  
chrysin (4) 9%   
viscidulin I 23) NA   
quercetin (24) 11%   
rutin (25) NA   
daidzein (30) 28% 39% 40% 
naringenin (27) 98% 90% 66% 
hesperetin (28) 10%   
NA
#
: no activity up to 250 µg/mL. NA: no activity up to 250 µM. E2: 17β-estradiol.  
% max E2 response: % maximal 17 β-estradiol response was calculated at the indicated doses in 
comparison to 100 nM E2 as 100%. 
 
5.3.5. Activation of PPARα and PPARγ in CHO cells 
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PPARs are ligand-activated transcription factors that belong to the subfamily of nuclear 
receptors (Schoonjans et al., 1997).  They are pivotal regulators of body lipid homeostasis and 
are proposed as possible therapeutic targets for metabolic disorders.  They show broad, but 
isoform-specific, tissue expression patterns.  Currently, PPARs subfamily has been divided into 
PPARα, PPARβ (also called PPARδ and NUC1) and PPARγ.  Three PPAR isoforms differ in 
their tissue distribution and ligand specificity (Forman et al., 1996).  PPARα is predominantly 
expressed in tissues exhibiting high catabolic rate of fatty acids (heart, liver, and kidney), 
whereas PPARβ expression is ubiquitous, and its physiological role is unclear.  PPARγ is 
expressed predominantly in adipose tissue, the adrenal gland, spleen, large colon and the immune 
system (Chawla et al., 1994; Kliewer et al., 1994; Tontonoz et al., 1994).  Therefore, PPARα is a 
major regulator of fatty acid metabolism and catabolism within the body (Spiegelman, 1998).  
PPARγ plays an important role in regulating adipocyte differentiation and glucose homeostasis 
(Berger et al., 2005).  Agonists of PPARα and PPARγ have been developed as 
antihyperlipidemic and antidiabetic agents. 
In the present study two skullcap extracts (SBE and SLE) together with thirteen 
flavonoids isolated from these extracts were first tested for their activation effects on PPARα and 
PPARγ in CHO cells.  Induction of PPARs activity by each compound was tested at 
concentrations ranging from 0.1 µM to 30 µM and fold induction was calculated against vehicle 
control.  Wy 14643 and ciglitazone were used as positive controls to evaluate the ability of tested 
samples to activate PPARα and PPARγ, respectively.  The results are summaried in Table 5-5 
and shown in Figure 5-2 and 5-3.  In this study a fold induction of 2 or more was considered as 
significant induction in comparison to vehicle control.  
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SLE significantly stimulated the PPARα activities in a dose-dependent manner.  At the 
dose of 10 µg/mL, the extract increased PPARα activity up to 2.6 folds over the vehicle control.  
It is more potent than the activity of SBE, which showed 1.6 fold increase in activity over the 
vehicle control (see figure 5-2).  At the dose of 30 µg/mL, the fold of PPARα induction of SLE 
is up to 4.9 compared to 2.4 of SBE.  Of the tested flavonoids, compounds baicalein (17), 
baicalin (18), wogonin (6), genkwanin (22), chrysin (4), quercetin (24), daidzein (30), naringenin 
(27), and hesperetin (28) exhibited significant activation of PPARα at 10 µM (2.8, 2.4, 2.5, 2.0, 
3.5, 2.1, 2.2, 2.2, and 2.9, respectively) (shown in Table 5-5).  Most of them induced the PPARα 
activity in a dose-dependent manner.  The activity of these compounds was comparable to the 
activity of the positive control Wy 14643 (1.8 fold) (Table 5-5 and Figure 5-2).  However, there 
was a cytotoxic effect in CHO cells with 30 µM of chrysin and hesperetin and a decrease in the 
activation of PPARα was observed (Figure 5-2).  Although another group (Fang et al., 2008) 
reported that quercetin inhibited the activation of all three isoforms of PPARs (PPARγ IC50 = 
56.3 μM; PPARα IC50 = 59.6 μM; PPARβ IC50 = 76.9 μM) in Cos-7 cells.  Our studies showed 
activiations at 10 μM.  Oroxylin A (5), viscidulin I (23), rutin (25), and hesperidin (29), had no 
effect on activation of PPARα, and the data are shown in Table 5-5. 
Only baicalein (17), wogonin (6), and chrysin (4) showed significant induction of PPARγ 
activity at a concentration of 10 µM (fold induction of 2.3, 2.0, and 3.4, respectively).  However, 
oroxylin A (5), quercetin (24), and daidzein (30) demonstrated an increase in the PPARγ activity 
at a concentration of 30 µM (2.6, 6.9, and 2.7 folds, respectively), which were comparable to 
positive control ciglitazone (3.0 fold induction).  Consistent with our results, chrysin was 
previously reported to increase the PPARγ activity in a dose-dependent manner, with the EC50 of 
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approximately 10 µM (Liang et al., 2001).  It is worth noticing that compounds baicalein (17), 
wogonin (6), and chrysin (4) demonstrated dual PPARα and PPARγ activity at the concentration 
of 10 µM (see Figure 5-4), whereas quercetin (24) and daidzein (30) showed the same effects at 
a concentration of 30 µM (Figure 5-5).  To date, there is no report on the effects of skullcap 
extracts on PPARs activation. The present study, for the first time, sheds some light on the fact 
that the skullcap extracts have the potential to act as PPARα agonists.  In our study, some of 
flavonoids, including baicalein (17), baicalin (18), wogonin (6), chrysin (4), etc. were also found 
to significantly induce PPARα activity.  Hence it may be concluded that the induction for 
PPARα activation produced by extracts may be due to the presence of these flavonoids, any of 
these, or a combination of them having direct or indirect effects on PPARα.  The mechanism of 
action needs further detailed studies using individual compounds.  Toxicity studies (data shown 
before) have already proven that no toxicity was observed at a dose far above the dose used in 
this investigation.  Therefore, compounds, such as baicalein (17), baicalin (18), wogonin (6), 
chrysin (4), quercetin (24), daidzein (30), etc. with significant PPARα activity might serve as 
new leads with less adverse effects for treatment of PPARα-related diseases, such as obesity and 
dyslipidemia.  A growing body of evidence suggests that combined treatments with PPARα and 
PPARγ agonists may potentially improve insulin resistance and alleviate atherogenic 
dyslipidemia.  A considerable amount of effort has thus been made in the development of dual 
PPARα/γ agonists for the treatment of diabetes as well as the associated dyslipidemia.  
Muraglitazar (Devasthale et al., 2005), tesaglitazar (McIntyre et al., 2003), KRP-297 (MK- 767) 
(Calkin et al., 2003), and TAK-559 (Sakamoto, J. et al., 2004) are examples of late stage dual 
PPARα/γ clinical candidates which have demonstrated efficacy in glucose normalization and 
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correction of lipid abnormalities in diabetic patients.  However, the development of all of these 
advanced clinical candidates has been discontinued for multiple reasons, mainly due to 
considerable side effects (Barlocco, 2005; Colca, A.C. 2007; Conlon, D. 2006; Najman, D.M. 
2006; Nissen, S.E. 2006; Parra et al., 2006).  Our discovery of the compounds with dual 
regulator function for PPARα/γ discovered in this study, such as baicalein (17), wogonin (6), and 
chrysin (4) etc. might lead to PPAR agonists with improved risk-benefit profile for the treatment 
of diabetic patients with the additional risk factor of dyslipidemia.  Future studies will be carried 
out to determine structure–activity relationships of potential PPARα and PPARγ agonists 
screened in this study using molecular modeling.  The elucidation of structure–activity 
relationships would help in identifying the key structural features of the ligand molecules for 
activation of each subtype of the PPAR, which in turn, will assist us in design and discovery of 
more safe and effective agonists.  
5.4. Conclusion  
In the present study the methanol extracts of American skullcap and Chinese skullcap 
along with thirteen flavonoids isolated from them were evaluated their activities on a panel of 
bioassays.  Neither extracts of SBE and SLE nor pure compounds tested showed cytotoxicity 
against a panel of mammalian normal and solid tumor cell lines at the high tested concentrations, 
suggesting that American skullcap has very low toxicity and the previous reports of hepatotoxic 
reactions of American skullcap might not be due to skullcap itself but could be due to its 
adulterant germander.  Significant antioxidant activity was observed for both skullcap extracts as 
well as compounds, such as baicalein (17), baicalin (18), wogonin (6), quercetin (24), rutin (25), 
and hesperidin (29).  The antioxidant activity of American skullcap was firstly observed in the 
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present study and was found to be stronger than Chinese skullcap.  Naringenin (27) and daidzein 
(30) showed marked estrogenic effects in the YES assay.  Only a moderate anti-inflammatoy 
activity was observed with wogonin (6) and chrysin (4) as indicated by the effect on NF-κB 
mediated transcription.  In this study, the most significant finding was the identification of 
PPARs activation of skullcap extracts as well as their components, such as baicalein (17), 
baicalin (18), wogonin (6), and chrysin (4), etc.  Results of our study provide useful information 
on possible new application of skullcap, especially American skullcap, for the treatment of 
diabetic-related diseases.  In addition, the activation of PPARs by pure flavonoids suggests their 
potential to become leads as PPARα and PPARγ agonists.  
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Table 5-5. Fold Induction of Tested Samples on PPARs at Different Concentrations 
*The concentration unit of the extract is µg/mL. 
 
 
PPARα              PPARγ  
30 µM 10 µM 1 µM 0.1 µM 30 µM 10 µM 1 µM 0.1 µM 
SBE* 2.4±0.9 1.2±0.15 1.3±0.55  1.9±0.30 1.7±0.45 1.2±0.25  
SLE* 4.9±0.85 2.6±0.7 1.3±0.1  1.4±0.55 1.4±0.20 0.9±0.25  
baicalein 
(17) 
4.2±0.98 2.8±0.73 1.3±0.22 1.1±0.24 2.4±0.62 2.3±0.49 1.2±0.18 0.9±0.11 
baicalin 
(18) 
3.1±0.47 2.4±0.64 0.8±0.16 0.9±0.29 1.6±0.55 1.3±0.25 1.0±0.40 1.1±0.40 
oroxylin A 
(5) 
1.3±0.30 1.2±0.10 1.2±0.60 0.9±0.20 2.6±0.05 1.3±0.05 1.1±0.25 1.0±0.25 
wogonin 
(6) 
4.1±0.76 2.5±0.47 1.4±0.36 1.1±0.29 2.9±0.70 2.0±0.40 1.4±0.33 1.2±0.16 
genkwanin 
(22) 
2.6±0.62 2.0±0.82 2.1±0.87 1.2±0.44 1.7±0.15 1.8±0.20 1.2±0.15 1.0±0.15 
chrysin (4) 3.1±0.05 3.5±0.00 1.9±0.10 1.4±0.20 2.0±0.05 3.4±0.05 1.4±0.50 1.1±0.15 
viscidulin 
I (23) 
1.1±0.10 0.8±0.10 0.8±0.00 1.1±0.05 1.1±0.05 1.2±0.00 1.1±0.05 0.9±0.20 
quercetin 
(24) 
2.8±0.45 2.1±0.45 1.0±0.15 1.1±0.20 6.7±0.15 1.2±0.60 1.0±0.55 0.9±0.10 
rutin (25) 0.7±0.05 1.1±0.05 0.7±0.00 0.6±0.00 1.1±0.05 1.0±0.05 0.9±0.10 1.0±0.00 
daidzein 
(30) 
5.3±0.65 2.2±0.40 1.2±0.4 1.4±0.55 2.7±0.10 1.8±0.25 1.8±0.55 1.0±0.10 
naringenin 
(27) 
4.9±1.70 2.2±0.55 1.2±0.15 1.2±0.70 1.5±0.40 1.3±0.33 1.0±0.18 0.9±0.20 
hesperetin 
(28) 
2.1±0.20 2.9±0.55 1.8±0.95 1.2±0.25 1.7±0.29 1.1±0.24 0.9±0.13 0.7±0.13 
hesperidin 
(29) 
1.0±0.10 0.9±0.20 0.7±0.10 0.7±0.00 1.1±0.30 1.3±0.10 1.0±0.40 0.9±0.15 
Wy 14643 1.9±0.05 1.8±0.05 1.2±0.00 0.9±0.10     
ciglitazone     3.0±0.05 3.1±0.25 1.6±0.20 1.6±0.05 
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Figure 5-2. Effect of tested samples on PPARα activation. 
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Figure 5-3. Effect of tested samples on PPARγ activation. 
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Figure 5-4. Dual effect of tested samples on PPARs activation at 10 µM. 
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Figure 5-5. Dual effect of tested samples on PPARs activation at 30 µM. 
 
 124 
 
 
 
 
 
 
Second Project 
 
 
Phytochemical Investigation of Pfaffia paniculata (Martius) Kuntze 
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Chapter 6 
Introduction of Pfaffia paniculata (Martius) Kuntze 
 
Around ninety species of Pfaffia (Amaranthaceae) are known in Central and South 
American.  In Brazil, twenty-seven species have been described to date, among which Pfaffia 
paniculata (Martius) Kuntze, commonly nameed suma, is the most employed species in 
commercial preparations in Brazil as “Brazilian ginseng” and has been commonly used for three 
centuries for the same indications as American and Asian ginseng (Taniguchi et al., 1997; 
Vasconcelos, 1982).  It
 
is a large, rambling, shrubby ground vine with an intricate, deep, and 
extensive root system.  It is indigenous to the Amazon basin and other tropical parts of 
(southern) Brazil, Ecuador, Panama, Paraguay, Peru, and Venezuela.  Although harvested wild, 
suma has been domesticated and farmed for quite some time.  For instance, it has been cultured 
successfully in Sichuan, Zejiang, and Guangxi province in China (Ling et al., 2006).  Since its 
first botanical recording in 1826, it has been referred to by several botanical names, including 
Pfaffia paniculata, Hebanthe paniculata, Gomphrena paniculata, Gomphrena eriantha, Iresine 
erianthos, Iresine paniculata, Iresine tenuis, Pfaffia eriantha, Xeraea paniculata 
(http://www.rain-tree.com/plants.htm). 
Traditionally suma has been used as a food that provided physical stamina and 
endurance.  The indigenous peoples of the Amazon region have used suma root for generations 
for a wide variety of health purposes, including as a general tonic, as an energy rejuvenating, and 
sexual tonic, and as a general cure-all for many types of illnesses, such as diabetes, ulcers, cancer 
etc (De Oliveira, 1986; Taniguchi et al., 1997).  The benefits of suma were such that the 
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indigenous people of the jungle call it “para todo,” a Spanish word that means “for all things.”  
In herbal medicine throughout the world today, suma is considered as a tonic and an adaptogen.  
The herbal definition of an adaptogen is a plant that increases the body's resistance to adverse 
influences by a wide range of physical, chemical, and biochemical factors and has a normalizing 
or restorative effect on the body as a whole (Panossian et al., 1999).  Therefore, suma was named 
as Brazilian ginseng with many applications same as regular ginseng. 
The root of this plant is such a rich source of β-ecdysterone that it is the subject of a 
Japanese patent for the extraction methods employed to obtain it from suma root.  
Approximately 2.5 g of β-ecdysterone can be extracted from 400 g of powdered suma root 
(0.63%) (Wakunaga, 1984).  Also it has very high saponin content (up to 11%) (De Oliveira et 
al., 1980).  The specific saponins found in the roots of suma include a group of novel 
nortriterpenoid saponins, named Pfaffic acid (hexacyclic nortriterpene) and their glycosides, 
pfaffosides A-F.  Besides these, a mixture of stigmasterol and sitosterol, their glycosides, and 
allantoin have been reported (Nakai et al., 1984; Nishimoto et al., 1984; Takemoto et al., 1983).  
Nutritionally, suma root contains 19 different amino acids, a large number of electrolytes, trace 
minerals, iron, magnesium, zinc, vitamins A, B1, B2, E, K, and pantothenic acid.  Its high 
germanium content probably accounts for its properties as an oxygenator at the cellular level.  
Besides, its high iron content may account for its traditional use for anemia (Zucchi et al., 2005).  
Pharmacological studies showed that suma has anticancer, anti-inflammatory, and sexual 
stimulatory activities. 
Anti-inflammatory activity 
The alcoholic extract of P. paniculata dried roots was studied for analgesic 
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antiinflammatory activity in the rat paw oedema test, writhing test, hot plate test and increased 
vascular permeability test.  P. paniculata inhibited the carrageenin-induced rat paw oedema and 
increased vascular permeability and showed analgesic activity on inflammatory pain but not on 
noninflammatory pain.  Moreover the extract was devoid of local irritant action (Mazzanti et al., 
1994). 
Anticancer activity 
The powdered root of P. paniculata orally administered to mice at a daily dose of 200 
mg/Kg, for 10 days reduced the ascetic volume of Ehrlich tumor cells in mouse peritoneal cavity, 
as well as the ascetic fluid volume.  The result indicates that this effect is related to the anti-
inflammatory activity (Matsuzaki et al., 2003).  Later, the same research group studied the 
effects of the ethanolic extract, butanolic residue, and aqueous residue of ethanolic extract of P. 
paniculata on animal survival and tumor growth in mice bearing Ehrlich tumor.  The results 
demonstrated antineoplastic effects on survival time of tumor bearing-mice following the 
treatment with the butanolic residue of ethanolic extract of P. paniculata (Matsuzaki et al., 
2006).  Also, a human breast tumor cell line, the MCF-7 Cells treated with butanolic extract 
showed degeneration of cytoplasmic components and profound morphological and nuclear 
alterations.  These results showed that this butanolic residue indeed contains cytotoxic 
substances (Nagamine et al., 2009).  The active components of this plant, at least in relation to 
survival parameter, are likely to be present in the butanolic fraction.  Since the main constituents 
of butanolic residue obtained from the ethanolic extract are saponins, indicating that saponins 
may be responsible for the antineoplastic effects.  In fact, pfaffic acid and its glycosides termed 
pfaffosides A-F, isolated from P. paniculata, have shown in vitro inhibitory effects on the 
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growth of B-16 melanoma (Nakai et al., 1984) and the pfaffosides as well as pfaffic acid 
derivatives in suma were patented as antitumor compounds in several Japanese patents in the 
mid-1980s (Takemoto et al., 1984).  These results support the hypothesis proposed above.  In 
another study, antiangiogenic activity was observed in the mouse cornea after the animal was 
treated with 1000 mg/Kg of the methanol extract of P. paniculata.  The anticancer activity 
mediated by the P. paniculata may result from the intense stimulation of macrophages, natural 
killer cells and cytotoxic T lymphocytes (Watanabe et al., 2000).  Increased macrophage activity 
was also observed by Pinello‟s group, suggesting that increased macrophage activity may be one 
of the effects contributing to inhibition of the Ehrlich ascetic tumor growth in mice (Pinello et 
al., 2006).  On the other hand, chemopreventive effects of P. paniculata have been demonstrated 
in vivo.  Watanabe et al. reported an inhibition of enlargement of thymic lymphoma in mice 
receiving 750 mg/Kg/week of a P. paniculata preparation for 24 week (Watanabe et al., 2000).  
This is consistent with the study of Silva et al. that demonstrated chemopreventive effects using a 
mouse hepatocarcinogensis model, when these animals received 2.0 % of the powdered roots of 
this plant (v./v.) mixed in their chow (Silva et al., 2005).  
Toxicity study was performed in which doses of 400 and 200 mg/Kg of powdered suma 
root were administrated orally for 10 days to mice.  The chosen doses are higher than that 
recommended for humans, which varied from 100 to 300 mg per day.  The evaluated parameters 
were the body weight, the presence of serum Alanine transaminase (ALT) indicative of necrosis 
in the liver, and the histopathological examination.  None of these parameters showed alterations 
in mice treated with P. paniculata (Matsuzaki et al., 2003).  In addition, oral intake of powdered 
P. paniculata root for 30 days induced no adverse reactions in mice, suggesting that P. 
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panicualta can be consumed safely for long periods (Oshima et al., 2003).  In another study, the 
ethanolic extract of P. paniculata administrated by intraperitoneal injection (i.p.) to mice did not 
produce behavioral effects up to 5 g/Kg in mice.  Sedation, motor incoordination, loss of 
reflexes, hypothermia and mortality were observed only with the dose of 10.0 g/Kg (Mazzanti et 
al., 1994).  
Sexual stimulatory activities 
P. paniculata extract, when administrated orally to male rats with the dose of 0.25, 0.5, 
and 1.0 mL/Kg, improved the copulatory performance of sexually sluggish/impotent rats, but had 
no effects on the copulatory behavior of sexually potent rats.  The highest dose of 1.0 mL/Kg 
increased the percentage of rats achieving ejaculation and significantly reduced mount, 
intromission and ejaculation latencies, post-ejaculatory interval and intercopulatory interval 
without affecting locomotor activity.  The selective effect might act mainly by increasing central 
noradrenergic and dopaminergic tone, and possibly oxytocinergic transmission (Arletti et al., 
1999; Oshima et al., 2003).  These results provide experimental support to the folk reputation of 
P. paniculata as sexual stimulant.  
Gingseng is one of the most widely used herbal medicines in the world for its physical, 
mental and sexual effects.  It is one of the best-selling herbs in the Unite States (Yuan et al., 
2004).  The general population might not be aware that different kinds of ginseng are prepared 
from plants belonging to different species even different family, for example, Chinese or Korean 
ginseng from Panax ginseng, American ginseng from Panax quinquefolium, Brazilian ginseng 
from Pfaffia paniculata, and Siberian ginseng from Eleutherococcus senticosus, etc. (Janetzky et 
al., 1997; Walker et al., 1994).  
 
More than fifty preparations, which were contained or produced 
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from plant P. paniculata are available on USA market (Lafont et al., 2003), but no analytical 
methods currently available to identify P. paniculata raw materials, and its products.  Therefore, 
the primary objective of this project was to investigate the chemical components which will be 
used as marker compounds for the quality control of suma raw material as well as the products 
claiming to contain this species.  
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Chapter 7 
Phytochemical investigation of Pfaffia paniculata (Martius) Kuntze 
 
7.1 Introduction 
As mentioned in Chapter 6, only very limited data associated with the chemical 
constituents of P. paniculata were reported even though it has been widely used as “Brazilian 
ginseng” for three centuries.  Previously, three types of secondary metabolites have been 
reported from it, including phytosterols, pfaffic acid and their glycosides, named pfaffosides A-F 
(saponins) and allantoin (Nakai et al., 1984; Nishimoto et al., 1984; Takemoto et al., 1983; 
Wakunaga, 1984).  
Herein, the detailed phytochemical investigation of P. paniculata was carried out.  Two 
new nortriterpenoids pfaffine A and B (40-41), one new compound pfaffine C (42a and b), 
along with eleven known compounds were isolated from the roots of this plant (see Figure 7-1).  
The structures of the new compounds were elucidated on the basis of extensive spectroscopic 
(1D, 2D-NMR, HR-ESI-MS) and chemical degradation studies.  Those known compounds were 
identified as ecdysone (43) (Chan et al., 2005), 20-hydroxyecdysone (44) (Wang, T. et al., 2004), 
pterosterone (45) (Coll et al., 1994), rapisterone (46) (Baltaev et al., 1987), pfaffic acid (47) 
(Takemoto et al., 1983), pfameric acid (48) (Shiobara et al., 1993), mesembryanthemoidigenic 
acid (49) (Ikuta et al., 1986), calenduloside E 6′-methyl ester (50) (Melek et al., 1996), oleanolic 
acid 28-O-β-D-glucopyranoside (51) (Gupta et al., 2003), (+)-angelicoidenol-2-O-β-D-
glucopyranoside (52) (Inoshiri et al.,1988), Vinillic acid (53) (Conrad et al., 2001), and 
iresinoside A (54) (Shiobara et al., 1992) by comparison of spectroscopic data with those 
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reported in the literature.  All the fourteen compounds except ecdysone are reported for the first 
time from this plant. 
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7.2 Experimental sections 
7.2.1. General experimental procedures 
Optical rotations were measured in MeOH using a Rudolph Research Auto Pol IV 
polarmeter with a sodium lamp (589 nm) and a 0.5 dm microcell.  High-resolution mass spectra 
(HRESIMS) were performed on Bruker MicroTOF.  NMR spectra were recorded in pyridine-d5 
on either a Varian 600 or Brucker Avance 400 NMR spectrometers.  All chemical shifts (δ) are 
given in ppm with reference to solvent and coupling constant (Ј) is given in Hz.  IR spectra were 
obtained on a Perkin Elmer 100 FT-IR spectrometer.  Column chromatography was carried out 
on silica gel (40 µm for flash chromatography, J. T. Baker) and C18-reversed phase silica (230-
400 mesh, Sigma-Aldrich).  The fractions were monitored by TLC on silica gel plates (0.25 mm, 
Merck) as well as on RP-18 F254 plates (0.25 mm, Merck).  Spots were visualized by heating at 
105 °C for 1-2 min after spraying with anisaldehyde/H2SO4 reagent.  HPLC was performed on 
an octadecyl silane (ODS) column [Phenomenex prodigy 5μ ODS (3) 100A] and elutes were 
monitored by a UV detector at 240 nm.  L-cysteine methyl ester hydrochloride, dioxane, D- and 
L-glucose were obtained from Sigma-Aldrich (USA). 
7.2.2. Plant material 
The roots of Pfaffia paniculata Kuntze was purchased from American Mercantile 
Corporation (american@americanmercantile.com) and authenticated by Dr. V. Joshi at the 
National Center for Natural Products Research, University of Mississippi, where a voucher 
specimen (No. 3096) has been deposited. 
7.2.3. Extraction and isolation 
The powder of the roots (2.4 Kg) of P. paniculata was extracted by stirring in MeOH (3 x 
 136 
2L) at room temperature three hrs each time and the MeOH extracts were combined.  The MeOH 
was evaporated under vacuum to get a brown viscous residue (437 g).  The concentrate was 
suspended in water and then partitioned with hexanes, chloroform and n-BuOH successively (see 
Chart 7-1).  The n-BuOH soluble fraction (72.1 g) was subjected to VLC on silica gel (600 g) 
eluting with CHCl3 (2 L), CHCl3-MeOH-H2O [930:80:10 (1 L), 830:180:10 (1 L), 680:300:50 
(2.5 L)] and MeOH (1.5 L) successively to give six fractions (A-F).  Fraction B [CHCl3-MeOH-
H2O 830:180:10 (1 L), 2.5438 g] was subjected to reversed-phase C-18 flash chromatography 
(100g, column: 4 x 15 cm) eluting with a gradient of MeOH-H2O (40:60 to 100:0 with elution 
volume of 1603 mL at the flow rate of 4 mL/min, 18 mL for fraction size) to afford twelve 
fractions.  Subfraction 7 (between 780 to 950 mL, 0.2312 g) was separated by silica gel column 
eluted with a gradient of CHCl3:EtOAc:MeOH or CHCl3:MeOH several times to get vinillic acid 
(53, 10.2 mg).  Subfraction 8-9 (between 958 to 1240 mL, 0.4154 g) was subjected to normal-
phase silica gel flash chromatography (Biotage Flash 12+M, 90g, column: 1.2 x 15 cm), eluted 
with CHCl3-EtOAc-MeOH-H2O (15:8:4:1 with elution volume of 1000 mL at a flow rate of 5 
mL/min and fraction volume of 18 mL for each) to afford pfameric acid (48, between 530 to 756 
mL, 4.0 mg).  Subfraction 10 (between 1242 to 1502 mL, 0.4268 g) was separated by silica gel 
flash chromatography (Biotage Flash 40+M, 100g, column: 4 x 15 cm], 96 fractions were 
collected through elution with a gradient of CHCl3-EtOAc-MeOH 1698 mL (1:1:2 to 1:1:8) at 
the flow rate of 6 mL/min.  Fractions 12-25 (between 72 to 150 mL, 287.2 mg) were subjected to 
normal-phase followed by reversed-phase silica gel VLC several times to afford pfaffic acid (47, 
6.3 mg) and emsembryanthemoidigenic acid (49, 9.3 mg).  Fractions 26-33 (between 156 to 198 
mL, 25.6 mg) were further purified by reversed-phase C-18 flash chromatography (Biotage Flash 
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12+M, 9g, column: 1.2 x 15 cm) eluting with MeOH-H2O mixtures of increasing polarity (40:60 
to 60:40 with elution volume of 2000 mL at a flow rate of 3 mL/min and fraction volume of 15 
mL for each) afford pfaffine A (40, between 1638 to 1716 mL, 4.5 mg).  Fraction C [CHCl3-
MeOH-H2O 680:300:50 (0.5 L), 0.4916 g] was subjected to silica gel VLC [500g, column: 4 x 
15 cm) eluting with CHCl3-MeOH-H2O (7:2:1, 3 L with fraction volume of 15 mL for each) to 
afford four subfractions.  Subfraction I (between 615 to 750 mL, 125.5 mg) was 
chromatographied on RP-C18 VLC (10g, column: 3 x 13 cm) eluting with MeOH-H2O [(80:20 
(200 mL), 84:16 (100 mL)] and MeOH (50mL)] to afford calenduloside E 6′-methyl ester (50, 
between 235 to 250 mL, 2.1 mg).  Subfraction II (between 915 to 1110 mL, 103.7 mg) was 
subjected to RP-C18 VLC [10g, 3 x 13 cm] eluting with a gradient of MeOH-H2O [74:26 (200 
mL), 75:25 (100 mL), 78:22 (200 mL), and MeOH (50 mL)], 86 fractions were collected.  
Fractions 56-66 (between 285 to 355 mL, 13.7mg) were purified by preparative HPLC with a 
gradient of MeOH-H2O as eluting solvent (60:40 to 90:10) at the flow rate of 2 min/mL to obtain 
pfaffine B (41, 4.0mg).  Fraction 81-86 (between 435 to 450 mL, 10.2 mg) was purified by 
crystallization from MeOH to give oleanolic acid 28-O-β-D-glucopyranoside (51, 4.8 mg).  
Subfraction III (between 1305 to 1525 mL, 99.2mg) was subjected to NP- as well as RP-C18 
silica gel flash chromatography to give rapisterone (7, 2.0 mg). Subfraction IV (between 1635 to 
1740 mL, 103.1 mg) afforded ptersterone (6, 13 mg) and (+)-angelicoidenol-2-O-β-D-
glucopyranoside (52, 2.9 mg) after repeated NP- and RP-C18 flash chromatographies.  Fraction 
D [CHCl3-MeOH-H2O 680:300:50 (between 500 to 1000 mL), 0.7686 g] was chromatographied 
on RP-C18 VLC (140g, column: 6 x 30 cm) eluting with a gradient of MeOH-H2O [5:95 (200 
mL), 15:85 (200 mL), 20:80 (200 mL), 30:70 (mL), 40:60 (200 mL), 40:40 (200 mL), 20:80 (200 
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mL), and MeOH (200 mL)] to afford ecdysone [43, MeOH-H2O 15:85 (200 mL), 100.3 mg] and 
20-hydroxyecdysone [45, MeOH-H2O 30:70 (200 mL), 286.2 mg], respectively.  Fraction F 
[CHCl3-MeOH-H2O 680:300:50 (between 1000 to 2000 mL), 0.9636 g] was chromatographied 
on RP-C18 VLC (140g, column: 6 x 30 cm) eluting with a gradient of MeOH-H2O [10:90 (200 
mL), 20:80 (200 mL), 30:70 (mL), 40:60 (200 mL), 40:40 (200 mL), 20:80 (200 mL), and 
MeOH (200 mL)].  Four fractions were obtained.  Subfraction VI was applied to Sephadex LH-
20 eluting with MeOH to obtain two yellow pigments iresinoside A (54, 6.2 mg) and pfaffine C 
(42, 5.4 mg). 
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Pfaffia paniculata
2.4 Kg
MeOH ext.
ANJ-35
437 g
residue
solvent partition
hexane portion
ANJ-3-36-1
3.8186 g
CHCl3 portion
ANJ-3-36-2
7.5411 g
n-butanol portion
ANJ-3-36-3
72.1 g
MeOH, 8 L
silica gel VLC
CHCl3
CHCl3:MeOH:H2O
ANJ-3-39-1-6 ANJ-3-39-7-8
2.5432 g ANJ-3-39-9 ANJ-3-39-10
ANJ-3-39-11-14
RP 18-silica gel
ANJ-3-46-7
0.1233 g
ANJ-3-46-8 & 9
0.4145 g
ANJ-3-46-10
0.4628 g
sil-gel, CHCl3:MeOH
RP-C18, MeOH:H2O
ANJ-3-39-15
compound 53
silica gel repeatedly
CHCL3:EtOAC:MeOH or
CHCl3:MeOH
compound 48
sil-gel
DCM"MeOH or
CHCl3:MeOH
compound 40, 47, 49
sil-gel, CHCL3:MeOH
RP-C18, MeOH:H2O
NP-VLC
CHCl3:MeOH:H2O
ANJ-3-85-7 ANJ-3-85-1-4
compound 41, 45, 46, 47, 50,51, 52
ANJ-3-67-1-3
RP-C18 VLC
MeOH:H2O
JL-6-63-6
RP-C18 VLC
MeOH:H2O
ANJ-3-67-4
compound 43, 44
ANJ-3-67-7-11
JL-6-93-1
JL-6-94-4
sil-gel, CHCL3:MeOH sil-gel, CHCL3:MeOH
HPLC, MeOH:H2O
ANJ-4-13-3 ANJ-4-13-4
RP-C18 VLC
MeOH:H2O
JL-6-95-1
JL-6-88-4
sil-gel, CHCl3:MeOH
RP-C18, MeOH:H2O
compound 42, 54
JL-6-77-3
sephadex LH-20, MeOH
sil-gel, CHCL3:MeOH
Chart 7-1. Scheme for isolation of chemical constituents from Pfaffia paniculata  
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Pfaffine A (40): white powder; [α]25D + 11.3 (c 0.1, MeOH); IR νmax = 3357 (OH), 2937, 
1650 (C=O), 1443, 1031 cm
-1
; 
1
H- (600 Hz) and 
13
C- NMR (150 Hz) data, see Table 7-1; HR-
ESI-MS: m/z = 455.31863 [M-H]
-
 (calcd. for 455.31614).   
Pfaffine B (41): white powder; [α]25D + 8.7 (c 0.46, MeOH); IR νmax = 3356 (OH), 2928, 
1731 cm
-1
 (C=O), 1380, 1027; 
1
H- (600 Hz) and 
13
C- NMR (150 Hz) data, see Table 7-2; HR-
ESI-MS: m/z =625.37055 [M + Na]
+
 (calcd. for 625.37109).  
Pfaffine C (42): yellow powder; [α]25D - 67.3 (c 0.1, MeOH); UV (MeOH) λmax (log ε) 
275 (0.72), 380 (1.21) nm; IR νmax = 3284 (OH), 2923, 1672 (C=O), 1602 (aromatic –C=C–); 
1531, 1514, 1259, 1163, 1060, 1019, 831 cm
-1
; 
1
H- (600 Hz) and 
13
C- NMR (150 Hz) data, see 
Table 7-3 and 7-4, respectively; HR-ESI-MS: m/z = 469.3183 [M-H]
-
 (calcd. for 469.3151).   
A solution (3.0 mg) of compound 41 in 1N HCl (1.5 mL) was stirred at 80 C for 4 h.  
After cooling, the solution was neutralized with NH4OH and partitioned between EtOAc (2 mL) 
and H2O (2 mL).  The aqueous layer after drying was dissolved in pyridine (0.3 mL) and 0.1 M 
L-cysteine methyl ester hydrochloride in pyridine (1.0 mL) was added.  The mixture was heated 
at 60 C for 1h and an equal volume of Ac2O was added and heated one more hour.  The 
acetylated thiazolidine derivatives were analyzed by GC using a capillary column DB-5 ms (30 
m x 0.25 mm x 0.25 µm).  Temperatures of injector and detector were 250 C for both.  A 
temperature gradient system was used starting at 100 C for 1 min and increasing to 250 C at a 
rate of 10 C/min.  D-glucose was identified by comparison of its retention time (tR 22.21 min) 
with that of authentic sample after being treated in the same manner.  
7.3. Results and discussion 
Structural elucidation of compounds 
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Compound 40 was obtained as a white powder, [α]D +11.3 (c 0.1, MeOH).  Its molecular 
formula C29H44O4 was deduced from the negative-ion high-resolution electrospray ionization 
mass spectrum (HR-ESI-TOF-MS), showing a pseudomolecular ion [M-H]
-
 at m/z 455.3186 
(calcd. for 455.3161), together with 
13
C NMR spectrum (29 carbon signals).  Its IR spectrum 
exhibited absorption bands due to free hydroxy (3357 cm
-1
), carbonyl groups (1650 cm
-1
).  The 
1
H NMR spectrum of 40 displayed five singlet resonances for tertiary methyl groups at δH 1.36, 
1.27, 1.06, 1.06, and 0.92, two singlets at δH 4.81 and 4.77 assigned to an exomethylene group, 
two oxymethine protons at δH 3.48 and 4.66, and an olefinic proton at δH 5.52 (brd) (shown in 
Table 7-1 and Figure 7-3).  The 
13
C NMR spectrum showed 29 carbon signals including five 
methyls, ten methylenes, six (two of which are oxygenated) methines, and eight quaternary 
carbons (shown in Figure 7-4 and 7-5).  The two signals at δ 122.3 and 144.4 ascribable to C-12 
and C-13 suggested a ∆12 oleanene skeleton (Mahato et al., 1994).  On the basis of the 1H-1H 
COSY (shown in Figure 7-6), HMQC (shown in Figure 7-7), DEPT ( shown in Figure 7-5) 
spectra, and molecular formula C29H44O4, compound 40 was suggested to be noroleanic acid type 
triterpene.  The 20(29)-exomethylene group was ascertained by long-range correlations between 
H-19α, β (δH = 2.75, 2.29) /C-20 (δC = 150.1), H-19α, β /C-29 (δC = 106.6), H-21α (δH = 2.60) /C-
20,29, H-29a, b (δH = 4.81, 4.77)/C-19 (δC = 42.3), H-29a, b /C-21 in the HMBC spectrum of 40 
(Figure 7-8).  The positions of the two hydroxy groups were established on the basis of the 
HMBC and nuclear overhauser effect spectroscopy (NOESY) experiments.  The HMBC 
spectrum of 40 (shown in Figure 7-8) showed correlations between the oxymethine proton at δH 
= 3.48 and the carbons C-4 (δC = 39.5), C-23 (δC = 28.9), and C-24 (δC = 16.7), conforming the 
location of one hydroxy group at C-3.  The 3β-OH equatorial orientation was established using 
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H-3 α coupling constant (Jtrans = 10.8 Hz) and the correlation observed in the NOESY spectrum 
(shown in Figure 7-9), between the two axial protons H-3α (δH = 3.48) and H-5 (δH = 0.89).  
Furthermore, the HMBC spectrum exhibited correlations between the second oxymethine proton 
at δH = 4.66 and the carbons C-17 (δC = 50.8), C-22 (δC = 33.9), and C-28 (δC = 183.0).  These 
data suggested the second hydroxy group to be located at C-16.  The NOESY spectrum displayed 
important correlations between the proton H-16 (δH = 4.66) and the methyl protons CH3-27 (δH = 
1.36), H-19 α (δH = 2.75), and H-21 α (δH = 2.60), suggesting α-axial orientation of the proton H-
16.  Therefore, the structure of compound 40 was established as 3β, 16β-dihydroxy-30-norolean-
12, 20(29)-dien-28-oic acid, for which the name pfaffine A was adopted. 
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Table 7-1. NMR Data of Compound 40 in Pyridine-d5 
No. 
1
H [δ (ppm), mult., 
J (Hz)] 
13
C 
[δ (ppm)] 
COSY HMBC 
 
1α 
1β 
1.02 (1H, m) 
1.57 (1H, m) 
39.0 H-2 
H-2 
 
2 1.82 (2H, m) 28.2 H-1α, β, 3  
3 3.48 (1H, dd, 10.8, 3.6) 78.1 H-2 C-4, 23, 24 
4  39.5   
5 0.89 (1H, brd, 10.8) 55.9 H-6α, 6β C-3, 4, 6, 7, 9, 10, 23, 24, 25 
6α 
6β 
1.60 (1H, m) 
1.39 (1H, m) 
18.9 H-5, 6β 
H-5, 6α 
 
C-5 
7α 
7β 
1.57 (1H) 
1.40 (1H) 
33.5  C-5, 8 
C-5 
8  39.8   
9 1.65 (1H, dd, 10.2, 7.2) 47.4 H-11 C-5, 8, 10, 11, 14, 25, 26 
10  37.4   
11 1.90 (1H, m) 23.9 H-9, 12 C-9 
12 5.52 (1H, brd) 122.3 H-11 C-9, 11, 14, 18 
13  144.4   
14  44.6   
15α 
15β 
1.81 (1H, m) 
2.44 (1H, t, 12.0) 
38.9 H-16, 15β 
H-16, 15α 
C-14, 16, 17, 27 
C-14, 16, 17, 27 
16 4.66 (1H, dd, 11.4, 4.2) 65.5 15α, β C-17, 22, 28 
17  50.8   
18 3.53 (1H, dd,13.8, 4.8) 50.3 H-19α, β C-12, 13, 14, 16, 17, 19, 28 
19α 
19β 
2.75 (1H, t, 13.8) 
2.29 (1H, dd  13.8, 4.8) 
42.3 H-18, 19β 
H-18, 19α 
C-17, 20, 29 
C-17, 20, 21, 29 
20  150.1   
21α 
21β 
2.60 (1H, brt, 13.8) 
2.28 (1H, brd, 16.2) 
30.7 H-21β, 22α, β 
H-21α, 22α, β 
C-20, 22, 29 
22α 
22β 
3.08 (1H, d 12.0) 
1.81 (1H, m) 
33.9 H-21α, β, 22β 
H-21α, β, 22α 
C-17, 20, 21 
C-17, 20 
23 1.27 (3H, s) 28.9  C-3, 4, 5 
24 1.06 (3H, s) 16.7  C-3, 4, 5 
25 0.92 (3H, s) 15.7  C-1, 5, 9, 10 
26 1.06 (3H, s) 17.8  C-7, 9, 14 
27 1.36 (3H, s) 27.0  C-8, 14, 15 
28  183.0   
29a 
29b 
4.81 (1H, s) 
4.77 (1H, s) 
106.6  C-19, 20, 21 
C-19, 20, 21 
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 Figure 7-2. Key HMBC and NOE correlations for compound 40. 
Green line indicates HMBC and red line shows NOE correlations 
 
 
Figure 7-3. 
1
H-NMR spectrum of compound 40 in pyridine-d5 
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Figure 7-4. 
13
C-NMR spectrum of compound 40 in pyridine-d5 
 
 
 
Figure 7-5. DEPT spectrum of compound 40 in pyridine-d5 
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Figure 7-6. 
1
H-
1
H COSY spectrum of compound 40 in pyridine-d5 
 
 
 
Figure 7-7. HSQC spectrum of compound 40 in pyridine-d5 
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Figure 7-8. HMBC spectrum of compound 40 in pyridine-d5 
 
 
 
Figure 7-9. ROESY spectrum of compound 40 in pyridine-d5 
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Compound 41 was obtained as a white powder, [α]D + 8.7 (c 0.46, MeOH).  The positive 
HR-ESI-MS of compound 41 gave an [M + Na]
+
 ion at m/z 625.37055 consistent with the 
pseudomolecular formula C35H54O8Na (calcd. for [M+Na]
+
 625.37109).  Compound 41 
displayed 35 carbon resonances in its 
13
C NMR spectrum (see Figure 7-11), of which 29 were 
assigned to a noroleanic acid type triterpene moiety and 6 to a monosaccharide portion.  For the 
aglycon portion, along with five methyl resonances (δC = 28.9, 26.1, 17.6, 16.6, 15.7), four sp
2
-
hybridized carbon signals (δC = 123.4, 143.5, 107.4, 148.6), and one signal for hydroxymethine 
group (δC = 78.7) could be observed (shown in Figure 7-12).  These data, when correlated with 
data from 
1
H NMR spectrum (shown in Figure 7-10) [five methyl singlets at δH = 1.26, 1.24, 
1.13, 1.05, 0.93, one olefinic proton at δH = 5.48, and one oxymethine at δH = 3.46], confirmed 
that the aglycon of 41 possessed a noroleanic acid type triterpene skeleton.  A detailed analysis 
of the NMR spectroscopic data (
1
H, 
13
C, HSQC, and H-H COSY) of the aglycon moiety of 41 in 
comparison with those of 40 showed that the difference of 41 from 40 is only for the absence of 
the secondary alcoholic function at C-16.  The 
1
H NMR spectrum for the sugar portion of 
compound 41 showed one anomeric proton signal at δH = 6.31 ( 1H, d, J=8.4 Hz).  The chemical 
shifts of all the individual protons and carbons of the sugar unit were assigned on the basis of 
COSY (see Figure 7-13) and HSQC (see Figure 7-14) spectral analysis.  The sugar unit, 
identified as β-glucopyranosyl which was deduced from its 3JH-1,H-2 coupling constant of 8.4 
(Woldemichael et al., 2001), was placed at C-28 of the aglycon on the basis of the HMBC 
correlation (shown in Figure 7-15) between the anomeric proton at δH = 6.31 and the C-28 
carbon resonance at δC = 175.8.  The configuration of the glucose unit was established as D after 
acid hydrolysis of 41 followed by derivatization and GC analysis (Hara et al., 1987) (see 
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Experimental section).  Thus the structure of compound 41 was deduced as 3β-hydroxy-30-
norolean-12,20(29)-dien-28-oic acid-28-O-β-D-glucoside based on the above evidence and was 
given the trivial name pfaffine B.  
 
Table 7-2. NMR Data of Compound 41 in Pridine-d5 
No. 
1
H [δ (ppm), 
mult., J (Hz)] 
13
C 
[δ 
(ppm)] 
HMBC COSY NOSEY 
1α 1.00 (1H, dt) 39.1  H-1β, 2 H-3 
1β 1.56 (1H, m)   H-1α  
2α 1.84 (1H, m) 28.3  H-1, 3 H-3 
2β 1.84 (1H, m)     
3 3.46 (1H, brd, 
7.2) 
78.2 H-23, 24 H-2 H-1α, 2α, 5, 23 
4  39.5 H-23, 24   
5 0.87 (1H, d, 
11.4) 
55.9 H-23, 24, 25 H-6β H-1α, 3, 23, 9, 6α, 7α 
6α 1.55(1H, m) 18.9 H-5 H-6β H-5, 23 
6β 1.37 (1H, m)   H-5, 6α H-26, 24, 25 
7α 1.50 (1H, brd 
14.4) 
33.2 H-26 H-7β H-5, 27, 9 
7β 1.37 (1H, m)   H-7α  
8  40.0 H-6α, 7β, 9, 26, 
27 
  
9 1.66 (1H, t, 8.7) 47.8 H-25, 26 H-11 H-1α, 5, 7α, 11, 27 
10  37.4 H-5, 9, 25   
11 1.92 (2H, m) 23.9 H-9 H-9, 12  
12 5.48 (1H, brd) 123.4 H-11, 18 H-11 H-11, 18, 19β 
13  143.5 H-11, 18, 27   
14  42.2 H-15β, 26, 27   
15α 1.22 (1H) 28.2 H-27 H-15β  
15β 2.38 (1H, dt)   H-15α, 16α H-26, 16β 
16α 2.20 (1H, dt) 23.7 H-18, 22β H-15β, 16α H-27 
16β 2.09 (1H, m)   H-16α H-15β 
17  47.4 H-18, 22β, 19β   
18 3.16 (1H, dd, 
13.8, 4.8) 
48.2  H-19α, β H-19β, 22β 
19α 2.63 (1H, t, 
13.8) 
41.8 H-18, 29α, β H-18, 19β H-27 
19β 2.23 (1H, m)   H-18, 19α H-12, 29α 
20  148.6 H-19α, 19β, 21β   
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21α 2.23 (1H, m) 30.2 H-19β, 22β, 29α, 
β 
H-21β, 22β  
21β 2.07 (1H, m)   H-21α  
22α 2.03 (1H, m) 37.7 H-21α, 16β H-22β  
22β 1.71 (1H, dt)   H-21α, 22α H-18 
23 1.26 (3H, s) 28.9 H-3, 5, 24  H-5, 24, 6α 
24 1.05 (3H, s) 16.6 H-3, 5, 23,  H-25, 23 
25 0.93 (3H, s) 15.7 H-5, 9  H-24, 26 
26 1.13 (3H, s) 17.6 H-9  H-24, 6β, 15β 
27 1.24 (3H, s) 26.1 H-15β  H-9, 7α, 16α, 19α 
28  175.8 H-18, 22β, 1′   
29a 4.78 (1H, s) 107.4 H-19α, 21α  H-19β 
29b 4.71 (1H, s)    H-21β, α 
1′ 6.31 (1H, d, 
8.4) 
95.9 H-2′ H-2′ H-5′, 3′ 
2′ 4.21 (1H, t, 8.4) 74.2  H-1′, 3′ H-4′ 
3′ 4.29 (1H, t, 9.0) 78.9 H-2′ H-2′, 4′ H-1′, 5′ 
4′ 4.35 (1H, t, 9.0) 71.2  H-3′, 5′ H-2′ 
5′ 4.03 (1H, brd, 
9.0) 
79.4  H-4′, 6′ α, 
β 
H-1′, 3′, 6′ α, β 
6′α 4.40 (1H, dd, 
11.4, 3.6) 
62.4  H-5′, 6′ β H-5′ 
6′β 4.47 (1H, brd, 
10.2) 
  H-5′, 6′ β H-5′ 
3-OH 5.75  C-2, 3, 4   
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Figure 7-10. 
1
H-NMR spectrum of compound 41 in pyridine-d5 
 
 
Figure 7-11. 
13
C-NMR spectrum of compound 41 in pyridine-d5 
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Figure 7-12. DEPT spectrum of compound 41 in pyridine-d5 
 
 
 
Figure 7-13. 
1
H-
1
H COSY spectrum of compound 41 in pyridine-d5 
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Figure 7-14. HSQC spectrum of compound 41 in pyridine-d5 
 
 
Figure 7-15. HMBC spectrum of compound 41 in pyridine-d5 
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Figure 7-16. ROESY spectrum of compound 41 in pyridine-d5 
 
Compound 42 was obtained as a yellow powder.  Its molecular formula was determined 
to be C29H30O12 by the negative-ion HRMS, showing a pseudomolecular ion [M-H]
-
 at m/z 
469.3183 (calcd. for 469.3151).  The IR spectrum exhibited absorption bands due to free 
hydroxy (3284 cm
-1
), carbonyl groups (1672 cm
-1
), and aromatic ring system (1602 cm
-1
).  The 
characteristic UV absorption at λ 275 and 380 nm suggested the existence of a α，β-unsaturated 
α-pyrone ring (Scott, 1964).  The 1H and 13C NMR spectra (see Figure 7-18 and 7-19) exhibited 
two sets of signals in a ratio of ca 3:2, indicating that compound 42 is a mixture of two 
components.  Further purification using preparative RP-HPLC resulted in obtaining two 
compounds. On the re-examination of each elute after removal of the solvent, two peaks were 
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again detected.  These results suggested that compound 42 is consisted of two interchangeable 
isomers (shown in Figure 7-17).  Two sets of AB olefinic signals at 6.58 (1H, d, J=16.2 Hz)/7.29 
(1H, d, J=16.2 Hz) (major) and 5.92 (1H, d, J=12.3 Hz)/6.68 (1H, d, J=12.3 Hz) (minor) were 
assigned to trans and cis double bonds, indicating that compound 42 was a mixture of trans and 
cis isomers.  Two p-substituted phenyl groups were suggested for each component by four sets of 
A2B2 quartets in 
1
H NMR spectrum, e.g. 7.34 (1H, d, J=9.0 Hz)/6.64 (1H, d, J=9.0 Hz) and 7.25 
(1H, d, J=9.0 Hz)/6.64 (1H, d, J=9.0 Hz) for the major component, and 7.25 (1H, d, J=8.4 
Hz)/6.68 (1H, d, J=8.4 Hz) and 7.22 (1H, d, J=8.4 Hz)/6.63 (1H, d, J=8.4 Hz) for the minor one.  
A CH3OOCCH2CH- unit for each component was deduced from the correlation of H-9 at δH = 
4.80/4.77 ppm (major/minor) and H2-10 at δH = 3.25/3.20 ppm (major/minor) in COSY spectrum 
(see Figure 7-20), and the HMBC (see Figure 7-22) correlations of C-11 at δC = 175.14/175.05 
ppm (major/minor) with H-10 and methyl protons at δH = 3.60/3.59 ppm (major/minor).  A 
glucose moiety was readily identified by the 
1
H and 
13
C NMR data listed in Table 7-3 and 7-4.  
The β-configuration of this glucose was determined by the large coupling constant (J=7.8 Hz) of 
the anomeric proton and the chemical shift of the anomeric carbon at δC = 100.98/101.26 ppm 
(major/minor).  There are five pairs of carbon at δC = 165.83/165.72 (C-2), 109.85/110.83 (C-3), 
166.92/166.25 (C-4), 98.82/100.12 (C-5), 160.97/160.44 (C-6) ppm (major/minor) and one pair 
of proton at δH = 6.47/6.58 (H-5) (major/minor) remained in the carbon and proton NMR 
respectively.  These signals and the HMBC correlations between H-5 and C-3,4,6 suggested a 
tri-substituted pyran-2-one unit. The HMBC correlations (shown in Figure 7-23) of H-9/C-2,3,5 
and H-7/C-5,6 confirmed the pyran-2-one ring and established the connections of C-9 to C-3 and 
C-7 to C-6.  The HMBC correlations of H-9/C-1′′,2′′,6′′ and H-2′′,6′′/C-9 indicated C-1′′ of one 
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of the phenyls connected to C-9.  The connection of another phenyl group to C-8 was established 
by the HMBC correlations of H-8/C1′,2′,6′ and H-2′,6′/C-8.  The glucose moiety was determined 
to connect to C-5 by the HMBC correlation of the anomeric proton and C-5.  The 
1
H and 
13
C 
NMR data of compound 42a are similar to those of compound 54 which was firstly reported 
from P. iresinoides (Shiobara et al, 1992), except that of the carboxylic group in 54 was 
esterified by a methyl group in 42a (see Table 7-3 and 7-4).  Thus, the structure of compound 42 
was determined as depicted.  The absolute configuration of C-9 needs to be determined. 
 
Figure 7-17. Z-E isomerization of compound 42 in aqueous MeOH
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Figure 7-18. 
1
H-NMR spectrum of compound 42 in MeOH-d4 
 
 
Figure 7-19. 
13
C-NMR spectrum of compound 42 in MeOH-d4 
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Figure 7-20. 
1
H-
1
H COSY spectrum of compound 42 in MeOH-d4 
 
 
Figure 7-21. HSQC spectrum of compound 42 in MeOH-d4 
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Figure 7-22. HMBC spectrum of compound 42 in MeOH-d4 
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Figure 7-23. Key HMBC correlations of compound 42a 
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Table 7-3. 
1
H-NMR Data of Compound 42a and 42b [δ (ppm), mult., J (Hz)] 
No. compound 42a compound 42b compound 54 
4 6.47 (1H, s) 6.58 (1H, s) 6.51 (1H, s) 
7 6.59 (1H, d, 16.2) 5.93 (1H, d, 12.3) 6.66 (1H, d, 16.2) 
8 7.31 (1H, d, 16.2) 6.76 (1H, d, 12.3) 7.29 (1H, d, 16.2) 
9 4.80 (1H, m) 4.77 (1H, m) 4.84 (1H, m) 
10 3.25 (2H, m) 3.20 (2H, m) 3.00 (2H, brd, 7.8) 
11-Me 3.60 (3H, s) 3.59 (1H, s)  
2′, 6′ 7.34 (1H, d, 9.0 for each) 7.25 (1H, d, 8.4 for each) 7.41 (1H, d, 9.0 for each) 
3′, 5′ 6.69 (1H, d, 9.0 for each) 6.68 (1H, d, 8.4 for each) 6.78 (1H, d, 9.0 for each) 
2′′, 6′′ 7.25 (1H, d, 9.0 for each) 7.22 (1H, d, 8.4 for each) 7.28 (1H, d, 9.0 for each) 
3′′, 5′′ 6.64 (1H, d, 9.0 for each) 6.63 (1H, d, 8.4 for each) 6.64 (1H, d, 9.0 for each) 
Glc-1 5.11 (1H, d, 7.8) 4.80 (1H, d, 7.8) 5.01 (1H, d, 7.8) 
Glc-2 3.54 (1H, m) 3.48 (1H, m) 3.63 (1H, t, 8.4) 
Glc-3 3.45 (1H, m) 3.45 (1H, m) 3.51 (1H, t, 9.0) 
Glc-4 3.35 (1H, m) 3.35 (1H, m) 3.40 (1H, t, 9.0) 
Glc-5 3.51 (1H, m) 3.51 (1H, m) 3.54 (1H, m) 
Glc-6 3.69 (1H, dd, 12.0, 6.3) 
3.92 (1H, dd, 12.0, 2.1) 
3.69 (1H, dd, 12.0, 6.3) 
3.92 (1H, dd, 12.0, 2.1) 
3.69 (1H, dd, 12.3, 6.3) 
3.93 (1H, dd, 12.3, 2.1) 
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Table 7-4. 
13
C-NMR Data of Compound 42a and 42b [δ (ppm)] 
No. compound 42a compound 42b compound 54 
2 165.83 165.72 166.6 
3 109.85 110.83 110.6 
4 98.28 100.12 99.4 
5 166.92 166.25 166.6 
6 160.97 160.44 159.9 
7 115.46 118.36 117.5 
8 137.3 139.6 138.1 
9 37.04 37.01 39.0 
10 37.28 37.14 41.9 
11 175.14 175.05 181.1 
11-Me 52.15 52.13  
1′ 126.1* 126.2* 128.6 
2′, 6′ 130.48 132.10 130.4 
3′, 5′ 118.18 117.66 116.9 
4′ 164.4* 162.8* 160.4 
1′′ 133.91 133.68 135.7 
2′′, 6′′ 129.97 130.00 130.3 
3′′, 5′′ 115.84 115.85 115.8 
4′′ 157.05 157.10 156.6 
Glc-1 100.98 101.26 101.6 
2 74.71 74.64 74.8 
3 78.20 78.22 78.2 
4 71.22 70.69 71.4 
5 78.62 78.30 78.7 
6 62.48 61.87 62.7 
*: Signals exchangeable 
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The behavior of compound 42 on HPLC can be explained by a trans-cis isomerization to 
afford a equilibrium of mixture in aqueous MeOH, by which a similar reaction was reported to 
occur for yangonin , that is, 6-(p-methoxystyryl)-4-methoxy-2-pyrone (Smith et al, 1984).  In the 
present study, compound 54 was purified as a single E-isomer using preparative normal-phase 
TLC and organic solvents.  Since compound 42 and several related compounds were not 
resolved on normal-phase TLC, the fraction containing compound 42 and others was then 
subjected to HPLC separation using a Phenomenex prodigy 5μ ODS column and gradient elution 
of methanol-water.  The peak at tR=7.2 min was collected and when examined by HPLC this 
peak gave two peaks.  Attempts to obtain the individual compounds were unsuccessful because 
each compound apparently re-equilibrated to give the mixture after separation was carried out 
again.  In order to confirm the proposed isomerization behavior of compound 42 NMR 
techniques were applied.  Compound 54 was prepared in MeOH-d4 for NMR analysis.  After one 
day standing in daylight the compound was stable and the NMR spectrum kept the same (shown 
in Figure 7-24).  When one drop of deuterium oxide was added into the solution, two sets of 
signals were detected after 20 min.  The signals at δH = 6.76 and 5.93 ppm (J=12.3) 
corresponding to a cis-double bond became more and more intense with the time increased.  
After 20 hrs two sets of signals were at the ratio of ca. 1:1.  Therefore, it can be concluded that 
trans-cis isomerization occurred in aqueous solution but in organic solvents such as chloroform 
and methanol virtually no change occurred.  
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MeOH, 1d  
 
 
MeOH+D2O, 20min 
 
 
MeOH+D2O, 2h 
 
 
MeOH+D2O, 20h 
 
Figure 7-24. Z-E isomerization test of compound 54 in aqueous MeOH  
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7.4. Conclusion  
In the present study, four types of compounds, including seven triterpenoids, four 
steroids, one monoterpenoid, two pigments and vanillic acid, have been isolated from the roots 
of P. paniculata.  The compounds reported herein will be served as markers for quantification of 
raw material as well as preparations claiming to contain P. paniculata.  Also, efforts have been 
made to investigate the isomerization of pigments. 
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Chapter 8 
Concluding Remarks 
American skullcap has been used more than three decades for its reputed tonic, 
tranquilizing, and antispasmodic remedies.  Currently it is one of the most popular botanicals 
with many products on the USA market.  The hepatotoxic reactions have been reported after 
skullcap-containing preparations were ingested.  Meanwhile, it was reported to be adulterated 
with germander, e.g. Teucrium chamaedry, and T. canadense, which is a group of plants with 
hepatotoxicity.  Due to the lack of stringent regulations from FDA there is a paucity of scientific 
evidence to evaluate the safety, quality, and efficacy of these products.  Therefore, safety, 
efficacy, and quality control of the products claiming to contain this species are of major 
concern.  Among them control quality of skullcap products presents a formidable analytical 
challenge in view of lack of information about the authenticity of raw materials, complexity of 
the constituents in the plant materials, and unavailability of qualified reference standards.  In this 
dissertation, investigation of the chemical constituents, development of analytical method for 
quality control, and evaluation of biological activities of the raw materials as well as the 
compounds isolated from it have been carried out.  
8.1. Contributions of this dissertation 
Chromatographic separation of the MeOH extract of the aerial parts of American skullcap 
resulted in the isolation of sixteen compounds, including three minor coumarins of which two are 
new compounds, six flavonoids, four triterpenes, two steroids, and one fatty acid.  The structures 
of all the compounds were elucidated via spectroscopic (NMR, UV, and FT-IR) and 
spectrometric (HRESI-MS) methods.  The absolute configuration of two new coumarins was 
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determined by comparison of the experimental and theoretical calculated CD spectra.  As a part 
of our efforts in phytochemical study HPLC-DAD/ESI-MS
n
 method has been developed to 
characterize thirteen flavonoids and one stilbene derivative without time-consuming isolation of 
compounds.  The ESI-MS
n
 fragmentation pathways of four types of flavonoid standards have 
been examined and analyzed.  These fragmentation patterns provide very useful guides for the 
characterization of different types of flavonoids.  Based on the results we obtained it can be 
concluded that flavonoids are the major constituents in the American skullcap, some of which 
are also reported from other species in this genus, such as S. baicalensis.  In order to compare 
and obtain more marker compounds, the chemical components of S. baicalensis, which is the 
most often used herb medicine in this genus, were also studied and seventeen flavonoids have 
been isolated. 
Using eleven major flavonoids isolated from S. baicalensis as well as S. lateriflora as 
chemical markers a simple HPLC-PDA fingerprinting method has been established.  In present 
study, two phenylpropanoids, verbascoside and teucrioside, and one diterpene, teucrin A isolated 
from T. canadense were also used as markers to provide comparative analysis.  The results 
indicated that this method can be applied to authenticate S. lateriflora, to distinguish it from its 
potential adulterants, to compare the chemical profiles of different species in this genus, and to 
assess the quality of the products claiming to contain S. lateriflora.  Since the UV patterns are 
different and specific for each type of compounds investigated, analysis of UV spectra of the 
known markers and relevant peaks in samples is quite valuable for the identification of each 
peak.  
Another major contribution of this dissertation is to put the two skullcap extracts and 
 167 
thirteen flavonoids isolated from them into one study to evaluate their bioactivities on a panel of 
bioassay.  Neither extracts of SBE and SLE nor pure compounds tested showed cytotoxicity 
against a panel of mammalian normal and solid tumor cell lines at the highest test concentrations, 
suggesting that the reports of hepatotoxic reactions on American skullcap might not due to 
skullcap itself but its adulterant germander.  Significant antioxidant activity was observed for 
both skullcap extracts as well as their components, such as baicalein, baicalin, wogonin, 
quercetin, rutin, and hesperidin.  The antioxidant activity of American skullcap was first 
observed in present study and it is stronger than Chinese skullcap.  Naringenin and daidzein 
showed strong estrogenic effects in the YES assay.  Moderate anti-inflammatoy activity was 
observed with wogonin and chrysin on NF-κB mediated transcription test.  The most significant 
finding was the identification of PPARs activation of skullcap extracts as well as their 
characteristic components, including baicalein, baicalin, wogonin, and chrysin, etc.  Results of 
our study provide useful information on possible new application of skullcap, especially 
American skullcap, for the treatment of diabetic-related diseases.  In addition, the capability of 
pure flavonoids on PPARs suggests their potential to become leads of PPARα and PPARγ 
agonists.  
Pfaffia paniculata is another species studied in this dissertation.  It is the most employed 
species in commercial preparations in Brazil as “Brazilian ginseng” and has been commonly 
used for three centuries as the same indications as American and Asian ginseng.  However, all 
these so-called ginsengs belong to different species even different family.  More than fifty 
preparations which contain or are produced from P. paniculata are available on USA market, but 
no analytical method existed to identify P. paniculata raw materials, and its products.  As a final 
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remark we investigated the chemical components of P. paniculata and obtained four types of 
compounds, including seven triterpenoids, four steroids, one monoterpenoid, two yellow 
compounds and vanillic acid, among which two triterpenoids pfaffine A and B, and one yellow 
compound pfaffine C are new.  All fourteen compounds except ecdysone are reported for the 
first time from this plant.  The compounds reported herein will be served as markers for 
quantification of raw material as well as preparations claiming to contain P. paniculata.  From 
the NMR-based stability study of pigment iresinoside A, it can be concluded that trans-cis 
isomerization of this type of compound occurred in aqueous solution but in organic solvents such 
as chloroform and methanol virtually no change occurred.  
8.2. Future work 
The characteristic components isolated from both of skullcap species, including baicalein, 
baicalin, wogonin, and chrysin, etc. showed significant PPARs activation effect.  The mechanism 
of action will be studied using isolated individual compounds.  Meanwhile, structure–activity 
relationships of potential PPARα and PPARγ agonists screened in this study will be carried out 
using molecular modeling.  The evaluation of structure–activity relationships would help in 
identifying the key structural features of the ligand molecules for activation of each subtype of 
the PPAR, which in turn, will assist us in design and discovery of more safe and effective 
agonists.  
NMR-based metabolomics analysis has been applied to a wide array of fields, such as on 
the identification of disease biomarkers and investigation of microbial fermentation processes 
and biotransformations, etc. Studying plant metabolomics is particularly challenging due to the 
occurrence of substantially more and complex compounds compared with animals and 
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microorganisms and still in its infancy.  Some pioneer applications to plant metabolomics 
analysis have been presented recently, mostly concentrating on the impact of environmental 
factors on plants.  We will try to use NMR-based metabolomics analysis to differentiate 
American skullcap from its potential adulterant and to assess the quality of its products.  This 
method may complement the HPLC-PDA fingerprint method discussed in this dissertation from 
different points of view. 
In order to evaluate and control the quality of the products produced from P. paniculata 
quantitative analysis method will be set up.  Primary analysis result indicated that the content of 
ecdysones in P. paniculata is overwhelming.  HPLC-PDA or HPLC-MS method will be applied 
to quantitatively analyze ecdysones using ecdysone and 20-hydroxyecdysone obtained in this 
dissertation as markers. 
8.3. Related publications 
The publications listed below are direct consequence of the evolution of this dissertation during 
my Ph. D. program. 
[1] Li, J.; Wang, Y.H.; Smillie,
 
T.; Khan, I.A. Identification of Phenolic Compounds in 
Scutellaria lateriflora Using High-Performance Liquid Chromatography-Electrospray Tandem 
Mass Spectrometry-Ultraviolet Photodiode Array. in preparation 
[2] Li, J.; Wang, Y.H.; Khan, I.A. Chemical Fingerprint Analysis of Scutellaria Species, 
Germander and Dietary Supplements Claiming to Contain Skullcap Using HPLC-PDA. in 
preparation. 
[3] Li, J.; Jadhav, A.N.; Khan, I.A. Triterpenoids from Brazilian Ginseng, Pfaffia paniculata. 
Planta Medica 2010, 76, 635-639.  
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T.; Khan, I.A. Scuteflorins A and 
B, Dihydropyranocoumarins from Scutellaria lateriflora J. Nat. Prod. 2009, 72(6), 983-987. 
[5] Li, J.; Jadhav, A.N.; Khan, I.A. New Terpenoids from Pfaffia paniculata Kuntze. Planta 
Medica 2009, 75(4), 424-425. 
[6] Li, J.; Khan, I.A. Chemical Investigation of Scutellaria lateriflora L. Planta Medica 2008, 
74(3), 355. 
[7] Li, J.; Khan, I.A. The Advanced Bioactivity Studies of Scutellaria baicalensis Georgi and Its 
Phenolic Compounds Acta Horticulturae 2006, 720, 157-169. 
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